WO2012027287A1 - Nutritional products including pea protein hydrolysates - Google Patents
Nutritional products including pea protein hydrolysates Download PDFInfo
- Publication number
- WO2012027287A1 WO2012027287A1 PCT/US2011/048665 US2011048665W WO2012027287A1 WO 2012027287 A1 WO2012027287 A1 WO 2012027287A1 US 2011048665 W US2011048665 W US 2011048665W WO 2012027287 A1 WO2012027287 A1 WO 2012027287A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nutritional
- protein
- pea protein
- needed
- pea
- Prior art date
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 277
- 108010084695 Pea Proteins Proteins 0.000 title claims abstract description 138
- 235000019702 pea protein Nutrition 0.000 title claims abstract description 138
- 239000003531 protein hydrolysate Substances 0.000 title claims abstract description 114
- 235000018102 proteins Nutrition 0.000 claims abstract description 113
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 113
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 113
- 239000000047 product Substances 0.000 claims description 156
- 235000013350 formula milk Nutrition 0.000 claims description 56
- 150000001720 carbohydrates Chemical class 0.000 claims description 41
- 235000014633 carbohydrates Nutrition 0.000 claims description 41
- 238000006460 hydrolysis reaction Methods 0.000 claims description 38
- 230000007062 hydrolysis Effects 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 28
- 230000000774 hypoallergenic effect Effects 0.000 claims description 23
- 235000020256 human milk Nutrition 0.000 claims description 17
- 210000004251 human milk Anatomy 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 235000019640 taste Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 abstract description 96
- 239000000843 powder Substances 0.000 abstract description 48
- 108010073771 Soybean Proteins Proteins 0.000 abstract description 41
- 229940001941 soy protein Drugs 0.000 abstract description 40
- 108010011756 Milk Proteins Proteins 0.000 abstract description 32
- 102000014171 Milk Proteins Human genes 0.000 abstract description 31
- 235000020247 cow milk Nutrition 0.000 abstract description 31
- 208000010668 atopic eczema Diseases 0.000 abstract description 24
- 230000000172 allergic effect Effects 0.000 abstract description 19
- 235000013305 food Nutrition 0.000 abstract description 13
- 206010025476 Malabsorption Diseases 0.000 abstract description 6
- 208000004155 Malabsorption Syndromes Diseases 0.000 abstract description 6
- 201000006549 dyspepsia Diseases 0.000 abstract description 6
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 description 67
- 239000000203 mixture Substances 0.000 description 63
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 48
- 239000000839 emulsion Substances 0.000 description 47
- 239000002002 slurry Substances 0.000 description 45
- 239000003921 oil Substances 0.000 description 43
- 235000019198 oils Nutrition 0.000 description 42
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 42
- 239000003925 fat Substances 0.000 description 38
- 235000019197 fats Nutrition 0.000 description 37
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 34
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 30
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 30
- 239000000427 antigen Substances 0.000 description 25
- 108091007433 antigens Proteins 0.000 description 25
- 102000036639 antigens Human genes 0.000 description 25
- 235000010323 ascorbic acid Nutrition 0.000 description 24
- 239000011668 ascorbic acid Substances 0.000 description 24
- 229960005070 ascorbic acid Drugs 0.000 description 24
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 22
- 239000001508 potassium citrate Substances 0.000 description 22
- 229960002635 potassium citrate Drugs 0.000 description 22
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 22
- 235000011082 potassium citrates Nutrition 0.000 description 22
- 235000013361 beverage Nutrition 0.000 description 21
- 239000000796 flavoring agent Substances 0.000 description 21
- 235000019634 flavors Nutrition 0.000 description 21
- 240000004713 Pisum sativum Species 0.000 description 20
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 20
- 239000007787 solid Substances 0.000 description 20
- 235000010582 Pisum sativum Nutrition 0.000 description 19
- 229940088594 vitamin Drugs 0.000 description 19
- 229930003231 vitamin Natural products 0.000 description 19
- 235000013343 vitamin Nutrition 0.000 description 19
- 239000011782 vitamin Substances 0.000 description 19
- 229930006000 Sucrose Natural products 0.000 description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 239000011790 ferrous sulphate Substances 0.000 description 18
- 235000003891 ferrous sulphate Nutrition 0.000 description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 18
- 229910052500 inorganic mineral Inorganic materials 0.000 description 18
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 18
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 18
- 239000011707 mineral Substances 0.000 description 18
- 239000005720 sucrose Substances 0.000 description 18
- 240000008042 Zea mays Species 0.000 description 17
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 17
- 235000005822 corn Nutrition 0.000 description 17
- 235000010755 mineral Nutrition 0.000 description 17
- 239000011780 sodium chloride Substances 0.000 description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 235000010469 Glycine max Nutrition 0.000 description 16
- 235000019742 Vitamins premix Nutrition 0.000 description 15
- 229910001629 magnesium chloride Inorganic materials 0.000 description 15
- 239000001103 potassium chloride Substances 0.000 description 15
- 235000011164 potassium chloride Nutrition 0.000 description 15
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 14
- 235000019743 Choline chloride Nutrition 0.000 description 14
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 14
- 229960003178 choline chloride Drugs 0.000 description 14
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 14
- 239000003240 coconut oil Substances 0.000 description 14
- 235000019864 coconut oil Nutrition 0.000 description 14
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 14
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 14
- 230000035764 nutrition Effects 0.000 description 13
- 239000007921 spray Substances 0.000 description 13
- 235000020357 syrup Nutrition 0.000 description 13
- 239000006188 syrup Substances 0.000 description 13
- 235000019485 Safflower oil Nutrition 0.000 description 12
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 12
- 239000001506 calcium phosphate Substances 0.000 description 12
- 235000008504 concentrate Nutrition 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 12
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 12
- 235000005713 safflower oil Nutrition 0.000 description 12
- 239000003813 safflower oil Substances 0.000 description 12
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 12
- 150000003722 vitamin derivatives Chemical class 0.000 description 12
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 11
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- 235000019192 riboflavin Nutrition 0.000 description 11
- 239000002151 riboflavin Substances 0.000 description 11
- 229960002477 riboflavin Drugs 0.000 description 11
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 229920002774 Maltodextrin Polymers 0.000 description 10
- 239000005913 Maltodextrin Substances 0.000 description 10
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 10
- 239000000413 hydrolysate Substances 0.000 description 10
- 229940035034 maltodextrin Drugs 0.000 description 10
- 229940099596 manganese sulfate Drugs 0.000 description 10
- 239000011702 manganese sulphate Substances 0.000 description 10
- 235000007079 manganese sulphate Nutrition 0.000 description 10
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 10
- 229940108325 retinyl palmitate Drugs 0.000 description 10
- 235000019172 retinyl palmitate Nutrition 0.000 description 10
- 239000011769 retinyl palmitate Substances 0.000 description 10
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 10
- 235000019731 tricalcium phosphate Nutrition 0.000 description 10
- 229940078499 tricalcium phosphate Drugs 0.000 description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 9
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 9
- 229960000304 folic acid Drugs 0.000 description 9
- 235000019152 folic acid Nutrition 0.000 description 9
- 239000011724 folic acid Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000001509 sodium citrate Substances 0.000 description 9
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 8
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 8
- 229960002685 biotin Drugs 0.000 description 8
- 235000020958 biotin Nutrition 0.000 description 8
- 239000011616 biotin Substances 0.000 description 8
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 8
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 150000002515 isoflavone derivatives Chemical class 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 8
- 229960003966 nicotinamide Drugs 0.000 description 8
- 235000005152 nicotinamide Nutrition 0.000 description 8
- 239000011570 nicotinamide Substances 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 239000011655 sodium selenate Substances 0.000 description 8
- 235000018716 sodium selenate Nutrition 0.000 description 8
- 229960001881 sodium selenate Drugs 0.000 description 8
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 8
- 229960001763 zinc sulfate Drugs 0.000 description 8
- 229910000368 zinc sulfate Inorganic materials 0.000 description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 7
- 108010009736 Protein Hydrolysates Proteins 0.000 description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 7
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 7
- 229940114079 arachidonic acid Drugs 0.000 description 7
- 235000021342 arachidonic acid Nutrition 0.000 description 7
- 235000013734 beta-carotene Nutrition 0.000 description 7
- 239000011648 beta-carotene Substances 0.000 description 7
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 7
- 229960002747 betacarotene Drugs 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 229960002104 cyanocobalamin Drugs 0.000 description 7
- 235000000639 cyanocobalamin Nutrition 0.000 description 7
- 239000011666 cyanocobalamin Substances 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 7
- 235000019797 dipotassium phosphate Nutrition 0.000 description 7
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 230000001900 immune effect Effects 0.000 description 7
- 229960000367 inositol Drugs 0.000 description 7
- 239000000787 lecithin Substances 0.000 description 7
- 229940067606 lecithin Drugs 0.000 description 7
- 235000010445 lecithin Nutrition 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 7
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 7
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 7
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 7
- 230000009257 reactivity Effects 0.000 description 7
- 235000019155 vitamin A Nutrition 0.000 description 7
- 239000011719 vitamin A Substances 0.000 description 7
- 229940045997 vitamin a Drugs 0.000 description 7
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 7
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 6
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical class OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 6
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 6
- 229930195722 L-methionine Natural products 0.000 description 6
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 6
- 229960002079 calcium pantothenate Drugs 0.000 description 6
- 229940078495 calcium phosphate dibasic Drugs 0.000 description 6
- 239000000828 canola oil Substances 0.000 description 6
- 235000019519 canola oil Nutrition 0.000 description 6
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 6
- 229910000365 copper sulfate Inorganic materials 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 210000000987 immune system Anatomy 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 229960004452 methionine Drugs 0.000 description 6
- 235000006180 nutrition needs Nutrition 0.000 description 6
- 235000019175 phylloquinone Nutrition 0.000 description 6
- 239000011772 phylloquinone Substances 0.000 description 6
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 6
- 235000002949 phytic acid Nutrition 0.000 description 6
- 229960001898 phytomenadione Drugs 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229960003975 potassium Drugs 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 230000000153 supplemental effect Effects 0.000 description 6
- 229960003080 taurine Drugs 0.000 description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 6
- 235000005282 vitamin D3 Nutrition 0.000 description 6
- 239000011647 vitamin D3 Substances 0.000 description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 6
- 229940021056 vitamin d3 Drugs 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 238000004977 Hueckel calculation Methods 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 108010046377 Whey Proteins Proteins 0.000 description 5
- 238000013019 agitation Methods 0.000 description 5
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 235000021466 carotenoid Nutrition 0.000 description 5
- 150000001747 carotenoids Chemical class 0.000 description 5
- 235000010418 carrageenan Nutrition 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 5
- 229920001525 carrageenan Polymers 0.000 description 5
- 229940113118 carrageenan Drugs 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 5
- 235000011888 snacks Nutrition 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- 102000011632 Caseins Human genes 0.000 description 4
- 241000199912 Crypthecodinium cohnii Species 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 4
- 108010059378 Endopeptidases Proteins 0.000 description 4
- 102000005593 Endopeptidases Human genes 0.000 description 4
- 208000004262 Food Hypersensitivity Diseases 0.000 description 4
- 206010017943 Gastrointestinal conditions Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 4
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229920000881 Modified starch Polymers 0.000 description 4
- 241000544198 Muscisaxicola alpinus Species 0.000 description 4
- 239000006057 Non-nutritive feed additive Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 4
- PDWGIAAFQACISG-QZBWVFMZSA-N beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)OC[C@@H]1[C@@H]([C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O1)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O PDWGIAAFQACISG-QZBWVFMZSA-N 0.000 description 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 4
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 4
- 239000001354 calcium citrate Substances 0.000 description 4
- 235000014510 cooky Nutrition 0.000 description 4
- 235000005687 corn oil Nutrition 0.000 description 4
- 239000002285 corn oil Substances 0.000 description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 description 4
- 235000013861 fat-free Nutrition 0.000 description 4
- 230000009969 flowable effect Effects 0.000 description 4
- 235000020932 food allergy Nutrition 0.000 description 4
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 4
- 239000004137 magnesium phosphate Substances 0.000 description 4
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 4
- 229960002261 magnesium phosphate Drugs 0.000 description 4
- 235000010994 magnesium phosphates Nutrition 0.000 description 4
- 235000021239 milk protein Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000004252 protein component Nutrition 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 239000011684 sodium molybdate Substances 0.000 description 4
- 235000015393 sodium molybdate Nutrition 0.000 description 4
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 150000005846 sugar alcohols Chemical class 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- 125000002640 tocopherol group Chemical class 0.000 description 4
- 235000019149 tocopherols Nutrition 0.000 description 4
- 235000020209 toddler milk formula Nutrition 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 235000013337 tricalcium citrate Nutrition 0.000 description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
- 229960004441 tyrosine Drugs 0.000 description 4
- 235000021119 whey protein Nutrition 0.000 description 4
- 108010006303 Carboxypeptidases Proteins 0.000 description 3
- 102000005367 Carboxypeptidases Human genes 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 240000007154 Coffea arabica Species 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 3
- 102000018389 Exopeptidases Human genes 0.000 description 3
- 108010091443 Exopeptidases Proteins 0.000 description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 240000003183 Manihot esculenta Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- HHGZUQPEIHGQST-UHFFFAOYSA-N [2-[(2-azaniumyl-2-carboxyethyl)disulfanyl]-1-carboxyethyl]azanium;dichloride Chemical compound Cl.Cl.OC(=O)C(N)CSSCC(N)C(O)=O HHGZUQPEIHGQST-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000008122 artificial sweetener Substances 0.000 description 3
- 235000021311 artificial sweeteners Nutrition 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000008429 bread Nutrition 0.000 description 3
- 235000014171 carbonated beverage Nutrition 0.000 description 3
- 108010079058 casein hydrolysate Proteins 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000012628 flowing agent Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000012680 lutein Nutrition 0.000 description 3
- 229960005375 lutein Drugs 0.000 description 3
- 239000001656 lutein Substances 0.000 description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 3
- 235000021073 macronutrients Nutrition 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 3
- 229940057917 medium chain triglycerides Drugs 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 235000011496 sports drink Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- XZKUCJJNNDINKX-HGLHLWFZSA-N (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4s)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy]oxane-3,4,5-triol;hydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 XZKUCJJNNDINKX-HGLHLWFZSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- 108010075409 Alanine carboxypeptidase Proteins 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 108090000087 Carboxypeptidase B Proteins 0.000 description 2
- 102100035024 Carboxypeptidase B Human genes 0.000 description 2
- 108090000018 Carboxypeptidase D Proteins 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- 229920002245 Dextrose equivalent Polymers 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 108010048963 Glutamate carboxypeptidase Proteins 0.000 description 2
- 108010051815 Glutamyl endopeptidase Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004395 L-leucine Substances 0.000 description 2
- 235000019454 L-leucine Nutrition 0.000 description 2
- 108030007165 Leucyl endopeptidases Proteins 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 102100033320 Lysosomal Pro-X carboxypeptidase Human genes 0.000 description 2
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 2
- GKEWHGPIQCSUCC-JJGOEJEFSA-N Monofucosyllacto-N-hexaose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)C[C@@H](OO[C@@H]2[C@@H]([C@H](O[C@H]3[C@@H](C(O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)NC(C)=O)[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O2)O)[C@@H]1NC(C)=O GKEWHGPIQCSUCC-JJGOEJEFSA-N 0.000 description 2
- SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 102000056251 Prolyl Oligopeptidases Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 108010092515 glycyl endopeptidase Proteins 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 235000020215 hypoallergenic milk formula Nutrition 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- -1 isolmalt Chemical compound 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 108010057284 lysosomal Pro-X carboxypeptidase Proteins 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 229940060155 neuac Drugs 0.000 description 2
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 235000015927 pasta Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000003075 phytoestrogen Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 235000015921 sodium selenite Nutrition 0.000 description 2
- 229960001471 sodium selenite Drugs 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 2
- 239000011747 thiamine hydrochloride Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 150000004684 trihydrates Chemical class 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 229940118149 zinc sulfate monohydrate Drugs 0.000 description 2
- RNZCSKGULNFAMC-UHFFFAOYSA-L zinc;hydrogen sulfate;hydroxide Chemical compound O.[Zn+2].[O-]S([O-])(=O)=O RNZCSKGULNFAMC-UHFFFAOYSA-L 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 102100032407 Carboxypeptidase D Human genes 0.000 description 1
- 102100026678 Carboxypeptidase N catalytic chain Human genes 0.000 description 1
- 108010080937 Carboxypeptidases A Proteins 0.000 description 1
- 102000000496 Carboxypeptidases A Human genes 0.000 description 1
- 108010059081 Cathepsin A Proteins 0.000 description 1
- 102000005572 Cathepsin A Human genes 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108700033740 EC 3.4.17.1 Proteins 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 108030000059 Gly-Xaa carboxypeptidases Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 description 1
- PNIWLNAGKUGXDO-UHFFFAOYSA-N Lactosamine Natural products OC1C(N)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 PNIWLNAGKUGXDO-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 108010085169 Lysine carboxypeptidase Proteins 0.000 description 1
- 102100028524 Lysosomal protective protein Human genes 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102100030612 Mast cell carboxypeptidase A Human genes 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical group CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108030001566 Peptidyl-Asp metalloendopeptidases Proteins 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 108700015930 Prolyl Oligopeptidases Proteins 0.000 description 1
- 101710178372 Prolyl endopeptidase Proteins 0.000 description 1
- 241000245026 Scoliopus bigelovii Species 0.000 description 1
- QUOQJNYANJQSDA-MHQSSNGYSA-N Sialyllacto-N-tetraose a Chemical compound O1C([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](OC2[C@H]([C@H](OC3[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@@H]1O QUOQJNYANJQSDA-MHQSSNGYSA-N 0.000 description 1
- SFMRPVLZMVJKGZ-JRZQLMJNSA-N Sialyllacto-N-tetraose b Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)OC[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]2O)O)O1 SFMRPVLZMVJKGZ-JRZQLMJNSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 description 1
- CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 description 1
- DUKURNFHYQXCJG-JEOLMMCMSA-N alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)O[C@@H]1CO DUKURNFHYQXCJG-JEOLMMCMSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000012791 bagels Nutrition 0.000 description 1
- 235000012820 baking ingredients and mixes Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- NPPRJALWPIXIHO-PNCMPRLYSA-N beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)OC[C@@H]1[C@@H]([C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O1)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O NPPRJALWPIXIHO-PNCMPRLYSA-N 0.000 description 1
- DMYPRRDPOMGEAK-XWDFSUOISA-N beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@H](O[C@H]4[C@H]([C@H](O)[C@H](O)[C@H](C)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)OC(O)[C@@H]1O DMYPRRDPOMGEAK-XWDFSUOISA-N 0.000 description 1
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 description 1
- UTVHXMGRNOOVTB-IXBJWXGWSA-N beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O UTVHXMGRNOOVTB-IXBJWXGWSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 235000012467 brownies Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 238000000641 cold extrusion Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- SUSQQDGHFAOUBW-PVLJGHBYSA-N difucosyllacto-n-hexaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO[C@H]3[C@@H]([C@@H](O[C@@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](C)O4)O)[C@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H]2O)O)O[C@@H]1CO SUSQQDGHFAOUBW-PVLJGHBYSA-N 0.000 description 1
- BCUMESVDMXHZRL-UHFFFAOYSA-N difucosyllacto-n-hexaose i Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(C(NC(C)=O)C(OC4C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C4O)O)OC3CO)OC3C(C(O)C(O)C(C)O3)O)OC(CO)C2O)O)OC1CO BCUMESVDMXHZRL-UHFFFAOYSA-N 0.000 description 1
- FCIROHDMPFOSFG-LAVSNGQLSA-N disialyllacto-N-tetraose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)OC[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@H]3[C@@H]([C@@H](O)C(O)O[C@@H]3CO)O)O[C@H](CO)[C@@H]2O)O)O1 FCIROHDMPFOSFG-LAVSNGQLSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 108010003914 endoproteinase Asp-N Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 235000019692 hotdogs Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- DMYPRRDPOMGEAK-UHFFFAOYSA-N lacto-N-difucohexaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(C(O)C(O)C(CO)O4)O)C(OC4C(C(O)C(O)C(C)O4)O)C(CO)O3)NC(C)=O)C(O)C(CO)O2)O)C(CO)OC(O)C1O DMYPRRDPOMGEAK-UHFFFAOYSA-N 0.000 description 1
- FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 description 1
- FKADDOYBRRMBPP-UHFFFAOYSA-N lacto-N-fucopentaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)OC1CO FKADDOYBRRMBPP-UHFFFAOYSA-N 0.000 description 1
- CMQZRJBJDCVIEY-UHFFFAOYSA-N lacto-N-fucopentaose III Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C1NC(C)=O CMQZRJBJDCVIEY-UHFFFAOYSA-N 0.000 description 1
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 description 1
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 description 1
- SJQVFWDWZSSQJI-RIIJGTCGSA-N lacto-n-decaose Chemical compound C[C@@H]1[C@@H](C)[C@@H](C)[C@@H](CC)OC1OC1[C@@H](CC)OC(OC[C@@H]2[C@@H](C(OC3[C@@H](C(OC4[C@@H]([C@@H](C)[C@@H](C)[C@@H](CC)O4)C)[C@@H](C)[C@@H](CC)O3)N=C(C)O)[C@@H](C)C(OC3[C@H](OC(OCC4[C@@H](C(OC5[C@@H](C(OC6[C@@H]([C@@H](C)[C@@H](C)[C@@H](CC)O6)C)[C@@H](C)[C@@H](CC)O5)N=C(C)O)[C@@H](C)C(OC5[C@@H]([C@@H](C)C(C)O[C@@H]5C)C)O4)C)[C@H](N=C(C)O)[C@H]3C)CC)O2)C)[C@H](N=C(C)O)[C@H]1C SJQVFWDWZSSQJI-RIIJGTCGSA-N 0.000 description 1
- 229940062780 lacto-n-neotetraose Drugs 0.000 description 1
- DOVBXGDYENZJBJ-ONMPCKGSSA-N lactosamine Chemical compound O=C[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DOVBXGDYENZJBJ-ONMPCKGSSA-N 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 235000021486 meal replacement product Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 235000012459 muffins Nutrition 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- ZDZMLVPSYYRJNI-CYQYEHMMSA-N p-lacto-n-hexaose Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1N=C(C)O)O[C@@H]1[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)OC([C@@H]1O)CO[C@H]1[C@@H]([C@H](C(O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1)O)N=C(O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O ZDZMLVPSYYRJNI-CYQYEHMMSA-N 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- LTUDISCZKZHRMJ-UHFFFAOYSA-N potassium;hydrate Chemical compound O.[K] LTUDISCZKZHRMJ-UHFFFAOYSA-N 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000012434 pretzels Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000012471 refrigerated dough Nutrition 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- SXMGGNXBTZBGLU-UHFFFAOYSA-N sialyllacto-n-tetraose c Chemical compound OCC1OC(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC(C(C(O)C1O)O)OC1COC1(C(O)=O)CC(O)C(NC(C)=O)C(C(O)C(O)CO)O1 SXMGGNXBTZBGLU-UHFFFAOYSA-N 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000019976 tricalcium silicate Nutrition 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000012773 waffles Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000036266 weeks of gestation Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 235000020125 yoghurt-based beverage Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present disclosure relates to nutritional products comprising pea protein hydrolysates. More particularly, the present disclosure relates to infant, pediatric and adult nutritional products comprising pea protein hydrolysates having lowered immunological reactivity and improved flavor and organoleptic properties, including emulsion stability.
- Intolerance is a non-immune system associated reaction and may be evidenced by behavior or stool or feeding pattern changes such as increased vomiting, an increased number of stools, or more watery stools as compared to individuals who tolerate nutritional ingredients well. Intolerance is most often indicated by gastrointestinal symptoms (e.g. emesis, stool patterns and gas) as well as behavioral characteristics (e.g. acceptance of formula, fussing and crying).
- Intolerance can be contrasted with the allergic-type reactions that some individuals, and especially infants, exhibit to certain nutritional compositions.
- These allergic-type reactions are immune system associated, and may be caused by the individual's sensitivity to the protein present (generally cow milk protein) in the nutritional.
- These immune system associated allergies or sensitivities often result in cutaneous, respiratory or gastrointestinal symptoms such as vomiting and diarrhea.
- Hydrolysate-based formulas some of which may be hypoallergenic, contain protein that has been hydrolyzed or broken down into short peptide fragments and amino acids and as a result is immunologically substantially inactive. Individuals who exhibit reactions to cow milk and soy proteins often will not react to hydrolysate formulas because their immune system does not recognize the hydrolyzed protein as the intact protein that causes their symptoms. Individuals who exhibit immune system-associated reactions to nutritional compositions including cow milk and/or soy proteins may also exhibit non-immune system associated reactions (formula intolerance), as previously described.
- the present disclosure is therefore directed to nutritional products in the form of nutritional liquids, powders, bars, and other food products comprising pea protein hydrolysates as the primary or sole source of protein.
- the pea protein hydrolysate has a degree of hydrolysis such that the resulting nutritional products are physically stable over shelf life and provide favorable organoleptic properties, while remaining substantially immunologically inactive.
- the nutritional product may also be used as a nutritional source for individuals who are intolerant and/or allergic to proteins other than pea proteins and/or who have malabsorption, maldigestion, or other gastroinstestinal conditions.
- One embodiment is a nutritional product including a pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% to less than 19.0%), including between about 8.0%> and about 16.0%, including between about 8%o and about 13.5%, and also including between about 12.0% and 16.0%.
- the proteins in the pea protein hydrolysate have a molecular weight of greater than 3 kDa.
- the product is in a form selected from the group consisting of a liquid beverage (e.g., nutritional emulsions, substantially clear nutritional liquids, and gels), a powder, a food product, a nutritional bar, and a nutritional supplement. Desirably, the product is an infant formula.
- Another embodiment is a nutritional product including a pea protein hydrolysate having less than 15,000 ⁇ g of immunologically active pea antigen per 1 gram of protein.
- Another embodiment is a method of making a nutritional product comprising combining a protein, a fat, and a carbohydrate.
- the nutritional product includes a pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% and less than 19.0% as its primary or sole source of protein.
- less than 5% of the proteins in the pea protein hydrolysate have a molecular weight of greater than 3 kDa.
- the pea protein hydrolysate has less than 15,000 ⁇ g of immunologically active pea antigen per 1 gram of protein.
- the nutritional products as described herein comprise pea protein hydrolysates as sole or primary source of protein that not only provide a nutritional source for individuals who are intolerant and/or allergic to cow milk proteins and/or soy proteins, but also is physically stable and/or has organoleptic benefits in each of the selected product forms.
- pea protein hydrolysate is the sole protein source such that the nutritional product is
- hypoallergenic and suitable for use in food-allergic patients are hypoallergenic and suitable for use in food-allergic patients.
- pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% and less than 19.0% which produces a specific molecular weight profile and antigen content.
- the use of these pea protein hydrolysates has been found to have reduced immunological activity.
- pea protein hydrolysates having an adjusted degree of hydrolysis of between about 7.0%> and less than 19.0% provide improved flavor and other improved organoleptic properties as compared to nutritional products including other hydro lyzed vegetable protein sources.
- utilizing the hydrolyzed pea protein of the present disclosure it is now possible to produce pleasant tasting, hypoallergenic, tolerant hydrolysate -based nutritionals.
- FIG. 1 is a chart depicting the composition comparison between pea protein hydrolysates of the present disclosure and intact soy protein.
- the nutritional products described herein comprise pea protein hydrolysates as a source of protein.
- the nutritional products comprise pea protein hydrolysates as a sole protein source such that the nutritional product is hypoallergenic and suitable for use in food-allergic patients.
- hypoallergenic refers to a nutritional product that causes symptoms of an allergic reaction to food in less than 10%> of food-allergic individuals.
- substantially clear nutritional liquid refers to a non-emulsified or similar other liquid having a visibly clear or translucent appearance, which liquid may and typically will have a thin or watery texture with a consistency similar to that of a clear juice and most typically having a viscosity of less than about 25 centipoise as determined by a Brookfield viscometer at 22°C using a #1 spindle at 60 rpm.
- spray dried nutritional powder refers to a nutritional powder wherein the majority of the components, including the pea protein hydrolysate, have been homogenized and subsequently subjected to a spray drying process during manufacturing. Additional ingredients can be added to the spray dried powder through dry blending so long as at least the pea protein hydrolysate has been previously homogenized and spray dried.
- adjusted degree of hydrolysis refers to the degree of hydrolysis of a specified protein material, generally pea protein material, that has been adjusted or corrected to account for the measurable amino nitrogen content of the intact protein material. For example, if the intact, unmodified protein material has an amino nitrogen content of 8.68 and a protein that has been subjected to a hydrolysis procedure has a degree of hydrolysis of 16.68, the hydrolyzed protein has an adjusted degree of hydrolysis of 8.00.
- fat and oil as used herein, unless otherwise specified, are used interchangeably to refer to lipid materials derived or processed from plants or animals. These terms also include synthetic lipid materials so long as such synthetic materials are suitable for oral administration to humans.
- human milk oligosaccharide refers generally to a number of complex carbohydrates found in human milk.
- Monomers found in milk oligosaccharides typically include D-glucose (Glc), D-galactose (Gal), N- acetylglucosamine (GlcNAC), L-fucose (Fuc), and sialic acid [N-acetylneuraminic acid (NeuAc)].
- Elongation of these monomers may be achieved by attachment of GlcNAc residues linked in ⁇ 1-3 or ⁇ 1-4 linkage to a Gal residue followed by further addition of Gal in a ⁇ -1-3 or ⁇ -1-4 bond.
- Most HMOs carry lactose at their reducing end. From these monomers, a large number of core structures may be formed.
- shelf stable refers to a nutritional product that remains commercially stable after being packaged and then stored at 18-24°C for at least 3 months, including from about 6 months to about 24 months, and also including from about 12 months to about 18 months.
- the terms "nutritional composition” or “nutritional product” as used herein, are used interchangeably and, unless otherwise specified, refer to nutritional liquids, nutritional powders, nutritional bars, nutritional supplements, and any other nutritional food product as known in the art.
- the nutritional powders may be reconstituted to form a nutritional liquid, all of which comprise one or more of fat, protein and carbohydrate and are suitable for oral consumption by a human.
- nutritional liquid refers to nutritional products in ready-to-drink liquid form, concentrated form, and nutritional liquids made by reconstituting the nutritional powders described herein prior to use.
- infant refers to a child 12 months or younger.
- toddler refers to a child from 6 months to three years of age.
- child refers to a user from birth up to 13 years of age.
- preterm infant refers to an infant born prior to 36 weeks of gestation.
- the various embodiments of the nutritional products of the present disclosure may also be substantially free of any optional or selected essential ingredient or feature described herein, provided that the remaining nutritional product still contains all of the required ingredients or features as described herein.
- the term "substantially free” means that the selected nutritional product contains less than a functional amount of the optional ingredient, typically less than about 1%, including less than about 0.5%, including less than about 0.1%, and also including zero percent, by weight of such optional or selected essential ingredient.
- the nutritional products may comprise, consist of, or consist essentially of the essential elements of the products as described herein, as well as any additional or optional element described herein or otherwise useful in nutritional product applications.
- the nutritional compositions of the present disclosure including the pea protein hydrolysate may be formulated and administered in any known or otherwise suitable oral product form. Any solid, liquid, or powder form, including combinations or variations thereof, are suitable for use herein, provided that such forms allow for safe and effective oral delivery to the individual of the essential ingredients as also defined herein.
- the nutritional compositions of the present disclosure include pea protein hydrolysates as described herein.
- the compositions may include pea protein hydro lysates as the sole source of protein (i.e., pea protein hydrolysates are 100% of the protein component of the composition) or they may include pea protein
- compositions include any product form comprising the essential ingredients described herein, and which is safe and effective for oral administration.
- the nutritional compositions may be formulated to include only the essential ingredients described herein, or may be modified with optional ingredients to form a number of different product forms.
- the nutritional compositions of the present disclosure are preferably formulated as dietary product forms, which are defined herein as those embodiments comprising the essential ingredients of the present disclosure in a product form that then contains at least one of fat, protein, and carbohydrate, and preferably also contains vitamins, minerals, or combinations thereof.
- the composition will comprise pea protein hydrolysate as the sole source of protein in combination with fat,
- hypoallergenic infant formula including 100% pea protein hydrolysates as the protein source, fat, carbohydrate, vitamins and minerals.
- the nutritional compositions of the present disclosure may therefore include a variety of different product forms, including most any conventional or otherwise known food product form, some non-limiting examples of which include confectionary products, cereals, food condiments (e.g., spreads, powders, sauces, jams, jelly, coffee creamer or sweetener), pasta, baking or cooking materials (e.g., flour, fats or oils, butter or margarine, breading or baking mixes), salted or seasoned snacks (e.g., extruded, baked, fried), beverages (e.g., coffee, juice, carbonated beverage, non-carbonated beverage, tea), snack or meal replacement bars (e.g., SlimfastTM bars, EnsureTM bars, Zone perfectTM bars, GlucernaTM bars), smoothies, breakfast cereals, cheeses, gummie products, salted or unsalted crisp snacks (e.g., chips, crackers, pretzels), dips, baked goods (e.g., cookies, cakes, pies, pastries, bread, bagels, cro
- the nutritional compositions of the present disclosure may also be formulated in product forms such as capsules, tablets, pills, caplets, gels, liquids (e.g., suspensions, solutions, emulsions, clear solutions), powders or other particulates, and so forth.
- product forms such as capsules, tablets, pills, caplets, gels, liquids (e.g., suspensions, solutions, emulsions, clear solutions), powders or other particulates, and so forth.
- product forms generally contain only the essential ingredients as described herein, optionally in combination with other actives, processing aids or other dosage form excipients.
- the nutritional products include liquid and spray dried powder forms, which includes ready-to-feed emulsified liquids and spray dried reconstitutable powders that can be diluted with water or other aqueous liquid to form a nutritional liquid prior to use.
- the nutritional composition may be human milk fortifiers for preterm infants intolerant to formulas based on cow milk proteins or soy proteins, human milk fortifiers for infants allergic to cow milk proteins or soy proteins, preterm infant formulas for preterm infants intolerant to formulas based on cow milk proteins or soy proteins, or preterm infant formulas for preterm infants allergic to cow milk proteins or soy proteins, infant formulas for infants intolerant to formulas based on cow milk proteins or soy proteins, infant formulas for infants allergic to cow milk proteins or soy proteins, hypoallergenic formulas for infants with food allergies generally, follow-on infant formulas for infants intolerant to formulas based on cow milk proteins or soy proteins, follow-on infant formulas for infants allergic to formulas based on cow milk proteins or soy proteins, toddler formulas for infants greater than six months of age who are intolerant to formulas based on cow milk proteins or soy proteins, toddler formulas for infants greater than six months of age who are allergic to formulas based on cow milk proteins or so
- the nutritional compositions of the present disclosure when formulated as a dietary product form, may potentially provide either a sole source or a supplemental source of nutrition to an individual.
- a sole source of nutrition is one that can be administered once or multiple times each day to potentially provide an individual with all or substantially all their fat, protein, carbohydrate, mineral, and vitamin needs per day or during the intended period of administration.
- a supplemental source of nutrition is defined herein as a dietary source that does not provide an individual with a potentially sole source of nutrition.
- Liquid beverages include concentrated and ready-to-feed liquids.
- liquid product forms suitable for use herein include liquid infant formulas (including both ready-to-feed formulations and concentrated formulations), liquid toddler formulas (including both ready-to-feed formulations and concentrated formulations), liquid human milk fortifiers (including both ready-to-feed and concentrated formulations), snack and meal replacement products, hot or cold beverages, carbonated or non carbonated beverages, juices or other acidified beverages, shakes, coffees, teas, enteral feeding compositions, and so forth.
- These liquid compositions are most typically formulated as suspensions or emulsions, but can also be formulated in any other suitable form such as clear liquid solutions, liquid gels, and so forth.
- the nutritional liquid beverages of the present disclosure may be used as nutritional drinks for pre-term infants, infants, toddlers, children, and adults, including geriatric patients, who are intolerant or allergic to nutritionals based on cow milk proteins and/or soy proteins.
- the liquid beverages may also be used as semi- elemental formulas for the nutritional needs of patients with malabsorption, maldigestion, and other gastrointestinal conditions.
- Nutritional emulsions comprise pea protein hydrolysate as the primary or sole source of protein and are aqueous emulsions further comprising fats and carbohydrates. These emulsions are flowable or drinkable liquids at from about 1°C to about 25°C and are typically in the form of oil-in- water, water-in-oil, or complex aqueous emulsions, although such emulsions are most typically in the form of oil-in-water emulsions having a continuous aqueous phase and a discontinuous oil phase.
- the nutritional emulsions may be and typically are shelf stable.
- the nutritional emulsions typically contain up to about 95% by weight of water, including from about 50%> to about 95%, also including from about 60%> to about 90%>, and also including from about 70% to about 85%, of water by weight of the nutritional emulsions.
- the nutritional emulsions may be formulated with sufficient kinds and amounts of nutrients so as to provide a sole, primary, or supplemental source of nutrition, or to provide a specialized nutritional emulsion for use in individuals afflicted with specific diseases or conditions.
- nutritional emulsions can be produced for use as infant, follow-on infant and toddler formulas, adult formulas and the like for users who are intolerant or allergic to nutritionals based on cow milk proteins and/or soy proteins.
- the emulsions can be used as a hypoallergenic nutritional emulsion by individuals that have general food allergies.
- These nutritional emulsions may thus have a variety of product densities, but most typically have a density greater than about 1.03 g/ml, including greater than about 1.04 g/ml, including greater than about 1.055 g/ml, including from about 1.06 g/ml to about 1.12 g/ml, and also including from about 1.085 g/ml to about 1.10 g/ml.
- the nutritional emulsions may have a caloric density tailored to the nutritional needs of the ultimate user, although in most instances the emulsions comprise from about 100 to about 500 kcal/240 ml, including from about 150 to about 350 kcal/240 ml, and also including from about 200 to about 320 kcal/240 ml.
- the nutritional emulsion is a low- calorie nutritional emulsion and has a caloric density of about 6.5 kcal/fl oz (52.8 kcal/240 ml). In another embodiment, the nutritional emulsion has a caloric density of about 7.1 kcal/fl oz (57.6 kcal/240 ml). In one embodiment, the nutritional emulsion has a caloric density of about 7.7 kcal/fl oz (62.4 kcal/ml).
- the nutritional emulsion may have a pH ranging from about 3.5 to about 8, but are most advantageously in a range of from about 4.5 to about 7.5, including from about 5.5 to about 7.3, including from about 6.2 to about 7.2.
- the serving size for the nutritional emulsion can vary depending upon a number of variables, a typical serving size ranges from about 100 to about 300 ml, including from about 150 to about 250 ml, and including from about 190 ml to about 240 ml.
- the nutritional emulsion can be used as a human milk fortifier.
- a typical single serving size includes about 5.0 ml.
- the substantially clear nutritional liquids of the present disclosure are thin liquids comprising at least protein, at least a portion of the proteins being pea protein hydrolysate, and carbohydrate as discussed below.
- the substantially clear nutritional liquids are substantially fat free; that is, the liquids are devoid of added fat except for that fat inherent to the raw materials or added fat at low concentrations to aid in the manufacture of the liquid.
- fat free means that the liquid typically contains less than 1.0 %, more typically less than 0.5%, and more typically less than 0.1%, including zero percent, fat by weight of the nutritional liquid.
- These substantially clear nutritional liquids are flowable or drinkable liquids at from about FC to about 25°C.
- the substantially clear nutritional liquids may be and typically are shelf-stable.
- the liquids typically contain up to about 95% by weight of water, including from about 50% to about 95%, also including from about 60% to about 90%), and also including from about 70%> to about 85%, of water by weight of the substantially clear nutritional liquid.
- the substantially clear nutritional liquids may be formulated with sufficient kinds and amounts of nutrients so as to provide a supplemental source of nutrition, or to provide a specialized nutritional liquid for use in individuals afflicted with specific diseases or conditions.
- the substantially clear nutritional liquids may be formulated with sufficient kinds and amounts of nutrients so as to provide a supplemental source of nutrition, or to provide a specialized nutritional liquid for use in individuals afflicted with specific diseases or conditions.
- the substantially clear nutritional liquids may be formulated with sufficient kinds and amounts of nutrients so as to provide a supplemental source of nutrition, or to provide a specialized nutritional liquid for use in individuals afflicted with specific diseases or conditions.
- the substantially clear nutritional liquids may be formulated with sufficient kinds and amounts of nutrients so as to provide a supplemental source of nutrition, or to provide a specialized nutritional liquid for use in individuals afflicted with specific diseases or conditions.
- the substantially clear nutritional liquids may be formulated with sufficient kinds and amounts of nutrients so as to provide a supplemental source of nutrition, or to provide a specialized nutritional liquid
- substantially clear nutritional liquid is a sports drink for use by users who are intolerant or allergic to nutritionals based on cow milk protein and/or soy proteins.
- the substantially clear nutritional liquid is a sports drink including hydro lyzed protein with improved organoleptic properties.
- These substantially clear nutritional liquids may thus have a variety of product densities, but most typically have a density greater than about 1.040 g/ml, including from 1.06 g/ml to 1.12 g/ml, and also including from about 1.085 g/ml to about 1.10 g/ml.
- the substantially clear nutritional liquids may have a caloric density tailored to the nutritional needs of the ultimate user, although in most instances the liquids comprise from about 90 to about 500 kcal/240 ml, including from about 150 to about 350 kcal/240 ml, including from about 180 to about 350 kcal/240 ml and also including from about 250 to about 320 kcal/240 ml. In other embodiments, the substantially clear nutritional liquids comprise from about 90 to about 500 kcal 480 ml, including from about 150 to about 350 kcal/480 ml, and also including from about 250 to about 320 kcal/480 ml. [0052] The substantially clear nutritional liquids have a pH ranging from about 2.8 to about 4.6, including from about 2.9 to about 4.2, and also including from about 3.1 to about 3.9.
- the serving size for the substantially clear nutritional liquid can vary depending upon a number of variables, a typical serving size ranges from about 100 to about 591 ml, including from about 150 to about 250 ml, including from about 190 ml to about 240 ml.
- Some specific serving sizes for the substantially clear nutritional liquid include 240 ml (8.1 ounce), 296 ml (10 ounce) and 480 ml (16 ounce).
- the nutritional powders comprise pea protein hydrolysates as a primary or sole source of protein and are typically in the form of flowable or substantially flowable particulate compositions, or at least particulate compositions.
- Particularly suitable product forms include spray dried, agglomerated or dryblended powder compositions.
- the compositions can easily be scooped and measured with a spoon or similar other device, wherein the compositions can easily be reconstituted by the intended user with a suitable aqueous liquid, typically water, to form a nutritional formulation for immediate oral or enteral use.
- "immediate" use generally means within about 48 hours, most typically within about 24 hours, preferably right after reconstitution.
- the nutritional powders may be formulated with sufficient kinds and amounts of nutrients so as to provide a sole, primary, or supplemental source of nutrition, or to provide a specialized nutritional powder for use in individuals afflicted with specific diseases or conditions.
- the nutritional powder may be formulated for use with individuals who are intolerant or allergic to nutritionals based on cow milk proteins and/or soy proteins.
- the emulsions can be used as hypoallergenic nutritional emulsions by individuals that have general food allergies.
- the nutritional powders may be reconstituted with water prior to use to a caloric density tailored to the nutritional needs of the ultimate user, although in most instances the powders are reconstituted with water to form compositions comprising from about 100 to about 500 kcal/240 ml, including from about 150 to about 350 kcal/240 ml, and also including from about 200 to about 320 kcal/240 ml.
- the nutritional powder may be reconstituted with water to form a low-calorie composition having a caloric density of about 52.8 kcal/240 ml. In another embodiment, the nutritional powder has a caloric density of about 57.6 kcal/240 ml. In one embodiment, the nutritional powder has a caloric density of about 62.4 kcal/240 ml.
- the serving size for the reconstituted nutritional liquid can vary depending upon a number of variables, a typical serving size ranges from about 100 to about 300 ml, including from about 150 to about 250 ml, including from about 190 ml to about 240 ml.
- the reconstituted nutritional liquid can be used as a human milk fortifier.
- a typical single serving size includes about 0.9 grams of powder per about 100 to about 300 ml of water.
- the nutritional products can alternatively be in the form of solid nutritional bars and food products.
- the nutritional products may be formulated as bars, sticks, or cookies, breads, cakes or other baked goods.
- the nutritional compositions of the present disclosure may also be formulated in product forms such as capsules, tablets, pills, caplets, and gels. These product forms generally contain only the essential ingredients as described herein, optionally in combination with other actives, processing aids or other dosage form excipients. Infant Formulas
- the nutritional product when the nutritional product is an infant formula, the nutritional product may be a liquid or solid nutritional product as described above.
- the liquid or solid infant formula products of the present disclosure may have any caloric density suitable for the targeted infants, or provide such a density upon reconstitution of a powder embodiment or upon dilution of a liquid concentrate embodiment.
- most common caloric densities for the infant formula embodiments of the present disclosure are generally at least about 19 kcal/fl oz (660 kcal/liter), more typically from about 20 kcal/fl oz (675-680 kcal/liter) to about 25 kcal/fl oz (820 kcal/liter), even more typically from about 20 kcal/fl oz (675-680 kcal/liter) to about 24 kcal/fl oz (800-810 kcal/liter).
- the 22-24 kcal/fl oz formulas are more commonly used in preterm or low birth weight infants, and the 20-21 kcal/fl oz (675- 680 to 700 kcal/liter) formulas are more often used in term infants.
- the infant formula is a low-calorie infant formula and has a caloric density of about 6.5 kcal/fl oz (220 kcal/liter). In another embodiment, the infant formula has a caloric density of about 7.1 kcal/fl oz (240 kcal/liter). In one embodiment, the infant formula has a caloric density of about 7.7 kcal/fl oz (260 kcal/liter).
- carbohydrate concentrations most typically range from about 5% to about 40%, including from about 7% to about 30%), including from about 10%> to about 25%, by weight of the nutritional product; fat concentrations most typically range from about 1% to about 30%, including from about 2%> to about 15%, and also including from about 4% to about 10%>, by weight of the nutritional product; and protein concentrations most typically range from about 0.5% to about 30%), including from about 1% to about 15%, and also including from about 2%) to about 10%>, by weight of the nutritional product.
- the liquid infant formula product is a low calorie liquid infant formula and includes less than about 5% by weight carbohydrate, about 1% by weight fat, and about 0.5%> by weight protein.
- the level or amount of carbohydrates, fats, and or proteins in the liquid nutritional products may also be characterized in addition to or in the alternative as a percentage of total calories in the nutritional compositions as set forth in the following table.
- These macronutrients for liquid nutritional products of the present disclosure are most typically formulated within any of the caloric ranges (embodiments A-F) described in the following table (each numerical value is preceded by the term "about").
- liquid infant formulas both ready-to-feed and concentrated liquids
- the protein component may comprise from about 7.5% to about 25% of the caloric content of the formula
- the carbohydrate component may comprise from about 35% to about 50% of the total caloric content of the infant formula
- the lipid component may comprise from about 30% to about 60% of the total caloric content of the infant formula.
- the protein component is present in an amount of from about 5% to about 35%, including from about 8% to about 12%, and including from about 10%> to about 12% by weight of the powdered nutritional product;
- the fat component is present in an amount of from about 10% to about 35%, including from about 25% to about 30%, and including from about 26% to about 28% by weight of the powdered nutritional product;
- the carbohydrate component is present in an amount of from about 30% to about 85%), including from about 45% to about 60%, including from about 50% to about 55% by weight of the powdered infant formula.
- the total amount or concentration of fat, carbohydrate, and protein, in the powdered nutritional products of the present disclosure can vary considerably depending upon the selected formulation and dietary or medical needs of the intended user. Additional suitable examples of macronutrient concentrations are set forth below.
- the total amount or concentration refers to all fat, carbohydrate, and protein sources in the powdered product.
- such total amounts or concentrations are most typically and preferably formulated within any of the embodied ranges described in the following table (all numbers have "about" in front of them).
- the nutritional products comprise pea protein hydrolysate as a primary or sole source of protein.
- a hypoallergenic composition such as a hypoallergenic infant formula
- the nutritional composition will include 100% pea protein hydrolysate, by weight of the protein component.
- the pea protein hydrolysates used in the products of the present disclosure have been found to show lowered immunological reactivity and improved flavor and organoleptic properties as compared to other vegetable protein
- the pea protein hydrolysates such as soy proteins, as well as cow milk proteins.
- the pea protein hydrolysates for use in the nutritional products of the present disclosure have reduced levels of phytoestrogen (i.e., genistein and daidzein, which are isoflavones), aluminum, manganese, and phytates, thus improving the nutrient profile of the end nutritional product.
- the pea protein hydrolysate has a reduced antigen content and/or a reduced
- the pea protein hydrolysates provide a good source of protein for nutritional products that are designed for individuals who are intolerant and/or allergic to cow milk proteins and/or soy proteins, as well as to meet the nutritional needs of individuals with malabsorption, maldigestion, and other gastrointestinal conditions. These nutritional products further have improved flavor and emulsion stability.
- the pea protein hydrolysates may be the sole source of protein in the nutritional products of the present disclosure.
- additional protein sources as described below, may be used in the products in combination with the pea protein hydrolysates to provide the total protein.
- the pea protein hydrolysate provides at least 50% of the total protein in the nutritional product, including from about 50% to about 100% of the total protein, including from about 60% to about 95% of the total protein, including from about 70% to about 90% of the total protein, and also including from about 75% to about 85% of the total protein in the nutritional product.
- the additional protein sources may include partially hydrolyzed, hydrolyzed, and/or unhydrolyzed (intact) proteins.
- pea protein hydrolysates can be produced with lowered antigen content, and thus lowered immunological reactivity, without adversely affecting the flavor attributes of the hydrolysate.
- the pea protein hydrolysates described herein are superior to previously known soy proteins as they have: (1) non-detectable levels of isoflavones; (2) decreased phytate, manganese, and aluminum concentrations; (3) improved organoleptic and flavor profiles; and (4) are not genetically modified.
- pea protein hydrolysates for use in the nutritional products of the present disclosure are produced by: (1) mixing a pea protein product having at least 65% protein (by weight dry matter) and water to form a slurry with a protein content of up to about 20%, preferably up to about 12%; (2) hydro lyzing the slurry; and (3) filtering the hydrolyzed slurry to obtain the protein hydrolysate.
- the pea protein product used as raw material in step (1) can be any pea protein product, provided that the protein content thereof is at least 65 % by weight dry matter, i.e. pea protein concentrates (with a protein content of above 70% by weight dry matter), or pea protein isolates (with a protein content of above 90% by weight dry matter).
- pea protein concentrates with a protein content of above 70% by weight dry matter
- pea protein isolates with a protein content of above 90% by weight dry matter.
- Commercially available pea protein concentrates and isolates are well known in the art.
- the pea protein product is mixed with water to form a slurry with a protein content of up to about 20%, preferably up to about 12%.
- the slurry may be heated prior to hydrolysis to further denaturing.
- the method further includes heating the slurry to a temperature above 60°C prior to hydrolysis. More suitably, the slurry can be heated to a temperature of from about 70°C to about 90°C for a period of from about 2 minutes to about 20 minutes prior to hydrolysis. In this manner, the protein is effectively denatured, and thus, the subsequent hydrolysis will generally proceed more rapidly. Further, by heating the slurry, the microbial stability during the hydrolysis, which can last for several hours, is secured effectively.
- the temperature of the slurry is preferably adjusted and maintained at from about 40°C to about 70°C, including from about 50°C to about 60°C, prior to and during the hydrolysis reaction in accordance with methods known in the art. Of course, other heating steps and/or temperatures can be utilized as are known in the art.
- Hydrolysis of the protein-containing slurry can be conducted enzymatically or non-enzymatically.
- the protein-containing slurry is hydrolyzed to have an adjusted degree of hydrolysis of between about 7.0% and less than 19.0%, including between about 8.0%> and about 16.0%, including between about 8.0%> and about 13.5%, also including between about 12.0% and about 14.00%, and also including about 14.0% and a molecular weight distribution and antigen content as set forth below.
- Such hydrolysis in one embodiment, may be conducted proteolytically as is known in the art.
- the hydrolysis is carried out with one or more unspecific acting endo- and/or exo-peptidase enzymes.
- Suitable unspecific acting endo- and/or exo-peptidase enzymes include, for example, enzymes derived from a strain of Aspergillus, in particular a strain of Aspergillus niger, a strain of Aspergillus oryzae, or a strain of Aspergillus soyae, or a strain of Bacillus, in particular a strain of Bacillus amyloliquefaciens, a strain of Bacillus lentus, a strain of Bacillus licheniformis or a strain of Bacillus subtilis.
- Additional suitable endopeptidase enzymes for use in hydrolysis step (2) include, for example: (i) a glutamyl endopeptidase (EC 3.4.21.19); (ii) a lysyl endopeptidase (EC 3.4.21.50); (iii) a leucyl endopeptidase (EC 3.4.21.57); (iv) a glycyl endopeptidase (EC 3.4.22.25); (v) a prolyl endopeptidase (EC 3.4.21.26); (vi) trypsin (EC 3.4.21.4) or a trypsin-like (lysine/arginine specific) endopeptidase; or (vii) a peptidyl-Asp metalloendopeptidase (EC 3.4.24.33).
- a glutamyl endopeptidase EC 3.4.21.19
- a carboxypeptidase such as: (i) a proline carboxypeptidase (EC 3.4.16.2); (ii) a carboxypeptidase A (EC 3.4.17.1); (iii) a carboxypeptidase B (EC 3.4.17.2); (iv) a carboxypeptidase C (EC 3.4.16.5); (v) a carboxypeptidase D (EC 3.4.16.6); (vi) a lysine(arginine) carboxypeptidase (EC 3.4.17.3); (vii) a glycine carboxypeptidase (EC 3.4.17.4); (viii) an alanine carboxypeptidase (EC 3.4.17.6); (ix) a glutamate carboxypeptidase (EC 3.4.17.11); (x) a peptidyl-dipeptidase A (EC 3.4.1 5.1); or (xi) a peptidyl-
- the exact amount of enzyme added to the slurry to obtain the desired characteristics of the pea protein hydrolysates will vary depending upon features such as: (1) the enzyme or enzyme system utilized; (2) the desired end degree of hydrolysis; and/or (3) the desired end molecular weight distribution. Because these are known parameters, one of ordinary skill in the art can easily determine the appropriate conditions to achieve the desired characteristics of the end pea protein hydrolysate.
- the enzyme or enzyme system is added to the slurry in amounts in the range of from about 10 mg to about 5000 g, including 35 mg to about 700 g per 35 kg of protein in the slurry.
- the hydrolysis reaction will typically run for a desired length of time in order to obtain the desired degree of hydrolysis and/or the desired molecular weight profile. Typically, the hydrolysis reaction will continue for a period of from about 15 minutes to about 24 hours, including from about 30 minutes to about 240 minutes, and also including from about 45 minutes to about 120 minutes. Again, the exact amount of time required for the hydrolysis reaction will depend on specific features as noted above, but can be easily determined by one skilled in the art.
- the protein-containing slurry may be hydrolyzed using non-enzymatic means, such as by chemical and/or mechanical (physical) hydrolysis. Such technique was one also well known in the art.
- the hydrolysis reaction is stopped, for example, by inactivating the enzyme or enzyme system, or by other conventional means.
- the inactivation of the enzyme or enzyme system is carried out by heat treatment. This inactivation is especially well suited in cases where the pH of the final pea protein hydrolysate is to be relatively high.
- the enzyme preparation may suitably be inactivated by increasing the temperature of the incubation slurry to a temperature where the enzymes become inactivated, e.g. to above about 70°C, and suitably to a temperature of about 90°C.
- the enzyme(s) can be inactivated by a suitable acid treatment. This inactivation is especially well suited in cases wherein the pH of the final pea protein hydrolysate is to be relatively low.
- the enzyme(s) can be inactivated by decreasing the pH of the slurry to a value where the enzymes become inactivated, e.g. below about 4.0.
- the method of preparation may further comprise treating the slurry with activated carbon for a suitable time period at a temperature of between about 50°C and about 70°C, for example, in an amount generally corresponding to between about 1 and about 5% carbon, calculated in relation to dry matter content.
- This optional carbon step may improve the color of the final pea protein hydrolysate and also further reduce the off- flavor of the pea protein hydrolysate.
- the hydrolyzed slurry is filtered utilizing a suitable conventional filtering process to obtain the pea protein hydrolysate.
- a filtration is carried out by nanofiltration at a temperature between 50°C and 70°C and/or by evaporation, whereafter the retentate is collected as the pea protein hydrolysate solution.
- a desalination can be carried out by proper selection of the membrane. Evaporation has the advantage of obtaining a high dry matter content in the concentrate before drying.
- the pea protein hydrolysate once obtained by the filtration process outlined above, is subjected to a second filtration process, such an ultrafiltration process, to provide a molecular weight distribution suitable for use in semi-elemental and related nutritional products.
- the ultrafiltration unit can be a hollow- fiber membrane, such as for example, the commercially available unit under the trademark Diaflo® from the Amicon Corporation and/or under the trademark Romicon® from the Romicon Corporation, having the desired nominal cut- off molecular weight values.
- the hollow- fiber membranes are packed within a filter cartridge to permit flow therethrough, whereby suitably small molecules pass through the membrane, the hydrolysate effluent rate being dependent upon the pressure drop across the membrane, and are taken in solution to a collecting zone, with the remainder of the solution, containing the higher molecular weight protein hydrolysate passing directly along the fibrous tubes, for recycle to the hydrolysis reactor or to a separate collecting zone, as desired.
- this optional second filtration step can reduce the resulting phytate levels in the pea protein hydrolysate.
- the phytate content is reduced in the pea protein hydro lysates by at least about 10%, including at least about 15%), including at least about 20%>, including at least about 25%, including at least about 30%), including at least about 35%, including at least about 40%>, and including at least about 45% or more.
- Pea protein hydro lysates for use in the nutritional products described herein are prepared using the above described methods and have the following characteristics.
- Exemplary pea protein hydrolysates made according to the above methods include those having a molecular weight distribution of less than 5% being greater than 5kD.
- the pea protein hydrolysates produced according to the above- described methods additionally have reduced immunological reactivity.
- the immunological reactivity of the pea protein hydrolysate is analyzed using inhibition ELISA (enzyme-linked immunosorbent assay) and is expressed as an amount of immunologically active antigen per amount of protein.
- one gram of pea protein hydrolysate prepared accordingly to the methods described herein will typically include less than about 15,000 ⁇ g of immunologically active pea antigen, including less than about 10,000 ⁇ g of immunologically active pea antigen, including less than about 7,500 ⁇ g of immunologically active pea antigen, including less than about 5,000 ⁇ g of immunologically active pea antigen, including less than about 2,500 ⁇ g of immunologically active pea antigen, including less than about 500 ⁇ g of immunologically active pea antigen, including less than about 250 ⁇ g of immunologically active pea antigen, including less than about 100 ⁇ g of immunologically active pea antigen, including less than about 50 ⁇ g of
- immunologically active pea antigen and including the pea protein hydrolysate being substantially free of immunologically active pea antigen.
- the pea protein hydrolysate produced by the methods described above additionally have an immune response index of less than 2.5 log IRI units, including less than 2.4 log IRI units, including less than 2.3 log IRI units, including less than 2.2 log IRI units, including less than 2.1 log IRI units, and also including less than 2.0 log IRI units.
- the nutritional products of the present disclosure may optionally further comprise an additional source or sources of protein in addition to the pea protein hydrolysate.
- Any additional protein source that is suitable for use in oral nutritional products and is compatible with the essential elements and features of such products is suitable for use in combination with the pea protein hydrolysates.
- the total protein concentration in the nutritional liquid beverage may range from about 0.5% to about 40%, including from about 0.5%) to about 30%>, including from about 1% to about 15%, and also including from about 1% to about 10%>, and also including from about 1% to about 7%, by weight of the nutritional liquid beverages.
- the protein is present in a nutritional emulsion in an amount of about 6.0% by weight of the nutritional emulsion.
- the total protein concentration in the solid nutritional products may range from about 1.0% to about 50%, including from about 10% to about 50%), and also including from about 10% to about 30%, by weight of the solid nutritional product.
- the protein is present in a spray dried nutritional powder in an amount of about 19%, by weight of the spray dried nutritional powder.
- Non-limiting examples of additional suitable protein or sources thereof for use in the nutritional products include hydrolyzed, partially hydrolyzed or non-hydrolyzed proteins or protein sources, which may be derived from any known or otherwise suitable source such as milk (e.g., casein, whey), animal (e.g., meat, fish), cereal (e.g., rice, corn), vegetable (e.g., soy) or combinations thereof.
- milk e.g., casein, whey
- animal e.g., meat, fish
- cereal e.g., rice, corn
- vegetable e.g., soy
- Non-limiting examples of such proteins include milk protein isolates, milk protein concentrates as described herein, casein protein isolates, whey protein, sodium or calcium casemates, whole cow milk, partially or completely defatted milk, soy protein isolates, soy protein concentrates, and so forth.
- the nutritional products may further comprise any carbohydrates that are suitable for use in an oral nutritional product and are compatible with the essential elements and features of such products.
- Carbohydrate concentrations in the nutritional liquid beverages may range from about 5% to about 40%, including from about 7% to about 30%, including from about 10%> to about 25%, by weight of the nutritional liquid beverage.
- the weight of the nutritional liquid beverage may be determined by weight of the nutritional liquid beverage.
- carbohydrate is present in a nutritional emulsion in an amount of about 10.2%, by weight of the nutritional emulsion.
- Carbohydrate concentrations in the solid nutritional products may range from about 10% to about 90%, including from about 20%> to about 80%>, further including from about 40%> to about 60%>, by weight of the solid nutritional product.
- the carbohydrate is present in a spray dried nutritional powder in an amount of about 58%, by weight of the spray dried nutritional powder.
- Non- limiting examples of suitable carbohydrates or sources thereof for use in the nutritional products described herein may include maltodextrin, hydrolyzed or modified starch or cornstarch, glucose polymers, corn syrup, corn syrup solids, rice-derived carbohydrates, pea-derived carbohydrates, potato-derived carbohydrates, tapioca, sucrose, glucose, fructose, lactose, high fructose corn syrup, honey, sugar alcohols (e.g., maltitol, erythritol, sorbitol), artificial sweeteners (e.g., sucralose, acesulfame potassium, stevia) and combinations thereof.
- a particularly desirable carbohydrate is a low dextrose equivalent (DE) maltodextrin.
- the nutritional products may further comprise fat, most typically as emulsified fat.
- the fat may be present in the nutritional liquid beverages in an amount of from 0% to about 30%, including 1% to about 30%>, including from about 1%) to about 20%), including from about 1% to about 15%, and also including from about 1.5% to about 5%, by weight of the nutritional emulsion.
- a nutritional emulsion includes fat in an amount of about 1.6%, by weight of the nutritional emulsion.
- the nutritional product will be substantially free of fat.
- the fat When used in solid nutritional products, the fat may be present in an amount of from about 1% to about 35%, including from about 1% to about 20%, including from about 1% to about 15%, and also including from about 5.0% to about 10%), by weight of the solid nutritional product.
- a spray dried nutritional powder includes fat in an amount of about 7.5%, by weight of the spray dried nutritional powder.
- Suitable sources of fat for use herein include any fat or fat source that is suitable for use in an oral nutritional product and is compatible with the essential elements and features of such products.
- Non-limiting examples of suitable fats or sources thereof for use in the nutritional products described herein include coconut oil, fractionated coconut oil, soy oil, corn oil, olive oil, safflower oil, high oleic safflower oil, MCT oil (medium chain triglycerides), sunflower oil, high oleic sunflower oil, palm and palm kernel oils, palm olein, canola oil, marine oils, cottonseed oils, and combinations thereof.
- Other Optional Ingredients include coconut oil, fractionated coconut oil, soy oil, corn oil, olive oil, safflower oil, high oleic safflower oil, MCT oil (medium chain triglycerides), sunflower oil, high oleic sunflower oil, palm and palm kernel oils, palm olein, canola oil, marine oils, cottonseed oils, and combinations thereof.
- Other Optional Ingredients include coconut oil, fractionated coconut oil, soy oil, corn oil, olive oil, safflower oil, high oleic safflower
- the nutritional products, including infant formulas, having the pea protein hydrolysate of the present disclosure may further comprise other optional components that may modify the physical, chemical, aesthetic or processing characteristics of the products or serve as pharmaceutical or additional nutritional components when used in the targeted population.
- optional ingredients are known or otherwise suitable for use in medical food or other nutritional products or pharmaceutical dosage forms and may also be used in the compositions herein, provided that such optional ingredients are safe for oral administration and are compatible with the essential and other ingredients in the selected product form.
- Non-limiting examples of such optional ingredients include preservatives, anti-oxidants, emulsifying agents, buffers, fructooligosaccharides, galactooligosaccharides, human milk oligosaccharides and other prebiotics, pharmaceutical actives, additional nutrients as described herein, colorants, flavors, thickening agents and stabilizers, emulsifying agents, lubricants, and so forth.
- compositions of the present disclosure include lacto-N-tetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N- fucopentaose V, lacto-N-hexaose, para-lacto-N-hexaose, lacto-N-neohexaose, para- lacto-N-neohexaose, monofucosyllacto-N-hexaose II, isomeric fucosylated lacto-N- hexaose (1), monofucosyllacto-N-hexaose, isomeric fucosylated lacto-N-hexaose (3), isomeric fucosylated lacto-N-hexaose (2), difucosyl-
- HMOs lacto-N-difuco- hexaose II, sialyla(2-3) lactose, sialyla(2-6) lactose, sialyl-lacto-N-tetraose a, sialyl- lacto-N-tetraose b, sialyl-lacto-N-tetraose c, sialyl-fucosyl-lacto-N-tetraose I, sialyl- fucosyl-lacto-N-tetraose II, and disialyl-lacto-N-tetraose.
- compositions may further comprise a sweetening agent, preferably including at least one sugar alcohol such as maltitol, erythritol, sorbitol, xylitol, mannitol, isolmalt, and lactitol, and also preferably including at least one artificial or high potency sweetener such as acesulfame K, aspartame, sucralose, saccharin, stevia, and tagatose.
- a sweetening agent preferably including at least one sugar alcohol such as maltitol, erythritol, sorbitol, xylitol, mannitol, isolmalt, and lactitol
- an artificial or high potency sweetener such as acesulfame K, aspartame, sucralose, saccharin, stevia, and tagatose.
- Optional sugar alcohol concentrations in the nutritional product may range from at least about 0.01%, including from 0.1% to about 10%, and also including from about 1 % to about 6%, by weight of the nutritional product.
- Optional artificial sweetener concentrations may range from about 0.01%, including from about 0.05%) to about 5%>, also including from about 0.1 %> to about 1.0%, by weight of the nutritional product.
- a flowing agent or anti-caking agent may be included in the nutritional products such as the nutritional powders as described herein to retard clumping or caking of the powder over time and to make a powder embodiment flow easily from its container.
- Any known flowing or anti-caking agents that are known or otherwise suitable for use in a nutritional powder or product form are suitable for use herein, non limiting examples of which include tricalcium phosphate, silicates, and combinations thereof.
- the concentration of the flowing agent or anti-caking agent in the nutritional product varies depending upon the product form, the other selected ingredients, the desired flow properties, and so forth, but most typically range from about 0.1%) to about 4%, including from about 0.5%> to about 2%, by weight of the nutritional product.
- a stabilizer may also be included in the nutritional products. Any stabilizer that is known or otherwise suitable for use in a nutritional product is also suitable for use herein, some non-limiting examples of which include gums such as xanthan gum.
- the stabilizer may represent from about 0.1% to about 5.0%, including from about 0.5%> to about 3%, including from about 0.7%> to about 1.5%, by weight of the nutritional product.
- compositions may further comprise any of a variety of other vitamins or related nutrients, non-limiting examples of which include vitamin A, vitamin D, vitamin E, vitamin K, thiamine, riboflavin, pyridoxine, vitamin Bi 2 , carotenoids (e.g., beta-carotene, zeaxanthin, lutein, lycopene), niacin, folic acid, pantothenic acid, biotin, vitamin C, choline, inositol, salts and derivatives thereof, and combinations thereof.
- carotenoids e.g., beta-carotene, zeaxanthin, lutein, lycopene
- niacin folic acid
- pantothenic acid biotin
- biotin vitamin C
- choline inositol
- salts and derivatives thereof salts and derivatives thereof, and combinations thereof.
- compositions may further comprise any of a variety of other additional minerals, non-limiting examples of which include calcium, phosphorus, magnesium, iron, zinc, manganese, copper, sodium, potassium, molybdenum, chromium, chloride, and combinations thereof.
- the nutritional products of the present disclosure may be prepared by any known or otherwise effective manufacturing technique for preparing the selected product solid or liquid form. Many such techniques are known for any given product form such as nutritional liquids or powders or nutritional bars and can easily be applied by one of ordinary skill in the art to the nutritional compositions described herein.
- the nutritional products of the present disclosure can therefore be prepared by any of a variety of known or otherwise effective formulation or manufacturing methods.
- at least three separate slurries are prepared, including a protein-in-fat (PIF) slurry, a carbohydrate-mineral (CHO-MIN) slurry, a protein-in-water (PIW) slurry.
- the PIF slurry is formed by heating and mixing the oil (e.g., canola oil, corn oil, etc.) and then adding an emulsifier (e.g., lecithin), fat soluble vitamins, and a portion of the total protein (e.g., milk protein concentrate, etc.) with continued heat and agitation.
- the CHO-MIN slurry is formed by adding with heated agitation to water: minerals (e.g., potassium citrate, dipotassium phosphate, sodium citrate, etc.), trace and ultra trace minerals (TM/UTM premix), thickening or suspending agents (e.g. avicel, gellan, carrageenan).
- minerals e.g., potassium citrate, dipotassium phosphate, sodium citrate, etc.
- trace and ultra trace minerals e.g. avicel, gellan, carrageenan
- thickening or suspending agents e.g. avicel, gellan, carrageenan
- additional minerals e.g., potassium chloride, magnesium carbonate, potassium iodide, etc.
- carbohydrates e.g., fructooligosaccharide, sucrose, corn syrup, etc.
- the resulting slurries are then blended together with heated agitation and the pH adjusted to 6.6-7.0, after which the composition is subjected to high- temperature short-time (HTST) processing during which the composition is heat treated, emulsified and homogenized, and then allowed to cool.
- HTST high- temperature short-time
- Water soluble vitamins and ascorbic acid are added, the pH is adjusted to the desired range if necessary, flavors are added, and water is added to achieve the desired total solid level.
- the composition is then aseptically packaged to form an aseptically packaged nutritional emulsion.
- This emulsion can then be further diluted, heat-treated, and packaged to form a ready-to-feed or concentrated liquid, or it can be heat-treated and subsequently processed and packaged as a reconstitutable powder, e.g., spray dried, dry mixed, agglomerated.
- a reconstitutable powder e.g., spray dried, dry mixed, agglomerated.
- Other product forms such as nutritional bars may be manufactured, for example, using cold extrusion technology as is known and commonly described in the bar manufacturing art.
- To prepare such products typically all of the powdered components are dry blended together, which typically includes any proteins, vitamin premixes, certain carbohydrates, and so forth.
- the fat-soluble components are then blended together and mixed with any powdered premixes.
- any liquid components are then mixed into the composition, forming a plastic like composition or dough.
- the resulting plastic mass can then be shaped, without further physical or chemical changes occurring, by cold forming or extrusion, wherein the plastic mass is forced at relatively low pressure through a die, which confers the desired shape.
- the resultant exudate is then cut off at an appropriate position to give products of the desired weight. If desired, the solid product is then coated, to enhance palatability, and packaged for distribution.
- the nutritional products including pea protein hydro lysates as the sole source of protein are useful as a hypoallergenic nutrition source and/or a semi- elemental nutrition source for preterm infants, infants, toddlers, children, adults, and geriatrics that are intolerant and/or allergic to cow milk proteins, soy proteins, and/or have other general food allergies. Additionally, the nutritional products may be particularly suitable for use by individuals having malabsorption, maldigestion, and other gastrointestinal conditions.
- the nutritional products may be useful as providing a nutrition source using hydrolyzed proteins and having improved organoleptic properties, such as in sports drinks.
- the nutritional products may be administered orally as needed to provide the desired level of nutrition, most typically in the form of one, two, three, four, five, six, seven, eight or more servings daily. Serving sizes may vary greatly and may range from about 1 to about 500 ml, including from about 5 to about 250 ml, including from about 10 to about 240 ml.
- exemplified amounts are weight percentages based upon the total weight of the
- compositions are nutritional products prepared in
- Filtered (F) indicates that the sample is subjected to the second
- control sample (Intact) is not subjected to any hydrolysis
- DH (% AN/TN) 8.68 12.63 15.07 16.67 17.07 22.17 21.91 22.75 23.64 26.43 28.56
- Example 2 the hypoallergenic potential of the pea protein hydrolysates analyzed in Example 1 are evaluated and compared to the intact pea
- enzyme-linked immunosorbent assay which measures the rabbits' antigen-specific IgG response to the intact pea protein/pea protein hydrolysate immunogen.
- each rabbit is immunized with 5.0 mg of pea
- CFA Complete Freund's Adjuvant
- an immune response index is determined by dividing the normalized day 35 antibody titer by the normalized baseline (day 0) titer of day 0 for each antiserum. Immunization groups contain 5-10 animals and the results for each animal are averaged. Comparisons of the antigen-specific IRI results predict hypoallergenic clinical performance. The results are provided in the table below:
- the pea protein hydrolysates show a wide range of antibody response.
- the low reactivity may indicate that the pea protein hydrolysates still have epitopes that are recognized as antigenic, but not immunogenic by the rabbits.
- pea protein hydrolysates BN, BF, CN, and CF showed a significantly lowered immunogenicity after hyperimmunization as compared to the other samples.
- the lowered immunogenicity of the pea protein hydrolysate samples indicates that the retained pea antigens do not have the capacity to stimulate an immune response.
- Example 2 the hypoallergenic potential of the pea protein hydrolysates analyzed in Example 1 are evaluated and compared to the intact pea protein isolate (ISO) sample of Example 1 using antigen content, measured by inhibition ELISA. In this assay, intact pea protein is coated onto ELISA plates.
- ISO intact pea protein isolate
- Example 1 sensory evaluation is conducted for two bench screening sessions to characterize the taste of the pea protein hydrolysate samples of Example 1 retorted in both water and an Alimentum® matrix (Abbott Laboratories, Columbus, Ohio).
- the Alimentum® matrix contains carbohydrate, fat, vitamins, and minerals so as to simulate the biochemistry of a hypoallergenic formula. It is used to assess the mutual organoleptic effects on hydrolysate and finished formula on each other within the product matrix following retort treatment.
- the samples are compared to the current hydrolysate (casein hydrolysate) used in Alimentum® and the intact pea protein isolate (ISO) of Example 1.
- hydrolyzed proteins are generally bitter, sour, salty, and/or beany.
- the samples are analyzed for intensity of various tastes, including for example: bitter, salt, sour, brothy, wet wool, acid sour, grassy/soybean, starchy, woody/sawdust, green/beany/dried peas, drying, powdery, oily, sulfidy/cabbage, burnt cheese, and gritty.
- intensity of various tastes including for example: bitter, salt, sour, brothy, wet wool, acid sour, grassy/soybean, starchy, woody/sawdust, green/beany/dried peas, drying, powdery, oily, sulfidy/cabbage, burnt cheese, and gritty.
- Aromatic styrene resin Aromatic styrene resin
- Examples 5-34 illustrate various infant formula nutritional powders of the present disclosure including pea protein hydrolysate as at least one source of protein, and in some cases the sole source of protein, the ingredients of which are listed in the table below.
- the pea protein hydrolysate has a degree of hydrolysis (adjusted) of from about 7.0% to less than 19.0%. These products are prepared by various methods in separate batches, are reconstituted with water prior to use to the desired target ingredient concentrations.
- the embodiments set forth below that include pea protein hydrolysate as the sole source of protein are hypoallergenic embodiments.
- Vitamin/Mineral/Taurine Premix 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg
- Vitamin A, D3, E, & Kl Premix 8.7 kg 8.7 kg 8.7 kg 8.7 kg 8.7 kg 8.7 kg
- Beta-Carotene in vegetable oil 28.3 g 28.3 g 28.3 g 28.3 g 28.3 g 28.3 g
- Example 10 Example 11 Example 12 Example 13 Example 14
- Vitamin/Mineral/Taurine Premix 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg
- Vitamin A, D3, E, & Kl Premix 8.7 kg 8.7 kg 8.7 kg 8.7 kg 8.7 kg 8.7 kg
- Beta-Carotene in vegetable oil 28.3 g 28.3 g 28.3 g 28.3 g 28.3 g 28.3 g
- Example 15 Example 16 Example 17 Example 18 Example 19
- Vitamin/Mineral/Taurine Premix 1.4 kg 1.4 kg 1.4 kg 1.4 kg
- Vitamin ADEK Premix 372.6 g 372.6 g 372.6 g 372.6 g 372.6 g 372.6 g
- Example 20 Example 21 Example 22 Example 23 Example 24
- Vitamin/Mineral/Taurine Premix 1.4 kg 1.4 kg 1.4 kg 1.4 kg
- Vitamin ADEK Premix 372.6 g 372.6 g 372.6 g 372.6 g 372.6 g 372.6 g
- Soybean Oil 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg
- Example 30 Example 31 Example 32 Example 33 Example 34
- Soybean Oil 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg
- Examples 35-54 illustrate nutritional emulsion embodiments of the
- pea protein hydrolysate as at least one source of protein, and in some cases, the sole source of protein, the ingredients of which are listed in the table below.
- pea protein hydrolysates as the sole source of protein are hypoallergenic embodiments.
- Arachidonic Acid Oil 366.4 g 366.4 g 366.4 g 366.4 g 366.4 g 366.4 g 366.4 g
- Docosahexaenoic Acid Oil 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g
- Vitamin ADEK Premix 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g
- Example 40 Example 41 Example 42 Example 43 Example 44
- Docosahexaenoic Acid Oil 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g
- Vitamin ADEK Premix 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g
- Oil Soluble Vitamin Premix 2.37 kg 2.37 kg 2.37 kg 2.37 kg
- Example 50 Example 51 Example 52 Example 53 Example 54
- Oil Soluble Vitamin Premix 2.37 kg 2.37 kg 2.37 kg 2.37 kg
- Examples 55-64 illustrate nutritional emulsions of the present disclosure, the ingredients of which are listed in the table below.
- nutritional emulsions at least three separate slurries (e.g., CHO-MIN slurry, PIW).
- slurries e.g., CHO-MIN slurry, PIW
- pea protein hydro lysates as the sole source of protein are hypoallergenic embodiments.
- Example 55 Example 56 Example 57 Example 58 Example 59
- Vitamin A,D, E Premix 0.0758 0.0758 0.0758 0.0758 0.0758 0.0758 0.0758 0.0758
- Example 60 Example 61 Example 62 Example 63 Example 64
- Vitamin A,D, E Premix 0.0758 0.0758 0.0758 0.0758 0.0758 0.0758 0.0758 0.0758
- Examples 65-74 illustrate substantially clear nutritional liquids of the present disclosure, the ingredients of which are listed in the table below.
- To prepare the nutritional liquids at least two separate slurries (e.g., CHO-MIN slurry and PIW slurry) are prepared and then blended together, heat-treated, homogenized, and standardized. The resulting composition is aseptically packaged into plastic bottles or retort sterilized.
- hydro lysates as the sole source of protein are hypoallergenic embodiments.
- Example 65 Example 66 Example 67 Example 68 Example 69
- Vitamin A Palmitate** 4.2 g 4.2 g 4.2 g 4.2 g 4.2 g 4.2 g
- WSV Vitamin Premix 37.9 g 37.9 g 37.9 g 37.9 g 37.9 g 37.9 g
- Niacinamide *** 14.2 g 14.2 g 14.2 g 14.2 g 14.2 g d-Calcium pantothenate*** 9.2 g 9.2 g 9.2 g 9.2 g 9.2 g
- Example 70 Example 71 Example 72 Example 73 Example 74
- Vitamin A Palmitate** 4.2 g 4.2 g 4.2 g 4.2 g 4.2 g 4.2 g
- WSV Vitamin Premix 37.9 g 37.9 g 37.9 g 37.9 g 37.9 g 37.9 g
- Niacinamide *** 14.2 g 14.2 g 14.2 g 14.2 g 14.2 g d-Calcium pantothenate*** 9.2 g 9.2 g 9.2 g 9.2 g 9.2 g
- Beta-Alanine 0 0 0 1.0 1.0
- Examples 75-84 illustrate concentrated liquid human milk fortifiers of the present disclosure, the ingredients of which are listed in the table
- At least three separate slurries e.g., CHO-MIN slurry and PIW slurry are prepared and then blended
- Example 75 Example 76 Example 77 Example 78 Example 79
- Vitamin D3 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g
- Example 80 Example 81 Example 82 Example 83 Example 84
- Vitamin D3 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g
- Example 85 Example 86 Example 87 Example 88 Example 89
- Vitamin D 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g
- Example 90 Example 91 Example 92 Example 93 Example 94
- Vitamin D 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g
- the gelled human milk fortifier is prepared by solubilizing and
- macronutrients (carbohydrate, protein, fat and minerals) are combined in multiple
- Example 95 Example 96 Example 97 Example 98 Example 99
- Vitamin D3 152 g 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg
- Example 100 Example 101 Example 102 Example 103 Example 104
- Non-Fat Milk Solids 682.5 kg 546 kg 409.5 kg 273 kg 136.5 kg
- Vitamin D3 152 g 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg
- Examples 105-114 illustrate nutritional powders of the present disclosure, the ingredients of which are listed in the table below. These products are prepared by spray drying methods in separate batches, are reconstituted with water prior to use to the desired target ingredient concentrations. All ingredient amounts are listed as kg per 1000 kg batch of product, unless otherwise specified.
- Example 105 Example 106 Example 107 Example 108 Example 109
- Vitamin premix 1.0 1.0 1.0 1.0 1.0
- Citric acid As needed As needed As needed As needed As needed As needed As needed As needed,
- Example 110 Example 111 Example 112 Example 113 Example 114
- Vitamin premix 1.0 1.0 1.0 1.0 1.0
- Citric acid As needed As needed As needed As needed As needed As needed As needed As needed,
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Abstract
Disclosed are nutritional products comprising pea protein hydrolysates as a primary or sole source of protein. The nutritional products include nutritional liquids, powders, bars, and other food products, wherein the resulting nutritional products are physically stable over shelf life and provide favorable organoleptic properties. These nutritional products may be used as a nutritional source for individuals who are intolerant and/or allergic to cow milk proteins and soy proteins and/or who have malabsorption, maldigestion, or other gastroinstestinal conditions.
Description
NUTRITIONAL PRODUCTS INCLUDING PEA PROTEIN HYDROLYSATES
FIELD OF THE DISCLOSURE
[0001] The present disclosure relates to nutritional products comprising pea protein hydrolysates. More particularly, the present disclosure relates to infant, pediatric and adult nutritional products comprising pea protein hydrolysates having lowered immunological reactivity and improved flavor and organoleptic properties, including emulsion stability.
BACKGROUND OF THE DISCLOSURE
[0002] Adult, pediatric, and infant manufactured nutritional liquids and powders comprising a targeted selection of nutritional ingredients are well known and widely available, some of which may provide a sole source of nutrition, while others may provide a supplemental source. These nutritionals include powders that can be reconstituted with water or other aqueous liquid, as well as concentrated and ready-to- drink nutritional liquids such as milk or protein based emulsions or non-emulsified or substantially clear liquids. These nutritional liquids are especially useful when formulated with selected nutritional ingredients.
[0003] Many individuals, and particularly infants, including preterm infants, experience intolerance to certain nutritional ingredients in the liquids and powders (formula intolerance). The terms "intolerance" and "formula intolerance" are used interchangeably herein. Intolerance is a non-immune system associated reaction and may be evidenced by behavior or stool or feeding pattern changes such as increased vomiting, an increased number of stools, or more watery stools as compared to individuals who tolerate nutritional ingredients well. Intolerance is most often indicated by gastrointestinal symptoms (e.g. emesis, stool patterns and gas) as well as behavioral characteristics (e.g. acceptance of formula, fussing and crying).
[0004] Intolerance can be contrasted with the allergic-type reactions that some individuals, and especially infants, exhibit to certain nutritional compositions. These allergic-type reactions are immune system associated, and may be caused by the individual's sensitivity to the protein present (generally cow milk protein) in the
nutritional. These immune system associated allergies or sensitivities often result in cutaneous, respiratory or gastrointestinal symptoms such as vomiting and diarrhea.
[0005] Many individuals who exhibit allergies or sensitivities to cow milk proteins are able to utilize nutritional products based on soy proteins, and in particular, isolated soy proteins.
[0006] Hydrolysate-based formulas, some of which may be hypoallergenic, contain protein that has been hydrolyzed or broken down into short peptide fragments and amino acids and as a result is immunologically substantially inactive. Individuals who exhibit reactions to cow milk and soy proteins often will not react to hydrolysate formulas because their immune system does not recognize the hydrolyzed protein as the intact protein that causes their symptoms. Individuals who exhibit immune system-associated reactions to nutritional compositions including cow milk and/or soy proteins may also exhibit non-immune system associated reactions (formula intolerance), as previously described.
[0007] Although products based on extensively hydrolyzed proteins or amino acid mixtures are generally acceptable for individuals who are allergic to cow milk and soy proteins, they suffer from significant taste and organoleptic issues. While many attempts to avoid formula allergies and intolerance have been made by preparing nutritional compositions using hydrolyzed proteins, and particularly hydrolyzed soy proteins, it was not previously known how to formulate a nutritional product using hydrolyzed proteins without significantly adversely affecting the organoleptic properties of the product, and in particular, taste. For example, the use of hydrolyzed proteins commonly results in nutritional products that easily separate and/or precipitate out of solution, and further, are bitter, salty, sour, and/or beany in flavor.
[0008] The present disclosure is therefore directed to nutritional products in the form of nutritional liquids, powders, bars, and other food products comprising pea protein hydrolysates as the primary or sole source of protein. The pea protein hydrolysate has a degree of hydrolysis such that the resulting nutritional products are physically stable over shelf life and provide favorable organoleptic properties, while
remaining substantially immunologically inactive. The nutritional product may also be used as a nutritional source for individuals who are intolerant and/or allergic to proteins other than pea proteins and/or who have malabsorption, maldigestion, or other gastroinstestinal conditions.
SUMMARY OF THE DISCLOSURE
[0009] One embodiment is a nutritional product including a pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% to less than 19.0%), including between about 8.0%> and about 16.0%, including between about 8%o and about 13.5%, and also including between about 12.0% and 16.0%.
Additionally, in one embodiment, less than 5% of the proteins in the pea protein hydrolysate have a molecular weight of greater than 3 kDa. The product is in a form selected from the group consisting of a liquid beverage (e.g., nutritional emulsions, substantially clear nutritional liquids, and gels), a powder, a food product, a nutritional bar, and a nutritional supplement. Desirably, the product is an infant formula.
[0010] Another embodiment is a nutritional product including a pea protein hydrolysate having less than 15,000 μg of immunologically active pea antigen per 1 gram of protein.
[0011] Another embodiment is a method of making a nutritional product comprising combining a protein, a fat, and a carbohydrate. The nutritional product includes a pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% and less than 19.0% as its primary or sole source of protein. In one embodiment, less than 5% of the proteins in the pea protein hydrolysate have a molecular weight of greater than 3 kDa. In another embodiment, the pea protein hydrolysate has less than 15,000 μg of immunologically active pea antigen per 1 gram of protein.
[0012] The nutritional products as described herein comprise pea protein hydrolysates as sole or primary source of protein that not only provide a nutritional source for individuals who are intolerant and/or allergic to cow milk proteins and/or soy proteins, but also is physically stable and/or has organoleptic benefits in each of
the selected product forms. In many embodiments, described herein, pea protein hydrolysate is the sole protein source such that the nutritional product is
hypoallergenic and suitable for use in food-allergic patients.
[0013] It has now been found that these intolerance and/or allergic issues can be minimized or eliminated by formulating the nutritional product with a pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% and less than 19.0%, which produces a specific molecular weight profile and antigen content. Specifically, the use of these pea protein hydrolysates has been found to have reduced immunological activity. Further, pea protein hydrolysates having an adjusted degree of hydrolysis of between about 7.0%> and less than 19.0% provide improved flavor and other improved organoleptic properties as compared to nutritional products including other hydro lyzed vegetable protein sources. As such, utilizing the hydrolyzed pea protein of the present disclosure it is now possible to produce pleasant tasting, hypoallergenic, tolerant hydrolysate -based nutritionals.
BRIEF DESCRIPTION OF THE DRAWINGS
[0014] FIG. 1 is a chart depicting the composition comparison between pea protein hydrolysates of the present disclosure and intact soy protein.
DETAILED DESCRIPTION OF THE DISCLOSURE
[0015] The nutritional products described herein comprise pea protein hydrolysates as a source of protein. In many embodiments, the nutritional products comprise pea protein hydrolysates as a sole protein source such that the nutritional product is hypoallergenic and suitable for use in food-allergic patients. These and other essential features of the nutritional products, as well as some of the many optional variations and additions, are described in detail hereafter.
[0016] The term "hypoallergenic" as used herein, unless otherwise specified, refers to a nutritional product that causes symptoms of an allergic reaction to food in less than 10%> of food-allergic individuals.
[0017] The term "substantially clear nutritional liquid" as used herein, unless otherwise specified, refers to a non-emulsified or similar other liquid having a visibly clear or translucent appearance, which liquid may and typically will have a thin or watery texture with a consistency similar to that of a clear juice and most typically having a viscosity of less than about 25 centipoise as determined by a Brookfield viscometer at 22°C using a #1 spindle at 60 rpm.
[0018] The term "spray dried nutritional powder" as used herein, unless otherwise specified, refers to a nutritional powder wherein the majority of the components, including the pea protein hydrolysate, have been homogenized and subsequently subjected to a spray drying process during manufacturing. Additional ingredients can be added to the spray dried powder through dry blending so long as at least the pea protein hydrolysate has been previously homogenized and spray dried.
[0019] The term "adjusted degree of hydrolysis" as used herein, unless otherwise specified, refers to the degree of hydrolysis of a specified protein material, generally pea protein material, that has been adjusted or corrected to account for the measurable amino nitrogen content of the intact protein material. For example, if the intact, unmodified protein material has an amino nitrogen content of 8.68 and a protein that has been subjected to a hydrolysis procedure has a degree of hydrolysis of 16.68, the hydrolyzed protein has an adjusted degree of hydrolysis of 8.00.
[0020] The terms "fat" and "oil" as used herein, unless otherwise specified, are used interchangeably to refer to lipid materials derived or processed from plants or animals. These terms also include synthetic lipid materials so long as such synthetic materials are suitable for oral administration to humans.
[0021] The term "human milk oligosaccharide" or "HMO" refers generally to a number of complex carbohydrates found in human milk. Monomers found in milk oligosaccharides typically include D-glucose (Glc), D-galactose (Gal), N- acetylglucosamine (GlcNAC), L-fucose (Fuc), and sialic acid [N-acetylneuraminic acid (NeuAc)]. Elongation of these monomers may be achieved by attachment of GlcNAc residues linked in β 1-3 or β 1-4 linkage to a Gal residue followed by further addition of Gal in a β-1-3 or β-1-4 bond. Most HMOs carry lactose at their reducing
end. From these monomers, a large number of core structures may be formed.
Further variations may occur due to the attachment of lactosamine, Fuc, and/or NeuAc.
[0022] The term "shelf stable" as used herein, unless otherwise specified, refers to a nutritional product that remains commercially stable after being packaged and then stored at 18-24°C for at least 3 months, including from about 6 months to about 24 months, and also including from about 12 months to about 18 months.
[0023] The terms "nutritional composition" or "nutritional product" as used herein, are used interchangeably and, unless otherwise specified, refer to nutritional liquids, nutritional powders, nutritional bars, nutritional supplements, and any other nutritional food product as known in the art. The nutritional powders may be reconstituted to form a nutritional liquid, all of which comprise one or more of fat, protein and carbohydrate and are suitable for oral consumption by a human.
[0024] The term "nutritional liquid" as used herein, unless otherwise specified, refers to nutritional products in ready-to-drink liquid form, concentrated form, and nutritional liquids made by reconstituting the nutritional powders described herein prior to use.
[0025] The term "infant" as used herein, unless otherwise specified, refers to a child 12 months or younger. The term "toddler" as used herein, refers to a child from 6 months to three years of age. The term "child" as used herein, refers to a user from birth up to 13 years of age. The term "preterm infant" as used herein, refers to an infant born prior to 36 weeks of gestation.
[0026] All percentages, parts and ratios as used herein, are by weight of the total composition, unless otherwise specified. All such weights, as they pertain to listed ingredients, are based on the active level and, therefore, do not include solvents or by-products that may be included in commercially available materials, unless otherwise specified.
[0027] All references to singular characteristics or limitations of the present disclosure shall include the corresponding plural characteristic or limitation, and vice versa, unless otherwise specified or clearly implied to the contrary by the context in which the reference is made.
[0028] All combinations of method or process steps as used herein can be performed in any order, unless otherwise specified or clearly implied to the contrary by the context in which the referenced combination is made.
[0029] The various embodiments of the nutritional products of the present disclosure may also be substantially free of any optional or selected essential ingredient or feature described herein, provided that the remaining nutritional product still contains all of the required ingredients or features as described herein. In this context, and unless otherwise specified, the term "substantially free" means that the selected nutritional product contains less than a functional amount of the optional ingredient, typically less than about 1%, including less than about 0.5%, including less than about 0.1%, and also including zero percent, by weight of such optional or selected essential ingredient.
[0030] The nutritional products may comprise, consist of, or consist essentially of the essential elements of the products as described herein, as well as any additional or optional element described herein or otherwise useful in nutritional product applications.
Product Form
[0031] The nutritional compositions of the present disclosure including the pea protein hydrolysate may be formulated and administered in any known or otherwise suitable oral product form. Any solid, liquid, or powder form, including combinations or variations thereof, are suitable for use herein, provided that such forms allow for safe and effective oral delivery to the individual of the essential ingredients as also defined herein.
[0032] The nutritional compositions of the present disclosure include pea protein hydrolysates as described herein. The compositions may include pea protein hydro lysates as the sole source of protein (i.e., pea protein hydrolysates are 100% of the protein component of the composition) or they may include pea protein
hydrolysates in combination with other hydrolyzed, partially hydrolyzed, or unhydrolyzed (intact) proteins as described herein. The compositions include any product form comprising the essential ingredients described herein, and which is safe and effective for oral administration. The nutritional compositions may be formulated to include only the essential ingredients described herein, or may be modified with optional ingredients to form a number of different product forms. The nutritional compositions of the present disclosure are preferably formulated as dietary product forms, which are defined herein as those embodiments comprising the essential ingredients of the present disclosure in a product form that then contains at least one of fat, protein, and carbohydrate, and preferably also contains vitamins, minerals, or combinations thereof. In many embodiments, the composition will comprise pea protein hydrolysate as the sole source of protein in combination with fat,
carbohydrate, vitamins, and minerals to produce a hypoallergenic composition. One specific example is a hypoallergenic infant formula including 100% pea protein hydrolysates as the protein source, fat, carbohydrate, vitamins and minerals.
[0033] The nutritional compositions of the present disclosure may therefore include a variety of different product forms, including most any conventional or otherwise known food product form, some non-limiting examples of which include confectionary products, cereals, food condiments (e.g., spreads, powders, sauces, jams, jelly, coffee creamer or sweetener), pasta, baking or cooking materials (e.g., flour, fats or oils, butter or margarine, breading or baking mixes), salted or seasoned snacks (e.g., extruded, baked, fried), beverages (e.g., coffee, juice, carbonated beverage, non-carbonated beverage, tea), snack or meal replacement bars (e.g., Slimfast™ bars, Ensure™ bars, Zone perfect™ bars, Glucerna™ bars), smoothies, breakfast cereals, cheeses, gummie products, salted or unsalted crisp snacks (e.g., chips, crackers, pretzels), dips, baked goods (e.g., cookies, cakes, pies, pastries, bread, bagels, croutons, dressings, dry mixes (e.g., mixes for muffins, cookies, waffles, pancakes, beverages), frozen desserts (e.g., ice cream, popsicles, fudge bars, crushed
ice, frozen yogurt), pasta, processed meats (e.g., corn dogs, hamburgers, hotdogs, sausage, pepperoni), pizza, pudding, flavored or unflavored gelatin, refrigerated dough (e.g., cookies, bread, brownies), yogurt or yogurt-based drinks, frozen yogurt, soups, vegetable-based burgers, and popcorn-based snacks.
[0034] The nutritional compositions of the present disclosure may also be formulated in product forms such as capsules, tablets, pills, caplets, gels, liquids (e.g., suspensions, solutions, emulsions, clear solutions), powders or other particulates, and so forth. These product forms generally contain only the essential ingredients as described herein, optionally in combination with other actives, processing aids or other dosage form excipients.
[0035] The nutritional products include liquid and spray dried powder forms, which includes ready-to-feed emulsified liquids and spray dried reconstitutable powders that can be diluted with water or other aqueous liquid to form a nutritional liquid prior to use.
[0036] Specifically, the nutritional composition may be human milk fortifiers for preterm infants intolerant to formulas based on cow milk proteins or soy proteins, human milk fortifiers for infants allergic to cow milk proteins or soy proteins, preterm infant formulas for preterm infants intolerant to formulas based on cow milk proteins or soy proteins, or preterm infant formulas for preterm infants allergic to cow milk proteins or soy proteins, infant formulas for infants intolerant to formulas based on cow milk proteins or soy proteins, infant formulas for infants allergic to cow milk proteins or soy proteins, hypoallergenic formulas for infants with food allergies generally, follow-on infant formulas for infants intolerant to formulas based on cow milk proteins or soy proteins, follow-on infant formulas for infants allergic to formulas based on cow milk proteins or soy proteins, toddler formulas for infants greater than six months of age who are intolerant to formulas based on cow milk proteins or soy proteins, toddler formulas for infants greater than six months of age who are allergic to formulas based on cow milk proteins or soy proteins, nutritional drinks for children and adults who are intolerant to nutritionals based on cow milk proteins or soy proteins, nutritional drinks for children and adults who are allergic to nutritionals based on cow milk proteins or soy proteins, nutritional drinks
for geriatric patients who are intolerant to nutritionals based on cow milk proteins or soy proteins, nutritional drinks for geriatric patients who are allergic to nutritionals based on cow milk proteins or soy proteins, sports nutritional drinks for people who are intolerant to nutritionals based on cow milk proteins or soy proteins, sports nutritional drinks for people who are allergic to nutritionals based on cow milk proteins or soy proteins, sports nutritional drinks using hydrolyzed proteins with improved organoleptic properties, nutritional bars using hydrolyzed proteins with improved organoleptic properties, semi-elemental formulas for the nutritional needs of patients with malabsorption, maldigestion, and other gastrointestinal conditions, and formulas, bars, liquid or powdered protein supplements, or other food forms based on hydrolyzed proteins designed for patients who require hydrolyzed protein to manage their diets.
[0037] The nutritional compositions of the present disclosure, when formulated as a dietary product form, may potentially provide either a sole source or a supplemental source of nutrition to an individual. In this context, a sole source of nutrition is one that can be administered once or multiple times each day to potentially provide an individual with all or substantially all their fat, protein, carbohydrate, mineral, and vitamin needs per day or during the intended period of administration. A supplemental source of nutrition is defined herein as a dietary source that does not provide an individual with a potentially sole source of nutrition.
Liquid Beverages
[0038] Liquid beverages include concentrated and ready-to-feed liquids. Non- limiting examples of liquid product forms suitable for use herein include liquid infant formulas (including both ready-to-feed formulations and concentrated formulations), liquid toddler formulas (including both ready-to-feed formulations and concentrated formulations), liquid human milk fortifiers (including both ready-to-feed and concentrated formulations), snack and meal replacement products, hot or cold beverages, carbonated or non carbonated beverages, juices or other acidified beverages, shakes, coffees, teas, enteral feeding compositions, and so forth. These liquid compositions are most typically formulated as suspensions or emulsions, but
can also be formulated in any other suitable form such as clear liquid solutions, liquid gels, and so forth.
[0039] The nutritional liquid beverages of the present disclosure may be used as nutritional drinks for pre-term infants, infants, toddlers, children, and adults, including geriatric patients, who are intolerant or allergic to nutritionals based on cow milk proteins and/or soy proteins. The liquid beverages may also be used as semi- elemental formulas for the nutritional needs of patients with malabsorption, maldigestion, and other gastrointestinal conditions.
A. Nutritional Emulsions
[0040] Nutritional emulsions comprise pea protein hydrolysate as the primary or sole source of protein and are aqueous emulsions further comprising fats and carbohydrates. These emulsions are flowable or drinkable liquids at from about 1°C to about 25°C and are typically in the form of oil-in- water, water-in-oil, or complex aqueous emulsions, although such emulsions are most typically in the form of oil-in-water emulsions having a continuous aqueous phase and a discontinuous oil phase.
[0041] The nutritional emulsions may be and typically are shelf stable. The nutritional emulsions typically contain up to about 95% by weight of water, including from about 50%> to about 95%, also including from about 60%> to about 90%>, and also including from about 70% to about 85%, of water by weight of the nutritional emulsions.
[0042] The nutritional emulsions may be formulated with sufficient kinds and amounts of nutrients so as to provide a sole, primary, or supplemental source of nutrition, or to provide a specialized nutritional emulsion for use in individuals afflicted with specific diseases or conditions. For example, nutritional emulsions can be produced for use as infant, follow-on infant and toddler formulas, adult formulas and the like for users who are intolerant or allergic to nutritionals based on cow milk proteins and/or soy proteins. In another embodiment, the emulsions can be used as a hypoallergenic nutritional emulsion by individuals that have general food allergies. These nutritional emulsions may thus have a variety of product densities, but most
typically have a density greater than about 1.03 g/ml, including greater than about 1.04 g/ml, including greater than about 1.055 g/ml, including from about 1.06 g/ml to about 1.12 g/ml, and also including from about 1.085 g/ml to about 1.10 g/ml.
[0043] The nutritional emulsions may have a caloric density tailored to the nutritional needs of the ultimate user, although in most instances the emulsions comprise from about 100 to about 500 kcal/240 ml, including from about 150 to about 350 kcal/240 ml, and also including from about 200 to about 320 kcal/240 ml.
[0044] In an alternative embodiment, the nutritional emulsion is a low- calorie nutritional emulsion and has a caloric density of about 6.5 kcal/fl oz (52.8 kcal/240 ml). In another embodiment, the nutritional emulsion has a caloric density of about 7.1 kcal/fl oz (57.6 kcal/240 ml). In one embodiment, the nutritional emulsion has a caloric density of about 7.7 kcal/fl oz (62.4 kcal/ml).
[0045] The nutritional emulsion may have a pH ranging from about 3.5 to about 8, but are most advantageously in a range of from about 4.5 to about 7.5, including from about 5.5 to about 7.3, including from about 6.2 to about 7.2.
[0046] Although the serving size for the nutritional emulsion can vary depending upon a number of variables, a typical serving size ranges from about 100 to about 300 ml, including from about 150 to about 250 ml, and including from about 190 ml to about 240 ml.
[0047] In one embodiment, the nutritional emulsion can be used as a human milk fortifier. In such embodiments, a typical single serving size includes about 5.0 ml.
B. Substantially Clear Liquid Beverages
[0048] The substantially clear nutritional liquids of the present disclosure are thin liquids comprising at least protein, at least a portion of the proteins being pea protein hydrolysate, and carbohydrate as discussed below. The substantially clear nutritional liquids are substantially fat free; that is, the liquids are devoid of added fat except for that fat inherent to the raw materials or added fat at low concentrations to aid in the manufacture of the liquid. In this context, the term "fat free" means that the
liquid typically contains less than 1.0 %, more typically less than 0.5%, and more typically less than 0.1%, including zero percent, fat by weight of the nutritional liquid. These substantially clear nutritional liquids are flowable or drinkable liquids at from about FC to about 25°C.
[0049] The substantially clear nutritional liquids may be and typically are shelf-stable. The liquids typically contain up to about 95% by weight of water, including from about 50% to about 95%, also including from about 60% to about 90%), and also including from about 70%> to about 85%, of water by weight of the substantially clear nutritional liquid.
[0050] The substantially clear nutritional liquids may be formulated with sufficient kinds and amounts of nutrients so as to provide a supplemental source of nutrition, or to provide a specialized nutritional liquid for use in individuals afflicted with specific diseases or conditions. For example, in one embodiment, the
substantially clear nutritional liquid is a sports drink for use by users who are intolerant or allergic to nutritionals based on cow milk protein and/or soy proteins. In another embodiment, the substantially clear nutritional liquid is a sports drink including hydro lyzed protein with improved organoleptic properties. These substantially clear nutritional liquids may thus have a variety of product densities, but most typically have a density greater than about 1.040 g/ml, including from 1.06 g/ml to 1.12 g/ml, and also including from about 1.085 g/ml to about 1.10 g/ml.
[0051] The substantially clear nutritional liquids may have a caloric density tailored to the nutritional needs of the ultimate user, although in most instances the liquids comprise from about 90 to about 500 kcal/240 ml, including from about 150 to about 350 kcal/240 ml, including from about 180 to about 350 kcal/240 ml and also including from about 250 to about 320 kcal/240 ml. In other embodiments, the substantially clear nutritional liquids comprise from about 90 to about 500 kcal 480 ml, including from about 150 to about 350 kcal/480 ml, and also including from about 250 to about 320 kcal/480 ml.
[0052] The substantially clear nutritional liquids have a pH ranging from about 2.8 to about 4.6, including from about 2.9 to about 4.2, and also including from about 3.1 to about 3.9.
[0053] Although the serving size for the substantially clear nutritional liquid can vary depending upon a number of variables, a typical serving size ranges from about 100 to about 591 ml, including from about 150 to about 250 ml, including from about 190 ml to about 240 ml. Some specific serving sizes for the substantially clear nutritional liquid include 240 ml (8.1 ounce), 296 ml (10 ounce) and 480 ml (16 ounce).
Nutritional Powders
[0054] The nutritional powders comprise pea protein hydrolysates as a primary or sole source of protein and are typically in the form of flowable or substantially flowable particulate compositions, or at least particulate compositions. Particularly suitable product forms include spray dried, agglomerated or dryblended powder compositions. The compositions can easily be scooped and measured with a spoon or similar other device, wherein the compositions can easily be reconstituted by the intended user with a suitable aqueous liquid, typically water, to form a nutritional formulation for immediate oral or enteral use. In this context, "immediate" use generally means within about 48 hours, most typically within about 24 hours, preferably right after reconstitution.
[0055] The nutritional powders may be formulated with sufficient kinds and amounts of nutrients so as to provide a sole, primary, or supplemental source of nutrition, or to provide a specialized nutritional powder for use in individuals afflicted with specific diseases or conditions. In one specific embodiment, the nutritional powder may be formulated for use with individuals who are intolerant or allergic to nutritionals based on cow milk proteins and/or soy proteins. In another embodiment, the emulsions can be used as hypoallergenic nutritional emulsions by individuals that have general food allergies.
[0056] The nutritional powders may be reconstituted with water prior to use to a caloric density tailored to the nutritional needs of the ultimate user, although in most instances the powders are reconstituted with water to form compositions comprising from about 100 to about 500 kcal/240 ml, including from about 150 to about 350 kcal/240 ml, and also including from about 200 to about 320 kcal/240 ml.
[0057] In an alternative embodiment, the nutritional powder may be reconstituted with water to form a low-calorie composition having a caloric density of about 52.8 kcal/240 ml. In another embodiment, the nutritional powder has a caloric density of about 57.6 kcal/240 ml. In one embodiment, the nutritional powder has a caloric density of about 62.4 kcal/240 ml.
[0058] Although the serving size for the reconstituted nutritional liquid can vary depending upon a number of variables, a typical serving size ranges from about 100 to about 300 ml, including from about 150 to about 250 ml, including from about 190 ml to about 240 ml.
[0059] In one specific embodiment, the reconstituted nutritional liquid can be used as a human milk fortifier. In such embodiments, a typical single serving size includes about 0.9 grams of powder per about 100 to about 300 ml of water.
Other Solid Nutritional Products
[0060] The nutritional products can alternatively be in the form of solid nutritional bars and food products. For example, the nutritional products may be formulated as bars, sticks, or cookies, breads, cakes or other baked goods.
[0061] In another embodiment, the nutritional compositions of the present disclosure may also be formulated in product forms such as capsules, tablets, pills, caplets, and gels. These product forms generally contain only the essential ingredients as described herein, optionally in combination with other actives, processing aids or other dosage form excipients.
Infant Formulas
[0062] When the nutritional product is an infant formula, the nutritional product may be a liquid or solid nutritional product as described above. The liquid or solid infant formula products of the present disclosure may have any caloric density suitable for the targeted infants, or provide such a density upon reconstitution of a powder embodiment or upon dilution of a liquid concentrate embodiment. For example, most common caloric densities for the infant formula embodiments of the present disclosure are generally at least about 19 kcal/fl oz (660 kcal/liter), more typically from about 20 kcal/fl oz (675-680 kcal/liter) to about 25 kcal/fl oz (820 kcal/liter), even more typically from about 20 kcal/fl oz (675-680 kcal/liter) to about 24 kcal/fl oz (800-810 kcal/liter). Generally, the 22-24 kcal/fl oz formulas are more commonly used in preterm or low birth weight infants, and the 20-21 kcal/fl oz (675- 680 to 700 kcal/liter) formulas are more often used in term infants.
[0063] In an alternative embodiment, the infant formula is a low-calorie infant formula and has a caloric density of about 6.5 kcal/fl oz (220 kcal/liter). In another embodiment, the infant formula has a caloric density of about 7.1 kcal/fl oz (240 kcal/liter). In one embodiment, the infant formula has a caloric density of about 7.7 kcal/fl oz (260 kcal/liter).
[0064] Although total concentrations or amounts of the fat, protein, and carbohydrates may vary depending upon the product form (i.e., powder, ready-to-feed liquid, or concentrated liquid) and targeted dietary needs of the intended user, such concentrations or amounts most typically fall within one of the following embodied ranges, inclusive of any other essential fat, protein, and or carbohydrate ingredients as described herein.
[0065] For the liquid infant formula products, carbohydrate concentrations most typically range from about 5% to about 40%, including from about 7% to about 30%), including from about 10%> to about 25%, by weight of the nutritional product; fat concentrations most typically range from about 1% to about 30%, including from about 2%> to about 15%, and also including from about 4% to about 10%>, by weight of the nutritional product; and protein concentrations most typically range from about
0.5% to about 30%), including from about 1% to about 15%, and also including from about 2%) to about 10%>, by weight of the nutritional product.
[0066] In an alternative embodiment, the liquid infant formula product is a low calorie liquid infant formula and includes less than about 5% by weight carbohydrate, about 1% by weight fat, and about 0.5%> by weight protein.
[0067] The level or amount of carbohydrates, fats, and or proteins in the liquid nutritional products may also be characterized in addition to or in the alternative as a percentage of total calories in the nutritional compositions as set forth in the following table. These macronutrients for liquid nutritional products of the present disclosure are most typically formulated within any of the caloric ranges (embodiments A-F) described in the following table (each numerical value is preceded by the term "about").
[0068] For example, liquid infant formulas (both ready-to-feed and concentrated liquids) include those embodiments in which the protein component may comprise from about 7.5% to about 25% of the caloric content of the formula; the carbohydrate component may comprise from about 35% to about 50% of the total caloric content of the infant formula; and the lipid component may comprise from about 30% to about 60% of the total caloric content of the infant formula. These
ranges are provided as examples only, and are not intended to be limiting. Additional suitable ranges are noted in the following table (each numerical value is preceded by the term "about").
[0069] When the nutritional product is a powdered infant formula, the protein component is present in an amount of from about 5% to about 35%, including from about 8% to about 12%, and including from about 10%> to about 12% by weight of the powdered nutritional product; the fat component is present in an amount of from about 10% to about 35%, including from about 25% to about 30%, and including from about 26% to about 28% by weight of the powdered nutritional product; and the carbohydrate component is present in an amount of from about 30% to about 85%), including from about 45% to about 60%, including from about 50% to about 55% by weight of the powdered infant formula.
[0070] The total amount or concentration of fat, carbohydrate, and protein, in the powdered nutritional products of the present disclosure can vary considerably depending upon the selected formulation and dietary or medical needs of the intended user. Additional suitable examples of macronutrient concentrations are set forth below. In this context, the total amount or concentration refers to all fat, carbohydrate, and protein sources in the powdered product. For powdered infant formulas, such total amounts or concentrations are most typically and preferably formulated within any of the embodied ranges described in the following table (all numbers have "about" in front of them).
Nutrient (% Calories) Embodiment A Embodiment B Embodiment C
Carbohydrate 20-85 30-60 35-55
Fat 5-70 20-60 25-50
Protein 2-75 5-50 7-40
Pea Protein Hydrolysate
[0071] The nutritional products comprise pea protein hydrolysate as a primary or sole source of protein. In nutritional embodiments where a hypoallergenic composition is desired (such as a hypoallergenic infant formula), the nutritional composition will include 100% pea protein hydrolysate, by weight of the protein component. The pea protein hydrolysates used in the products of the present disclosure have been found to show lowered immunological reactivity and improved flavor and organoleptic properties as compared to other vegetable protein
hydrolysates, such as soy proteins, as well as cow milk proteins. For example, as shown in FIG. 1, the pea protein hydrolysates for use in the nutritional products of the present disclosure have reduced levels of phytoestrogen (i.e., genistein and daidzein, which are isoflavones), aluminum, manganese, and phytates, thus improving the nutrient profile of the end nutritional product. Additionally, as described herein, the pea protein hydrolysate has a reduced antigen content and/or a reduced
immunological reactivity. Thus, the pea protein hydrolysates provide a good source of protein for nutritional products that are designed for individuals who are intolerant and/or allergic to cow milk proteins and/or soy proteins, as well as to meet the nutritional needs of individuals with malabsorption, maldigestion, and other gastrointestinal conditions. These nutritional products further have improved flavor and emulsion stability.
[0072] The pea protein hydrolysates may be the sole source of protein in the nutritional products of the present disclosure. Alternatively, additional protein sources, as described below, may be used in the products in combination with the pea protein hydrolysates to provide the total protein. Accordingly, the pea protein hydrolysate provides at least 50% of the total protein in the nutritional product, including from about 50% to about 100% of the total protein, including from about 60% to about 95% of the total protein, including from about 70% to about 90% of the total protein, and also including from about 75% to about 85% of the total protein in the nutritional product. As noted herein, the additional protein sources may include partially hydrolyzed, hydrolyzed, and/or unhydrolyzed (intact) proteins.
[0073] Particularly, it has been surprisingly found that by controlling the hydrolysis of a pea protein source, such as pea protein isolate or pea protein concentrate, to a particular degree, pea protein hydrolysates can be produced with lowered antigen content, and thus lowered immunological reactivity, without adversely affecting the flavor attributes of the hydrolysate. The pea protein hydrolysates described herein are superior to previously known soy proteins as they have: (1) non-detectable levels of isoflavones; (2) decreased phytate, manganese, and aluminum concentrations; (3) improved organoleptic and flavor profiles; and (4) are not genetically modified.
[0074] Generally, pea protein hydrolysates for use in the nutritional products of the present disclosure are produced by: (1) mixing a pea protein product having at least 65% protein (by weight dry matter) and water to form a slurry with a protein content of up to about 20%, preferably up to about 12%; (2) hydro lyzing the slurry; and (3) filtering the hydrolyzed slurry to obtain the protein hydrolysate.
[0075] The pea protein product used as raw material in step (1) can be any pea protein product, provided that the protein content thereof is at least 65 % by weight dry matter, i.e. pea protein concentrates (with a protein content of above 70% by weight dry matter), or pea protein isolates (with a protein content of above 90% by weight dry matter). Commercially available pea protein concentrates and isolates are well known in the art.
[0076] The pea protein product is mixed with water to form a slurry with a protein content of up to about 20%, preferably up to about 12%. In one or more embodiments, the slurry may be heated prior to hydrolysis to further denaturing. For example, in one embodiment, the method further includes heating the slurry to a temperature above 60°C prior to hydrolysis. More suitably, the slurry can be heated to a temperature of from about 70°C to about 90°C for a period of from about 2 minutes to about 20 minutes prior to hydrolysis. In this manner, the protein is effectively denatured, and thus, the subsequent hydrolysis will generally proceed more rapidly. Further, by heating the slurry, the microbial stability during the hydrolysis, which can last for several hours, is secured effectively.
[0077] Once formed, and optionally heated, the temperature of the slurry is preferably adjusted and maintained at from about 40°C to about 70°C, including from about 50°C to about 60°C, prior to and during the hydrolysis reaction in accordance with methods known in the art. Of course, other heating steps and/or temperatures can be utilized as are known in the art.
[0078] Hydrolysis of the protein-containing slurry can be conducted enzymatically or non-enzymatically. In one embodiment, the protein-containing slurry is hydrolyzed to have an adjusted degree of hydrolysis of between about 7.0% and less than 19.0%, including between about 8.0%> and about 16.0%, including between about 8.0%> and about 13.5%, also including between about 12.0% and about 14.00%, and also including about 14.0% and a molecular weight distribution and antigen content as set forth below. Such hydrolysis, in one embodiment, may be conducted proteolytically as is known in the art.
[0079] In another embodiment, the hydrolysis is carried out with one or more unspecific acting endo- and/or exo-peptidase enzymes. Suitable unspecific acting endo- and/or exo-peptidase enzymes include, for example, enzymes derived from a strain of Aspergillus, in particular a strain of Aspergillus niger, a strain of Aspergillus oryzae, or a strain of Aspergillus soyae, or a strain of Bacillus, in particular a strain of Bacillus amyloliquefaciens, a strain of Bacillus lentus, a strain of Bacillus licheniformis or a strain of Bacillus subtilis.
[0080] Additional suitable endopeptidase enzymes for use in hydrolysis step (2) include, for example: (i) a glutamyl endopeptidase (EC 3.4.21.19); (ii) a lysyl endopeptidase (EC 3.4.21.50); (iii) a leucyl endopeptidase (EC 3.4.21.57); (iv) a glycyl endopeptidase (EC 3.4.22.25); (v) a prolyl endopeptidase (EC 3.4.21.26); (vi) trypsin (EC 3.4.21.4) or a trypsin-like (lysine/arginine specific) endopeptidase; or (vii) a peptidyl-Asp metalloendopeptidase (EC 3.4.24.33). Additional suitable exopeptidase enzymes include, for example, a carboxypeptidase, such as: (i) a proline carboxypeptidase (EC 3.4.16.2); (ii) a carboxypeptidase A (EC 3.4.17.1); (iii) a carboxypeptidase B (EC 3.4.17.2); (iv) a carboxypeptidase C (EC 3.4.16.5); (v) a carboxypeptidase D (EC 3.4.16.6); (vi) a lysine(arginine) carboxypeptidase (EC 3.4.17.3); (vii) a glycine carboxypeptidase (EC 3.4.17.4); (viii) an alanine
carboxypeptidase (EC 3.4.17.6); (ix) a glutamate carboxypeptidase (EC 3.4.17.11); (x) a peptidyl-dipeptidase A (EC 3.4.1 5.1); or (xi) a peptidyl-dipeptidase (EC
3.4.15.5).
[0081] The exact amount of enzyme added to the slurry to obtain the desired characteristics of the pea protein hydrolysates will vary depending upon features such as: (1) the enzyme or enzyme system utilized; (2) the desired end degree of hydrolysis; and/or (3) the desired end molecular weight distribution. Because these are known parameters, one of ordinary skill in the art can easily determine the appropriate conditions to achieve the desired characteristics of the end pea protein hydrolysate. Typically, the enzyme or enzyme system is added to the slurry in amounts in the range of from about 10 mg to about 5000 g, including 35 mg to about 700 g per 35 kg of protein in the slurry.
[0082] The hydrolysis reaction will typically run for a desired length of time in order to obtain the desired degree of hydrolysis and/or the desired molecular weight profile. Typically, the hydrolysis reaction will continue for a period of from about 15 minutes to about 24 hours, including from about 30 minutes to about 240 minutes, and also including from about 45 minutes to about 120 minutes. Again, the exact amount of time required for the hydrolysis reaction will depend on specific features as noted above, but can be easily determined by one skilled in the art.
[0083] In other embodiments, the protein-containing slurry may be hydrolyzed using non-enzymatic means, such as by chemical and/or mechanical (physical) hydrolysis. Such technique was one also well known in the art.
[0084] Once the pea protein material has been hydrolyzed to the desired degree, the hydrolysis reaction is stopped, for example, by inactivating the enzyme or enzyme system, or by other conventional means. In one embodiment, the inactivation of the enzyme or enzyme system is carried out by heat treatment. This inactivation is especially well suited in cases where the pH of the final pea protein hydrolysate is to be relatively high.
[0085] In accordance with established practice, the enzyme preparation may suitably be inactivated by increasing the temperature of the incubation slurry to a temperature where the enzymes become inactivated, e.g. to above about 70°C, and suitably to a temperature of about 90°C.
[0086] Alternatively, the enzyme(s) can be inactivated by a suitable acid treatment. This inactivation is especially well suited in cases wherein the pH of the final pea protein hydrolysate is to be relatively low. For example, the enzyme(s) can be inactivated by decreasing the pH of the slurry to a value where the enzymes become inactivated, e.g. below about 4.0.
[0087] Optionally, after the hydrolysis reaction has been quenched, the method of preparation may further comprise treating the slurry with activated carbon for a suitable time period at a temperature of between about 50°C and about 70°C, for example, in an amount generally corresponding to between about 1 and about 5% carbon, calculated in relation to dry matter content. This optional carbon step may improve the color of the final pea protein hydrolysate and also further reduce the off- flavor of the pea protein hydrolysate.
[0088] Finally, the hydrolyzed slurry is filtered utilizing a suitable conventional filtering process to obtain the pea protein hydrolysate. For example, in one embodiment, a filtration is carried out by nanofiltration at a temperature between 50°C and 70°C and/or by evaporation, whereafter the retentate is collected as the pea protein hydrolysate solution. By means of the nanofiltration, a desalination can be carried out by proper selection of the membrane. Evaporation has the advantage of obtaining a high dry matter content in the concentrate before drying.
[0089] In one specific embodiment, the pea protein hydrolysate, once obtained by the filtration process outlined above, is subjected to a second filtration process, such an ultrafiltration process, to provide a molecular weight distribution suitable for use in semi-elemental and related nutritional products. The ultrafiltration unit can be a hollow- fiber membrane, such as for example, the commercially available unit under the trademark Diaflo® from the Amicon Corporation and/or under the trademark Romicon® from the Romicon Corporation, having the desired nominal cut-
off molecular weight values. The hollow- fiber membranes are packed within a filter cartridge to permit flow therethrough, whereby suitably small molecules pass through the membrane, the hydrolysate effluent rate being dependent upon the pressure drop across the membrane, and are taken in solution to a collecting zone, with the remainder of the solution, containing the higher molecular weight protein hydrolysate passing directly along the fibrous tubes, for recycle to the hydrolysis reactor or to a separate collecting zone, as desired.
[0090] Further, this optional second filtration step can reduce the resulting phytate levels in the pea protein hydrolysate. Particularly, the phytate content is reduced in the pea protein hydro lysates by at least about 10%, including at least about 15%), including at least about 20%>, including at least about 25%, including at least about 30%), including at least about 35%, including at least about 40%>, and including at least about 45% or more.
[0091 ] Pea protein hydro lysates for use in the nutritional products described herein are prepared using the above described methods and have the following characteristics. Exemplary pea protein hydrolysates made according to the above methods include those having a molecular weight distribution of less than 5% being greater than 5kD.
[0092] The pea protein hydrolysates produced according to the above- described methods additionally have reduced immunological reactivity. In one embodiment, the immunological reactivity of the pea protein hydrolysate is analyzed using inhibition ELISA (enzyme-linked immunosorbent assay) and is expressed as an amount of immunologically active antigen per amount of protein. For example, one gram of pea protein hydrolysate prepared accordingly to the methods described herein will typically include less than about 15,000 μg of immunologically active pea antigen, including less than about 10,000 μg of immunologically active pea antigen, including less than about 7,500 μg of immunologically active pea antigen, including less than about 5,000 μg of immunologically active pea antigen, including less than about 2,500 μg of immunologically active pea antigen, including less than about 500 μg of immunologically active pea antigen, including less than about 250 μg of immunologically active pea antigen, including less than about 100 μg of
immunologically active pea antigen, including less than about 50 μg of
immunologically active pea antigen, and including the pea protein hydrolysate being substantially free of immunologically active pea antigen.
[0093] The pea protein hydrolysate produced by the methods described above additionally have an immune response index of less than 2.5 log IRI units, including less than 2.4 log IRI units, including less than 2.3 log IRI units, including less than 2.2 log IRI units, including less than 2.1 log IRI units, and also including less than 2.0 log IRI units.
Protein
[0094] The nutritional products of the present disclosure may optionally further comprise an additional source or sources of protein in addition to the pea protein hydrolysate. Any additional protein source that is suitable for use in oral nutritional products and is compatible with the essential elements and features of such products is suitable for use in combination with the pea protein hydrolysates.
[0095] When used in a liquid beverage, the total protein concentration in the nutritional liquid beverage may range from about 0.5% to about 40%, including from about 0.5%) to about 30%>, including from about 1% to about 15%, and also including from about 1% to about 10%>, and also including from about 1% to about 7%, by weight of the nutritional liquid beverages. In one specific embodiment, the protein is present in a nutritional emulsion in an amount of about 6.0% by weight of the nutritional emulsion.
[0096] When used in solid nutritional products, such as nutritional powders, bars, and other food products, the total protein concentration in the solid nutritional products may range from about 1.0% to about 50%, including from about 10% to about 50%), and also including from about 10% to about 30%, by weight of the solid nutritional product. In one specific embodiment, the protein is present in a spray dried nutritional powder in an amount of about 19%, by weight of the spray dried nutritional powder.
[0097] Non-limiting examples of additional suitable protein or sources thereof for use in the nutritional products include hydrolyzed, partially hydrolyzed or non-hydrolyzed proteins or protein sources, which may be derived from any known or otherwise suitable source such as milk (e.g., casein, whey), animal (e.g., meat, fish), cereal (e.g., rice, corn), vegetable (e.g., soy) or combinations thereof. Non-limiting examples of such proteins include milk protein isolates, milk protein concentrates as described herein, casein protein isolates, whey protein, sodium or calcium casemates, whole cow milk, partially or completely defatted milk, soy protein isolates, soy protein concentrates, and so forth.
Carbohydrate
[0098] The nutritional products may further comprise any carbohydrates that are suitable for use in an oral nutritional product and are compatible with the essential elements and features of such products. Carbohydrate concentrations in the nutritional liquid beverages, for example, may range from about 5% to about 40%, including from about 7% to about 30%, including from about 10%> to about 25%, by weight of the nutritional liquid beverage. In one specific embodiment, the
carbohydrate is present in a nutritional emulsion in an amount of about 10.2%, by weight of the nutritional emulsion.
[0099] Carbohydrate concentrations in the solid nutritional products may range from about 10% to about 90%, including from about 20%> to about 80%>, further including from about 40%> to about 60%>, by weight of the solid nutritional product. In one specific embodiment, the carbohydrate is present in a spray dried nutritional powder in an amount of about 58%, by weight of the spray dried nutritional powder.
[0100] Non- limiting examples of suitable carbohydrates or sources thereof for use in the nutritional products described herein may include maltodextrin, hydrolyzed or modified starch or cornstarch, glucose polymers, corn syrup, corn syrup solids, rice-derived carbohydrates, pea-derived carbohydrates, potato-derived carbohydrates, tapioca, sucrose, glucose, fructose, lactose, high fructose corn syrup, honey, sugar alcohols (e.g., maltitol, erythritol, sorbitol), artificial sweeteners (e.g.,
sucralose, acesulfame potassium, stevia) and combinations thereof. A particularly desirable carbohydrate is a low dextrose equivalent (DE) maltodextrin.
Fat
[0101] The nutritional products may further comprise fat, most typically as emulsified fat. The fat may be present in the nutritional liquid beverages in an amount of from 0% to about 30%, including 1% to about 30%>, including from about 1%) to about 20%), including from about 1% to about 15%, and also including from about 1.5% to about 5%, by weight of the nutritional emulsion. In one specific embodiment, a nutritional emulsion includes fat in an amount of about 1.6%, by weight of the nutritional emulsion.
[0102] It should be recognized by one skilled in the art that in some embodiments, such as in a substantially clear liquid beverage, the nutritional product will be substantially free of fat.
[0103] When used in solid nutritional products, the fat may be present in an amount of from about 1% to about 35%, including from about 1% to about 20%, including from about 1% to about 15%, and also including from about 5.0% to about 10%), by weight of the solid nutritional product. In one specific embodiment, a spray dried nutritional powder includes fat in an amount of about 7.5%, by weight of the spray dried nutritional powder.
[0104] Suitable sources of fat for use herein include any fat or fat source that is suitable for use in an oral nutritional product and is compatible with the essential elements and features of such products.
[0105] Non-limiting examples of suitable fats or sources thereof for use in the nutritional products described herein include coconut oil, fractionated coconut oil, soy oil, corn oil, olive oil, safflower oil, high oleic safflower oil, MCT oil (medium chain triglycerides), sunflower oil, high oleic sunflower oil, palm and palm kernel oils, palm olein, canola oil, marine oils, cottonseed oils, and combinations thereof.
Other Optional Ingredients
[0106] The nutritional products, including infant formulas, having the pea protein hydrolysate of the present disclosure may further comprise other optional components that may modify the physical, chemical, aesthetic or processing characteristics of the products or serve as pharmaceutical or additional nutritional components when used in the targeted population. Many such optional ingredients are known or otherwise suitable for use in medical food or other nutritional products or pharmaceutical dosage forms and may also be used in the compositions herein, provided that such optional ingredients are safe for oral administration and are compatible with the essential and other ingredients in the selected product form.
[0107] Non-limiting examples of such optional ingredients include preservatives, anti-oxidants, emulsifying agents, buffers, fructooligosaccharides, galactooligosaccharides, human milk oligosaccharides and other prebiotics, pharmaceutical actives, additional nutrients as described herein, colorants, flavors, thickening agents and stabilizers, emulsifying agents, lubricants, and so forth.
[0108] Examples of suitable HMOs that may be included in the
compositions of the present disclosure include lacto-N-tetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N- fucopentaose V, lacto-N-hexaose, para-lacto-N-hexaose, lacto-N-neohexaose, para- lacto-N-neohexaose, monofucosyllacto-N-hexaose II, isomeric fucosylated lacto-N- hexaose (1), monofucosyllacto-N-hexaose, isomeric fucosylated lacto-N-hexaose (3), isomeric fucosylated lacto-N-hexaose (2), difucosyl-para-lacto-N-neohexaose, difucosyl-para-lacto-N-hexaose, difucosyllacto-N-hexaose, lacto-N-neoocataose, para-lacto-N-octanose, iso-lacto-N-octaose, lacto-N-octaose, monofucosyllacto- neoocataose, monofucosyllacto-N-ocataose, difucosyllacto-N-octaose I,
difucosyllacto-N-octaose II, difucosyllacto-N-neoocataose II, difucosyllacto-N- neoocataose I, lacto-N-decaose, trifucosyllacto-N-neooctaose, trifucosyllacto-N- octaose, trifucosyl-iso-lacto-N-octaose, and combinations thereof. These HMOs are described more fully in U.S. Patent Application No. 2009/0098240, which is herein incorporated by reference in its entirety. Other suitable examples of HMOs that may be included in the compositions of the present disclosure include lacto-N-difuco-
hexaose II, sialyla(2-3) lactose, sialyla(2-6) lactose, sialyl-lacto-N-tetraose a, sialyl- lacto-N-tetraose b, sialyl-lacto-N-tetraose c, sialyl-fucosyl-lacto-N-tetraose I, sialyl- fucosyl-lacto-N-tetraose II, and disialyl-lacto-N-tetraose.
[0109] The compositions may further comprise a sweetening agent, preferably including at least one sugar alcohol such as maltitol, erythritol, sorbitol, xylitol, mannitol, isolmalt, and lactitol, and also preferably including at least one artificial or high potency sweetener such as acesulfame K, aspartame, sucralose, saccharin, stevia, and tagatose. These sweetening agents, especially as a combination of a sugar alcohol and an artificial sweetener, are especially useful in formulating liquid beverage embodiments of the present disclosure having a desirable favor profile. These sweetener combinations are especially effective in masking
undesirable flavors sometimes associated with the addition of vegetable proteins to a liquid beverage. Optional sugar alcohol concentrations in the nutritional product may range from at least about 0.01%, including from 0.1% to about 10%, and also including from about 1 % to about 6%, by weight of the nutritional product. Optional artificial sweetener concentrations may range from about 0.01%, including from about 0.05%) to about 5%>, also including from about 0.1 %> to about 1.0%, by weight of the nutritional product.
[0110] A flowing agent or anti-caking agent may be included in the nutritional products such as the nutritional powders as described herein to retard clumping or caking of the powder over time and to make a powder embodiment flow easily from its container. Any known flowing or anti-caking agents that are known or otherwise suitable for use in a nutritional powder or product form are suitable for use herein, non limiting examples of which include tricalcium phosphate, silicates, and combinations thereof. The concentration of the flowing agent or anti-caking agent in the nutritional product varies depending upon the product form, the other selected ingredients, the desired flow properties, and so forth, but most typically range from about 0.1%) to about 4%, including from about 0.5%> to about 2%, by weight of the nutritional product.
[0111] A stabilizer may also be included in the nutritional products. Any stabilizer that is known or otherwise suitable for use in a nutritional product is also suitable for use herein, some non-limiting examples of which include gums such as xanthan gum. The stabilizer may represent from about 0.1% to about 5.0%, including from about 0.5%> to about 3%, including from about 0.7%> to about 1.5%, by weight of the nutritional product.
[0112] The compositions may further comprise any of a variety of other vitamins or related nutrients, non-limiting examples of which include vitamin A, vitamin D, vitamin E, vitamin K, thiamine, riboflavin, pyridoxine, vitamin Bi2, carotenoids (e.g., beta-carotene, zeaxanthin, lutein, lycopene), niacin, folic acid, pantothenic acid, biotin, vitamin C, choline, inositol, salts and derivatives thereof, and combinations thereof.
[0113] The compositions may further comprise any of a variety of other additional minerals, non-limiting examples of which include calcium, phosphorus, magnesium, iron, zinc, manganese, copper, sodium, potassium, molybdenum, chromium, chloride, and combinations thereof.
Methods of Manufacture
[0114] The nutritional products of the present disclosure may be prepared by any known or otherwise effective manufacturing technique for preparing the selected product solid or liquid form. Many such techniques are known for any given product form such as nutritional liquids or powders or nutritional bars and can easily be applied by one of ordinary skill in the art to the nutritional compositions described herein.
[0115] The nutritional products of the present disclosure can therefore be prepared by any of a variety of known or otherwise effective formulation or manufacturing methods. In one suitable manufacturing process, for example, at least three separate slurries are prepared, including a protein-in-fat (PIF) slurry, a carbohydrate-mineral (CHO-MIN) slurry, a protein-in-water (PIW) slurry. The PIF slurry is formed by heating and mixing the oil (e.g., canola oil, corn oil, etc.) and then adding an emulsifier (e.g., lecithin), fat soluble vitamins, and a portion of the total
protein (e.g., milk protein concentrate, etc.) with continued heat and agitation. The CHO-MIN slurry is formed by adding with heated agitation to water: minerals (e.g., potassium citrate, dipotassium phosphate, sodium citrate, etc.), trace and ultra trace minerals (TM/UTM premix), thickening or suspending agents (e.g. avicel, gellan, carrageenan). The resulting CHO-MIN slurry is held for 10 minutes with continued heat and agitation before adding additional minerals (e.g., potassium chloride, magnesium carbonate, potassium iodide, etc.), and/or carbohydrates (e.g., fructooligosaccharide, sucrose, corn syrup, etc.). The PIW slurry is then formed by mixing with heat and agitation the remaining protein, if any.
[0116] The resulting slurries are then blended together with heated agitation and the pH adjusted to 6.6-7.0, after which the composition is subjected to high- temperature short-time (HTST) processing during which the composition is heat treated, emulsified and homogenized, and then allowed to cool. Water soluble vitamins and ascorbic acid are added, the pH is adjusted to the desired range if necessary, flavors are added, and water is added to achieve the desired total solid level. The composition is then aseptically packaged to form an aseptically packaged nutritional emulsion. This emulsion can then be further diluted, heat-treated, and packaged to form a ready-to-feed or concentrated liquid, or it can be heat-treated and subsequently processed and packaged as a reconstitutable powder, e.g., spray dried, dry mixed, agglomerated.
[0117] When a substantially clear liquid beverage is desired, the above described manufacturing process is modified such that only a CHO-MIN slurry and a PIW slurry are blended to form the nutritional liquid beverage.
[0118] Other product forms such as nutritional bars may be manufactured, for example, using cold extrusion technology as is known and commonly described in the bar manufacturing art. To prepare such products, typically all of the powdered components are dry blended together, which typically includes any proteins, vitamin premixes, certain carbohydrates, and so forth. The fat-soluble components are then blended together and mixed with any powdered premixes. Finally any liquid components are then mixed into the composition, forming a plastic like composition or dough. The resulting plastic mass can then be shaped, without further physical or
chemical changes occurring, by cold forming or extrusion, wherein the plastic mass is forced at relatively low pressure through a die, which confers the desired shape. The resultant exudate is then cut off at an appropriate position to give products of the desired weight. If desired, the solid product is then coated, to enhance palatability, and packaged for distribution.
[0119] Other suitable methods for making nutritional products are described, for example, in U.S. Pat. No. 6,365,218 (Borschel, et al), U.S Patent 6,589,576 (Borschel, et al), U.S. Pat. No. 6,306,908 (Carlson, et al), U.S. Patent Application 20030118703 Al (Nguyen, et al), which descriptions are incorporated herein by reference to the extent that they are consistent herewith.
Methods of Use
[0120] The nutritional products including pea protein hydro lysates as the sole source of protein are useful as a hypoallergenic nutrition source and/or a semi- elemental nutrition source for preterm infants, infants, toddlers, children, adults, and geriatrics that are intolerant and/or allergic to cow milk proteins, soy proteins, and/or have other general food allergies. Additionally, the nutritional products may be particularly suitable for use by individuals having malabsorption, maldigestion, and other gastrointestinal conditions.
[0121] In one embodiment, the nutritional products may be useful as providing a nutrition source using hydrolyzed proteins and having improved organoleptic properties, such as in sports drinks.
[0122] The nutritional products may be administered orally as needed to provide the desired level of nutrition, most typically in the form of one, two, three, four, five, six, seven, eight or more servings daily. Serving sizes may vary greatly and may range from about 1 to about 500 ml, including from about 5 to about 250 ml, including from about 10 to about 240 ml.
EXAMPLES
[0123] The following examples illustrate specific embodiments and/or features of the pea protein hydrolysates and/or nutritional products of the present
disclosure. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present disclosure, as many variations thereof are possible without departing from the spirit and scope of the disclosure. All
exemplified amounts are weight percentages based upon the total weight of the
composition, unless otherwise specified.
[0124] The exemplified compositions are nutritional products prepared in
accordance with manufacturing methods well known in the nutrition industry for
preparing nutritional emulsions, other nutritional liquid beverages, nutritional
powders, and/or nutritional bars.
Example 1
[0125] In this Example, 10 samples of filtered (F) and non- filtered (N) pea protein hydrolysates prepared according to process as described herein are evaluated and compared to an intact pea protein isolate (ISO) sample for various physical
characteristics. Filtered (F) indicates that the sample is subjected to the second
filtration step described above. All samples are subjected to the first filtration step
described above. The control sample (Intact) is not subjected to any hydrolysis
procedure. Specifically, the samples are evaluated for degree of hydrolysis, molecular weight distribution, isoflavone content, and phytate content using standard analytical techniques. The results of the evaluations are shown in the table below.
Samples Intact AN AF BN BF CN CF DN DF EN EF
Attribute
% Nitrogen 12.90 13.30 13.60 13.20 14.00 12.90 13.60 13.10 14.00 12.90 13.90
% Protein 80.63 83.13 85 82.5 87.5 80.63 85 81.88 87.5 80.63 86.88
% Nitrogen X 6.25 from AN Proximates
Prot. from AA 82.05 81.34 88.83 81.12 88.64 80.20 83.03 82.70 91.27 83.65 94.36
B+F%
Amino N 1.12 1.68 2.05 2.2 2.39 2.88 2.98 2.95 3.31 3.41 3.97
DH (% AN/TN) 8.68 12.63 15.07 16.67 17.07 22.17 21.91 22.75 23.64 26.43 28.56
Adjusted DH 0.00 3.95 6.39 7.99 8.39 13.49 13.23 14.07 14.96 17.75 19.88
Mg for 100 ml @ 620 601 588 606 571 620 588 610 571 620 576
5 mg protein/ml
Gm Par = 500 ml 12.4 12.02 1 1.75 12.12 11.42 12.4 1 1.76 12.2 11.42 12.4 1 1.52 @ 2% Prot.
MW Range by HPLC
>3 KD 97.00% 37.50% 27.20% 10.40% 4.80% 6.70% 1.70% 6.90% 2.60% 5.80% 1.60%
> 5 KD 93.30% 26.30% 16.50% 4.10% 1.00% 2.70% 0.40% 2.50% 0.60% 2.00% 0.40%
3-5 KD 3.70% 1 1.20% 10.70% 6.30% 3.80% 4.00% 1.30% 4.40% 2.00% 3.80% 1.20%
1-3 KD 1.00% 28.80% 34.50% 31.30% 33.10% 18.10% 17.80% 22.90% 24.60% 18.40% 19.20%
0.5-1 KD 0.40% 20.30% 23.60% 30.40% 33.20% 29.30% 31.80% 29.40% 31.60% 28.10% 30.30%
<0.5 KD 1.60% 13.40% 14.70% 27.90% 28.90% 45.90% 48.70% 40.80% 41.20% 47.70% 48.90%
Phytoestrogen Content
Daldzein mg/kg < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2
Genistein mg kg < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2 < 2
Total Phos g/kg 8.3 8.55 6.41 8.3 4.58 8.27 5.73 8.27 5.05 8.21 4.89
Phytic Acid g/kg 20.6 21.2 15.9 20.6 1 1.4 20.6 14.2 20.6 12.5 20.4 12.2
Example 2
[0126] In this Example, the hypoallergenic potential of the pea protein hydrolysates analyzed in Example 1 are evaluated and compared to the intact pea
protein isolate (ISO) sample of Example 1 using hyperimmunization of rabbits, in
which rabbits are given multiple immunizations over a period of 35 days as described below. Immunogenicity of the pea protein hydrolysates is then tested by ELISA
(enzyme-linked immunosorbent assay), which measures the rabbits' antigen-specific IgG response to the intact pea protein/pea protein hydrolysate immunogen.
[0127] The rabbits used in this Example are placed on a diet free of cow
milk, soy, and pea proteins for fourteen days prior to the first immunization. At day 0, baseline antibody status of each of the rabbits is evaluated by blood sample from
the rabbits. After obtaining baseline, each rabbit is immunized with 5.0 mg of pea
protein equivalent amino acid content contained in 4.5 ml of antigen emulsified in
Complete Freund's Adjuvant (CFA). The immunizations are delivered as follows: 20 X 0.1 ml per site/shaved flank intradermally, and 0.25 ml/popliteal lymph node area of the hind leg. On day 21, the second immunization is as follows: 0.50 ml/site X 2 sites/hind leg, intramuscularly; and, 0.25 ml/site X 4 sites subscapularly. For each
immunization, a constant dose of 5 mg antigen amino acid equivalent is administered. Exsanguination of the rabbits is on study day 35.
[0128] A direct ELISA is used to quantitate antibody responses for each rabbit following hyperimmunization. Assay optimization is achieved using block titrations to determine antigen coating concentration and conjugate dilution.
Following assay optimization, the pea protein-specific rabbit antibodies in the day 0 and day 35 serum samples are quantified. Additionally, an immune response index (IRI units) is determined by dividing the normalized day 35 antibody titer by the normalized baseline (day 0) titer of day 0 for each antiserum. Immunization groups contain 5-10 animals and the results for each animal are averaged. Comparisons of the antigen-specific IRI results predict hypoallergenic clinical performance. The results are provided in the table below:
[0129] As shown in the table, the pea protein hydrolysates show a wide range of antibody response. The low reactivity may indicate that the pea protein hydrolysates still have epitopes that are recognized as antigenic, but not immunogenic by the rabbits. Moreover, pea protein hydrolysates BN, BF, CN, and CF showed a significantly lowered immunogenicity after hyperimmunization as compared to the other samples. The lowered immunogenicity of the pea protein hydrolysate samples indicates that the retained pea antigens do not have the capacity to stimulate an immune response.
Example 3
[0130] In this Example, the hypoallergenic potential of the pea protein hydrolysates analyzed in Example 1 are evaluated and compared to the intact pea protein isolate (ISO) sample of Example 1 using antigen content, measured by inhibition ELISA. In this assay, intact pea protein is coated onto ELISA plates.
Separately incubation tubes containing samples or pea protein solutions at standard concentrations plus anti-pea protein antibodies are prepared. After an incubation
period aliquots of the sample (or standard) plus antibody solutions are added to the coated plates. Following incubation and washing an anti-rabbit IgG enzyme- conjugated antibody is added. The plates are incubated, washed, and an enzyme substrate is added. A color reaction occurs that is inversely proportional to the concentration of pea antigen in the sample which is quantified based on a standard curve. Results of this test for the 10 samples are shown in table below:
Example 4
[0131] In this Example, sensory evaluation is conducted for two bench screening sessions to characterize the taste of the pea protein hydrolysate samples of Example 1 retorted in both water and an Alimentum® matrix (Abbott Laboratories, Columbus, Ohio). The Alimentum® matrix contains carbohydrate, fat, vitamins, and minerals so as to simulate the biochemistry of a hypoallergenic formula. It is used to assess the mutual organoleptic effects on hydrolysate and finished formula on each other within the product matrix following retort treatment. The samples are compared to the current hydrolysate (casein hydrolysate) used in Alimentum® and the intact pea protein isolate (ISO) of Example 1. Particularly, it is known that hydro lyzed proteins are generally bitter, sour, salty, and/or beany. Thus, it is difficult to incorporate this functional ingredient into nutritional formulations without drastically impairing the taste of the product.
[0132] The samples are analyzed for intensity of various tastes, including for example: bitter, salt, sour, brothy, wet wool, acid sour, grassy/soybean, starchy, woody/sawdust, green/beany/dried peas, drying, powdery, oily, sulfidy/cabbage, burnt cheese, and gritty. Specifically, once the samples are prepared, four trained
descriptive flavor panelists tasted each sample. After tasting, each panelist assessed the flavor attributes of the sample using a scoring system set forth in the table below and the results are then averaged.
Score Description
1/2 Very Slight
1 Slight
1 1/2 Slight to Moderate
2 Moderate
2 1/2 Moderate to Strong
3 Strong
Hydrolysates in water (2% solution)
Non-Filtered Hydrolysates in water (2% solution)
Basic Tastes AN BN CN DN EN ISO and
Aromatic s
Bitter 1 1 1 ½ 1 1 ½
Salt 1 ½
Sour 1 1 1 1 1 1
Brothy 1 1 1 1 1 ½
Acid Sour 1
Grassy/soybe 2 2 1 1 ½ 1 ½
an
Starchy 1 1 1 1 1 1
Woody/sawd 2 1 1
ust
Green/beany/ 1 ½ dried peas
Drying 2 2 2 2 2 2
Powdery 1 ½ 1 ½ 1 ½ 1 ½ 1 ½ 1 ½ mouthfeel
Appearance: Cloudy Cloudy Cloudy Cloudy Cloudy Opaque pale yellow-tan yellow-tan yellow-tan yellow-tan yellow-tan yellow-tan
Filtered Hydrolysates in Alimentum Matrix
Non-Filtered Hydrolysates in Alimentum Matrix
Examples 5-34
[0133] Examples 5-34 illustrate various infant formula nutritional powders of the present disclosure including pea protein hydrolysate as at least one source of protein, and in some cases the sole source of protein, the ingredients of which are listed in the table below. The pea protein hydrolysate has a degree of hydrolysis
(adjusted) of from about 7.0% to less than 19.0%. These products are prepared by various methods in separate batches, are reconstituted with water prior to use to the desired target ingredient concentrations. The embodiments set forth below that include pea protein hydrolysate as the sole source of protein are hypoallergenic embodiments.
Examples 5-9
Ingredient Amounts per 22727.3 kg
Example 5 Example 6 Example 7 Example 8 Example 9
Corn Syrup 9091.6 kg 9091.6 kg 8925.1 kg 9091.6 kg 8758.7 kg
Pea Protein Hydrolysate 3329.4 kg 3162.9 kg 3495.9 kg 2996.5 kg 3662.3 kg
High Oleic Safflower Oil 2608.1 kg 2608.1 kg 2608.1 kg 2608.1 kg 2608.1 kg
Sugar (Sucrose) 2328.6 kg 2495.1 kg 2328.6 kg 2661.5 kg 2328.6 kg
Soy Oil 1908.3 kg 1908.3 kg 1908.3 kg 1908.3 kg 1908.3 kg
Coconut Oil 1844.7 kg 1844.7 kg 1844.7 kg 1844.7 kg 1844.7 kg
5% Potassium Hydroxide 600 kg 600 kg 600 kg 600 kg 600 kg
Potassium Citrate #1, #2 279.8 kg 279.8 kg 279.8 kg 279.8 kg 279.8 kg
Calcium Phosphate Tribasic 252.5 kg 252.5 kg 252.5 kg 252.5 kg 252.5 kg
Calcium Phosphate Dibasic 147.6 kg 147.6 kg 147.6 kg 147.6 kg 147.6 kg
Sodium Chloride 76.2 kg 76.2 kg 76.2 kg 76.2 kg 76.2 kg
Magnesium Chloride 58.8 kg 58.8 kg 58.8 kg 58.8 kg 58.8 kg
L-Methionine 36.2 kg 36.2 kg 36.2 kg 36.2 kg 36.2 kg
Ascorbic Acid 36.1 kg 36.1 kg 36.1 kg 36.1 kg 36.1 kg
Vitamin/Mineral/Taurine Premix 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg
Choline Chloride 1 1.5 kg 11.5 kg 1 1.5 kg 1 1.5 kg 1 1.5 kg
Vitamin A, D3, E, & Kl Premix 8.7 kg 8.7 kg 8.7 kg 8.7 kg 8.7 kg
Ascorbyl Palmitate 8.1 kg 8.1 kg 8.1 kg 8.1 kg 8.1 kg
Ferrous Sulfate 6.9 kg 6.9 kg 6.9 kg 6.9 kg 6.9 kg
Potassium Chloride 4.3 kg 4.3 kg 4.3 kg 4.3 kg 4.3 kg
Mixed Tocopherols 3.7 kg 3.7 kg 3.7 kg 3.7 kg 3.7 kg
L-Carnitine 2.5 kg 2.5 kg 2.5 kg 2.5 kg 2.5 kg
Beta-Carotene in vegetable oil 28.3 g 28.3 g 28.3 g 28.3 g 28.3 g
Potassium Iodide 22.9 g 22.9 g 22.9 g 22.9 g 22.9 g
Examples 10-14
Ingredient Amounts per 22727.3 kg
Example 10 Example 11 Example 12 Example 13 Example 14
Corn Syrup 9091.6 kg 9091.6 kg 9091.6 kg 9091.6 kg 9091.6 kg
Pea Protein Hydrolysate 2996.5 kg 2663.5 kg 2330.6 kg 1997.6 kg 1664.7 kg
Soy Protein Isolate 332.9 kg 665.9 kg 998.8 kg 1331.8 kg 1664.7 kg
High Oleic Safflower Oil 2608.1 kg 2608.1 kg 2608.1 kg 2608.1 kg 2608.1 kg
Sugar (Sucrose) 2328.6 kg 2495.1 kg 2328.6 kg 2661.5 kg 2328.6 kg
Soy Oil 1908.3 kg 1908.3 kg 1908.3 kg 1908.3 kg 1908.3 kg
Coconut Oil 1844.7 kg 1844.7 kg 1844.7 kg 1844.7 kg 1844.7 kg
5% Potassium Hydroxide 600 kg 600 kg 600 kg 600 kg 600 kg
Potassium Citrate #1, #2 279.8 kg 279.8 kg 279.8 kg 279.8 kg 279.8 kg
Calcium Phosphate Tribasic 252.5 kg 252.5 kg 252.5 kg 252.5 kg 252.5 kg
Calcium Phosphate Dibasic 147.6 kg 147.6 kg 147.6 kg 147.6 kg 147.6 kg
Sodium Chloride 76.2 kg 76.2 kg 76.2 kg 76.2 kg 76.2 kg
Magnesium Chloride 58.8 kg 58.8 kg 58.8 kg 58.8 kg 58.8 kg
L-Methionine 36.2 kg 36.2 kg 36.2 kg 36.2 kg 36.2 kg
Ascorbic Acid 36.1 kg 36.1 kg 36.1 kg 36.1 kg 36.1 kg
Vitamin/Mineral/Taurine Premix 32.5 kg 32.5 kg 32.5 kg 32.5 kg 32.5 kg
Choline Chloride 1 1.5 kg 11.5 kg 1 1.5 kg 1 1.5 kg 1 1.5 kg
Vitamin A, D3, E, & Kl Premix 8.7 kg 8.7 kg 8.7 kg 8.7 kg 8.7 kg
Ascorbyl Palmitate 8.1 kg 8.1 kg 8.1 kg 8.1 kg 8.1 kg
Ferrous Sulfate 6.9 kg 6.9 kg 6.9 kg 6.9 kg 6.9 kg
Potassium Chloride 4.3 kg 4.3 kg 4.3 kg 4.3 kg 4.3 kg
Mixed Tocopherols 3.7 kg 3.7 kg 3.7 kg 3.7 kg 3.7 kg
L-Carnitine 2.5 kg 2.5 kg 2.5 kg 2.5 kg 2.5 kg
Beta-Carotene in vegetable oil 28.3 g 28.3 g 28.3 g 28.3 g 28.3 g
Potassium Iodide 22.9 g 22.9 g 22.9 g 22.9 g 22.9 g
Examples 15-19
Ingredient Amounts per 1000 kg
Example 15 Example 16 Example 17 Example 18 Example 19
Corn Syrup 412.6 kg 419.9 kg 405.3 kg 427.3 kg 397.9 kg
Pea Protein Hydrolysate 146.7 kg 139.4 kg 154.0 kg 132.0 kg 161.4 kg
High Oleic Safflower Oil 1 14.7 kg 1 14.7 kg 114.7 kg 114.7 kg 114.7 kg
Sucrose 97.9 kg 97.9 kg 97.9 kg 97.9 kg 97.9 kg
Soy Oil 83.9 kg 83.9 kg 83.9 kg 83.9 kg 83.9 kg
Coconut Oil 77.3 kg 77.3 kg 77.3 kg 77.3 kg 77.3 kg
Fructooligosaccharides 16.2 kg 16.2 kg 16.2 kg 16.2 kg 16.2 kg
Potassium Citrate 15.3 kg 15.3 kg 15.3 kg 15.3 kg 15.3 kg
Tricalcium Phosphate 1 1.7 kg 1 1.7 kg 1 1.7 kg 1 1.7 kg 1 1.7 kg
Calcium Phosphate Dibasic 6.8 kg 6.8 kg 6.8 kg 6.8 kg 6.8 kg
Sodium Chloride 3.4 kg 3.4 kg 3.4 kg 3.4 kg 3.4 kg
Arachidonic Acid 2.9 kg 2.9 kg 2.9 kg 2.9 kg 2.9 kg
Magnesium Chloride 2.6 kg 2.6 kg 2.6 kg 2.6 kg 2.6 kg
L-Methionine 1.7 kg 1.7 kg 1.7 kg 1.7 kg 1.7 kg
Ascorbic Acid 1.6 kg 1.6 kg 1.6 kg 1.6 kg 1.6 kg
Vitamin/Mineral/Taurine Premix 1.4 kg 1.4 kg 1.4 kg 1.4 kg 1.4 kg
Docosahexaenoic Acid 1.1 kg 1.1 kg 1.1 kg 1.1 kg 1.1 kg
Choline Chloride 507.7 g 507.7 g 507.7 g 507.7 g 507.7 g
Vitamin ADEK Premix 372.6 g 372.6 g 372.6 g 372.6 g 372.6 g
Ascorbyl Palmitate 357.5 g 357.5 g 357.5 g 357.5 g 357.5 g
Ferrous Sulfate 305.3 g 305.3 g 305.3 g 305.3 g 305.3 g
Potassium Chloride 198.5 g 198.5 g 198.5 g 198.5 g 198.5 g
Mixed Carotenoid Premix 187.4 g 187.4 g 187.4 g 187.4 g 187.4 g
Mixed Tocopherols 157.2 g 157.2 g 157.2 g 157.2 g 157.2 g
L-Carnitine 107.8 g 107.8 g 107.8 g 107.8 g 107.8 g
Potassium Iodide 1.0 g 1.0 g 1.0 g 1.0 g 1.0 g
5% KOH as needed as needed as needed as needed as needed
Examples 20-24
Ingredient Amounts per 1000 kg
Example 20 Example 21 Example 22 Example 23 Example 24
Corn Syrup 412.6 kg 412.6 kg 412.6 kg 412.6 kg 412.6 kg
Pea Protein Hydrolysate 132.0 kg 1 17.4 kg 102.7 kg 88.0 kg 73.35 kg
Soy Protein 14.7 kg 29.3 kg 44.0 kg 58.7 kg 73.35 kg
High Oleic Safflower Oil 1 14.7 kg 1 14.7 kg 114.7 kg 114.7 kg 114.7 kg
Sucrose 97.9 kg 97.9 kg 97.9 kg 97.9 kg 97.9 kg
Soy Oil 83.9 kg 83.9 kg 83.9 kg 83.9 kg 83.9 kg
Coconut Oil 77.3 kg 77.3 kg 77.3 kg 77.3 kg 77.3 kg
Fructooligosaccharides 16.2 kg 16.2 kg 16.2 kg 16.2 kg 16.2 kg
Potassium Citrate 15.3 kg 15.3 kg 15.3 kg 15.3 kg 15.3 kg
Tricalcium Phosphate 1 1.7 kg 1 1.7 kg 1 1.7 kg 1 1.7 kg 1 1.7 kg
Calcium Phosphate Dibasic 6.8 kg 6.8 kg 6.8 kg 6.8 kg 6.8 kg
Sodium Chloride 3.4 kg 3.4 kg 3.4 kg 3.4 kg 3.4 kg
Arachidonic Acid 2.9 kg 2.9 kg 2.9 kg 2.9 kg 2.9 kg
Magnesium Chloride 2.6 kg 2.6 kg 2.6 kg 2.6 kg 2.6 kg
L-Methionine 1.7 kg 1.7 kg 1.7 kg 1.7 kg 1.7 kg
Ascorbic Acid 1.6 kg 1.6 kg 1.6 kg 1.6 kg 1.6 kg
Vitamin/Mineral/Taurine Premix 1.4 kg 1.4 kg 1.4 kg 1.4 kg 1.4 kg
Docosahexaenoic Acid 1.1 kg 1.1 kg 1.1 kg 1.1 kg 1.1 kg
Choline Chloride 507.7 g 507.7 g 507.7 g 507.7 g 507.7 g
Vitamin ADEK Premix 372.6 g 372.6 g 372.6 g 372.6 g 372.6 g
Ascorbyl Palmitate 357.5 g 357.5 g 357.5 g 357.5 g 357.5 g
Ferrous Sulfate 305.3 g 305.3 g 305.3 g 305.3 g 305.3 g
Potassium Chloride 198.5 g 198.5 g 198.5 g 198.5 g 198.5 g
Mixed Carotenoid Premix 187.4 g 187.4 g 187.4 g 187.4 g 187.4 g
Mixed Tocopherols 157.2 g 157.2 g 157.2 g 157.2 g 157.2 g
L-Carnitine 107.8 g 107.8 g 107.8 g 107.8 g 107.8 g
Potassium Iodide 1.0 g 1.0 g 1.0 g 1.0 g 1.0 g
5% KOH as needed as needed as needed as needed as needed
Examples 25-29
Ingredients Amount per 22679.62 kg
Example 25 Example 26 Example 27 Example 28 Example 29
Maltodextrin 7595 kg 7793.9 kg 7396.1 kg 7992.8 kg 7197.2 kg
Pea Protein Hydrolysate 3978 kg 3779.1 kg 4176.9 kg 3580.2 kg 4375.8 kg
Sucrose 3288 kg 3288 kg 3288 kg 3288 kg 3288 kg
High Oleic Safflower Oil 2204 kg 2204 kg 2204 kg 2204 kg 2204 kg
Fractionated Coconut Oil (MCT) 2162 kg 2162 kg 2162 kg 2162 kg 2162 kg
Soybean Oil 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg
Micronized Tricalcium Phosphate 329 kg 329 kg 329 kg 329 kg 329 kg
Examples 30-34
Ingredients Amount per 22679.62 kg
Example 30 Example 31 Example 32 Example 33 Example 34
Maltodextrin 7595 kg 7595 kg 7595 kg 7595 kg 7595 kg
Pea Protein Hydrolysate 3580.2 kg 3182.4 kg 2784.6 kg 2386.8 kg 1989 kg
Casein Hydrolysate 397.8 kg 795.6 kg 1 193.4 kg 1591.2 kg 1989 kg
Sucrose 3288 kg 3288 kg 3288 kg 3288 kg 3288 kg
High Oleic Safflower Oil 2204 kg 2204 kg 2204 kg 2204 kg 2204 kg
Fractionated Coconut Oil (MCT) 2162 kg 2162 kg 2162 kg 2162 kg 2162 kg
Soybean Oil 1825 kg 1825 kg 1825 kg 1825 kg 1825 kg
Micronized Tricalcium Phosphate 329 kg 329 kg 329 kg 329 kg 329 kg
Panodan FDPK 326 kg 326 kg 326 kg 326 kg 326 kg
Potassium Citrate 276 kg 276 kg 276 kg 276 kg 276 kg
Xanthan Gum, Extra Fine 128 kg 128 kg 128 kg 128 kg 128 kg
Magnesium Chloride 69.6 kg 69.6 kg 69.6 kg 69.6 kg 69.6 kg
Distilled Monoglycerides 65.2 kg 65.2 kg 65.2 kg 65.2 kg 65.2 kg
Arachidonic Acid (AA) 60.0 kg 60.0 kg 60.0 kg 60.0 kg 60.0 kg
Sodium Chloride 59.2 kg 59.2 kg 59.2 kg 59.2 kg 59.2 kg
Ascorbic Acid 51.2 kg 51.2 kg 51.2 kg 51.2 kg 51.2 kg
L-Cystine Dihydrochloride 46.6 kg 46.6 kg 46.6 kg 46.6 kg 46.6 kg
Calcium Carbonate 33.7 kg 33.7 kg 33.7 kg 33.7 kg 33.7 kg
Examples 35-54
[0134] Examples 35-54 illustrate nutritional emulsion embodiments of the
present disclosure including pea protein hydrolysate as at least one source of protein, and in some cases, the sole source of protein, the ingredients of which are listed in the table below. To prepare the nutritional emulsions, at least three separate slurries (e.g.,
CHO-MIN slurry, PIW slurry, PIF slurry) are prepared and then blended together,
heat-treated, homogenized, and standardized. The resulting composition is aseptically packaged into plastic bottles or retort sterilized. The embodiments set forth below
that include pea protein hydrolysates as the sole source of protein are hypoallergenic embodiments.
Examples 35-39
Ingredient Amount per 1000 Kg
Example 35 Example 36 Example 37 Example 38 Example 39
Ingredient Water Q.S. Q.S. Q.S. Q.S. Q.S.
Corn Syrup 63.5 kg 63.5 kg 63.5 kg 63.5 kg 63.5 kg
Pea Protein Hydrolysate 18.9 kg 17.9 kg 19.8 kg 17.0 kg 20.8 kg
High Oleic Safflower Oil 14.0 kg 14.0 kg 14.0 kg 14.0 kg 14.0 kg
Sucrose 12.6 kg 12.6 kg 12.6 kg 12.6 kg 12.6 kg
Soy Oil 10.5 kg 10.5 kg 10.5 kg 10.5 kg 10.5 kg
Coconut Oil 10.0 kg 10.0 kg 10.0 kg 10.0 kg 10.0 kg
Fructooligosaccharides 2.3 kg 2.3 kg 2.3 kg 2.3 kg 2.3 kg
Calcium Citrate 1.7 kg 1.7 kg 1.7 kg 1.7 kg 1.7 kg
Micro Tricalcium Phosphate 1.1 kg 1.1 kg 1.1 kg 1.1 kg 1.1 kg
Potassium Phosphate Monobasic 744.4 g 744.4 g 744.4 g 744.4 g 744.4 g
Ascorbic Acid 437.2 g 437.2 g 437.2 g 437.2 g 437.2 g
Potassium Citrate 406.0 g 406.0 g 406.0 g 406.0 g 406.0 g
Magnesium Chloride 373.4 373.4 373.4 373.4 373.4
Arachidonic Acid Oil 366.4 g 366.4 g 366.4 g 366.4 g 366.4 g
Monoglycerides 350.0 g 350.0 g 350.0 g 350.0 g 350.0 g
Lecithin 350.0 g 350.0 g 350.0 g 350.0 g 350.0 g
Sodium Chloride 309.5 g 309.5 g 309.5 g 309.5 g 309.5 g
Potassium Phosphate Dibasic 237.9 g 237.9 g 237.9 g 237.9 g 237.9 g
L-Methionine 208.0 g 208.0 g 208.0 g 208.0 g 208.0 g
Seakem RLC 200.1 g 200.1 g 200.1 g 200.1 g 200.1 g
Vitamin/Mineral/Taurine Premix 176.4 g 176.4 g 176.4 g 176.4 g 176.4 g
Potassium Chloride 143.6 g 143.6 g 143.6 g 143.6 g 143.6 g
Docosahexaenoic Acid Oil 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g
Choline Chloride 71.3 g 71.3 g 71.3 g 71.3 g 71.3 g
Vitamin ADEK Premix 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g
Ferrous Sulfate 44.8 g 44.8 g 44.8 g 44.8 g 44.8 g
Mixed Carotenoid Premix 26.5 g 26.5 g 26.5 g 26.5 g 26.5 g
L-Carnitine 13.8 g 13.8 g 13.8 g 13.8 g 13.8 g
Riboflavin 2.0 g 2.0 g 2.0 g 2.0 g 2.0 g
Vitamin A Palmitate 780.0 mg 780.0 mg 780.0 mg 780.0 mg 780.0 mg
Potassium Iodide 150.0 mg 150.0 mg 150.0 mg 150.0 mg 150.0 mg
5% KOH as needed as needed as needed as needed as needed
Examples 40-44
Ingredient Amount per 1000 Kg
Example 40 Example 41 Example 42 Example 43 Example 44
Ingredient Water Q.S. Q.S. Q.S. Q.S. Q.S.
Corn Syrup 63.5 kg 63.5 kg 63.5 kg 63.5 kg 63.5 kg
Pea Protein Hydrolysate 17.0 kg 15.1 kg 13.2 kg 1 1.3 kg 9.45 kg
Soy Protein 1.9 kg 3.9 kg 5.8 kg 7.7 kg 9.45 kg
High Oleic Safflower Oil 14.0 kg 14.0 kg 14.0 kg 14.0 kg 14.0 kg
Sucrose 12.6 kg 12.6 kg 12.6 kg 12.6 kg 12.6 kg
Soy Oil 10.5 kg 10.5 kg 10.5 kg 10.5 kg 10.5 kg
Coconut Oil 10.0 kg 10.0 kg 10.0 kg 10.0 kg 10.0 kg
Fructooligosaccharides 2.3 kg 2.3 kg 2.3 kg 2.3 kg 2.3 kg
Calcium Citrate 1.7 kg 1.7 kg 1.7 kg 1.7 kg 1.7 kg
Micro Tricalcium Phosphate 1.1 kg 1.1 kg 1.1 kg 1.1 kg 1.1 kg
Potassium Phosphate Monobasic 744.4 g 744.4 g 744.4 g 744.4 g 744.4 g
Ascorbic Acid 437.2 g 437.2 g 437.2 g 437.2 g 437.2 g
Potassium Citrate 406.0 g 406.0 g 406.0 g 406.0 g 406.0 g
Magnesium Chloride 373.4 373.4 373.4 373.4 373.4
Arachidonic Acid Oil 366.4 g 366.4 g 366.4 g 366.4 g 366.4 g
Monoglycerides 350.0 g 350.0 g 350.0 g 350.0 g 350.0 g
Lecithin 350.0 g 350.0 g 350.0 g 350.0 g 350.0 g
Sodium Chloride 309.5 g 309.5 g 309.5 g 309.5 g 309.5 g
Potassium Phosphate Dibasic 237.9 g 237.9 g 237.9 g 237.9 g 237.9 g
L-Methionine 208.0 g 208.0 g 208.0 g 208.0 g 208.0 g
Seakem RLC 200.1 g 200.1 g 200.1 g 200.1 g 200.1 g
Vitamin/Mineral/Taurine Premix 176.4 g 176.4 g 176.4 g 176.4 g 176.4 g
Potassium Chloride 143.6 g 143.6 g 143.6 g 143.6 g 143.6 g
Docosahexaenoic Acid Oil 135.4 g 135.4 g 135.4 g 135.4 g 135.4 g
Choline Chloride 71.3 g 71.3 g 71.3 g 71.3 g 71.3 g
Vitamin ADEK Premix 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g
Ferrous Sulfate 44.8 g 44.8 g 44.8 g 44.8 g 44.8 g
Mixed Carotenoid Premix 26.5 g 26.5 g 26.5 g 26.5 g 26.5 g
L-Carnitine 13.8 g 13.8 g 13.8 g 13.8 g 13.8 g
Riboflavin 2.0 g 2.0 g 2.0 g 2.0 g 2.0 g
Vitamin A Palmitate 780.0 mg 780.0 mg 780.0 mg 780.0 mg 780.0 mg
Potassium Iodide 150.0 mg 150.0 mg 150.0 mg 150.0 mg 150.0 mg
5% KOH as needed as needed as needed as needed as needed
Examples 45-49
Ingredients Amount per 45359.24 kg
Example 45 Example 46 Example 47 Example 48 Example 49
Ingredient Water Q.S. Q.S. Q.S. Q.S. Q.S.
Sucrose 2007 kg 2007 kg 2007 kg 2007 kg 2007 kg
Pea Protein Hydrolysate 1025 kg 973.8 kg 1076.2 kg 922.5 kg 1 127.5 kg
Modified Tapioca Starch 989 kg 989 kg 989 kg 989 kg 989 kg
Safflower Oil 644 kg 644 kg 644 kg 644 kg 644 kg
Fractionated Coconut Oil 568 kg 568 kg 568 kg 568 kg 568 kg
Soy Oil 479 kg 479 kg 479 kg 479 kg 479 kg
5% KOH (processing aid) 187 kg 187 kg 187 kg 187 kg 187 kg
Calcium Citrate 69.9 kg 69.9 kg 69.9 kg 69.9 kg 69.9 kg
Calcium Phosphate Dibasic 48.1 kg 48.1 kg 48.1 kg 48.1 kg 48.1 kg
Carrageenan 45.4 kg 45.4 kg 45.4 kg 45.4 kg 45.4 kg
Potassium Phosphate Dibasic 26.2 kg 26.2 kg 26.2 kg 26.2 kg 26.2 kg
Ascorbic Acid 24.2 kg 24.2 kg 24.2 kg 24.2 kg 24.2 kg
Magnesium Chloride 18.6 kg 18.6 kg 18.6 kg 18.6 kg 18.6 kg
M. Alpina Oil (ARA Oil) 17.9 kg 17.9 kg 17.9 kg 17.9 kg 17.9 kg
Potassium Citrate 15.9 kg 15.9 kg 15.9 kg 15.9 kg 15.9 kg
Sodium Chloride 14.9 kg 14.9 kg 14.9 kg 14.9 kg 14.9 kg
Calcium Hydroxide 14.0 kg 14.0 kg 14.0 kg 14.0 kg 14.0 kg
L-Cystine Dihydrochloride 12.1 kg 12.1 kg 12.1 kg 12.1 kg 12.1 kg
Potassium Chloride 1 1.2 kg 11.2 kg 1 1.2 kg 1 1.2 kg 1 1.2 kg
Water Soluble Vitamin Premix 8.00 kg 8.00 kg 8.00 kg 8.00 kg 8.00 kg
C. Cohnii Oil (DHA Oil) 6.71 kg 6.71 kg 6.71 kg 6.71 kg 6.71 kg
L-Tyrosine 5.08 kg 5.08 kg 5.08 kg 5.08 kg 5.08 kg
L-Tryptophan 4.67 kg 4.67 kg 4.67 kg 4.67 kg 4.67 kg
Choline Chloride 3.36 kg 3.36 kg 3.36 kg 3.36 kg 3.36 kg
Oil Soluble Vitamin Premix 2.37 kg 2.37 kg 2.37 kg 2.37 kg 2.37 kg
Ferrous Sulfate 2.32 kg 2.32 kg 2.32 kg 2.32 kg 2.32 kg
L-Carnitine 650 g 650 g 650 g 650 g 650 g
Riboflavin 87.9 g 87.9 g 87.9 g 87.9 g 87.9 g
Vitamin A Palmitate 17.6 g 17.6 g 17.6 g 17.6 g 17.6 g
Potassium Iodide 8.70 g 8.70 g 8.70 g 8.70 g 8.70 g
Examples 50-54
Ingredients Amount per 45359.24 kg
Example 50 Example 51 Example 52 Example 53 Example 54
Ingredient Water Q.S. Q.S. Q.S. Q.S. Q.S.
Sucrose 2007 kg 2007 kg 2007 kg 2007 kg 2007 kg
Pea Protein Hydrolysate 922.5 kg 820.0 kg 717.5 kg 615.0 kg 512.5 kg
Casein Hydrolysate 102.5 kg 205.0 kg 307.52 kg 410.0 kg 512.5 kg
Modified Tapioca Starch 989 kg 989 kg 989 kg 989 kg 989 kg
Safflower Oil 644 kg 644 kg 644 kg 644 kg 644 kg
Fractionated Coconut Oil 568 kg 568 kg 568 kg 568 kg 568 kg
Soy Oil 479 kg 479 kg 479 kg 479 kg 479 kg
5% KOH (processing aid) 187 kg 187 kg 187 kg 187 kg 187 kg
Calcium Citrate 69.9 kg 69.9 kg 69.9 kg 69.9 kg 69.9 kg
Calcium Phosphate Dibasic 48.1 kg 48.1 kg 48.1 kg 48.1 kg 48.1 kg
Carrageenan 45.4 kg 45.4 kg 45.4 kg 45.4 kg 45.4 kg
Potassium Phosphate Dibasic 26.2 kg 26.2 kg 26.2 kg 26.2 kg 26.2 kg
Ascorbic Acid 24.2 kg 24.2 kg 24.2 kg 24.2 kg 24.2 kg
Magnesium Chloride 18.6 kg 18.6 kg 18.6 kg 18.6 kg 18.6 kg
M. Alpina Oil (ARA Oil) 17.9 kg 17.9 kg 17.9 kg 17.9 kg 17.9 kg
Potassium Citrate 15.9 kg 15.9 kg 15.9 kg 15.9 kg 15.9 kg
Sodium Chloride 14.9 kg 14.9 kg 14.9 kg 14.9 kg 14.9 kg
Calcium Hydroxide 14.0 kg 14.0 kg 14.0 kg 14.0 kg 14.0 kg
L-Cystine Dihydrochloride 12.1 kg 12.1 kg 12.1 kg 12.1 kg 12.1 kg
Potassium Chloride 1 1.2 kg 11.2 kg 1 1.2 kg 1 1.2 kg 1 1.2 kg
Water Soluble Vitamin Premix 8.00 kg 8.00 kg 8.00 kg 8.00 kg 8.00 kg
C. Cohnii Oil (DHA Oil) 6.71 kg 6.71 kg 6.71 kg 6.71 kg 6.71 kg
L-Tyrosine 5.08 kg 5.08 kg 5.08 kg 5.08 kg 5.08 kg
L-Tryptophan 4.67 kg 4.67 kg 4.67 kg 4.67 kg 4.67 kg
Choline Chloride 3.36 kg 3.36 kg 3.36 kg 3.36 kg 3.36 kg
Oil Soluble Vitamin Premix 2.37 kg 2.37 kg 2.37 kg 2.37 kg 2.37 kg
Ferrous Sulfate 2.32 kg 2.32 kg 2.32 kg 2.32 kg 2.32 kg
L-Carnitine 650 g 650 g 650 g 650 g 650 g
Vitamin A Palmitate 17.6 g 17.6 g 17.6 g 17.6 g 17.6 g
Potassium Iodide 8.70 g 8.70 g 8.70 g 8.70 g 8.70 g
Examples 55-64
[0135] Examples 55-64 illustrate nutritional emulsions of the present disclosure, the ingredients of which are listed in the table below. To prepare the
nutritional emulsions, at least three separate slurries (e.g., CHO-MIN slurry, PIW
slurry, PIF slurry) are prepared and then blended together, heat-treated, homogenized, and standardized. The resulting composition is aseptically packaged into plastic
bottles or retort sterilized. The embodiments set forth below that include pea protein hydro lysates as the sole source of protein are hypoallergenic embodiments.
Ingredients Amounts (kg) per 1000 kg
Example 55 Example 56 Example 57 Example 58 Example 59
Water Q.S Q.S. Q.S. Q.S. Q.S.
Maltodextrin 120.0 120.0 120.0 120.0 120.0
Sucrose 71.38 71.38 71.38 71.38 71.38
Pea Protein Hydrolysate 62.88 66.02 59.74 69.17 56.59
Canola Oil 27.5 27.5 27.5 27.5 27.5
Corn Oil 15.70 15.70 15.70 15.70 15.70
Magnesium Phosphate 1.92 1.92 1.92 1.92 1.92
Potassium Citrate 6.92 6.92 6.92 6.92 6.92
Sodium Citrate 0.903 0.903 0.903 0.903 0.903
Lecithin 1.50 1.50 1.50 1.50 1.50
Sodium Tripolyphosphate 1.06 1.06 1.06 1.06 1.06
Potassium Phosphate dibasic 0.730 0.730 0.730 0.730 0.730
Potassium Chloride 1.04 1.04 1.04 1.04 1.04
Ascorbic Acid 0.235 0.235 0.235 0.235 0.235
Carrageenan 0.150 0.150 0.150 0.150 0.150
Potassium Hydroxide 0.136 0.136 0.136 0.136 0.136
TM UTM Premix 0.1684 0.1684 0.1684 0.1684 0.1684
Gellan Gum 0.050 0.050 0.050 0.050 0.050
Vitamin A,D, E Premix 0.0758 0.0758 0.0758 0.0758 0.0758
Water sol. Vitamin premix 0.0728 0.0728 0.0728 0.0728 0.0728
Potassium Iodide 0.00022 0.00022 0.00022 0.00022 0.00022
Chromium Chloride 0.000217 0.000217 0.000217 0.000217 0.000217
Flavor 3.3 3.3 3.3 3.3 3.3
Amounts (kg) per 1000 kg
Ingredients
Example 60 Example 61 Example 62 Example 63 Example 64
Water Q.S Q.S. Q.S. Q.S. Q.S.
Maltodextrin 120.0 120.0 120.0 120.0 120.0
Sucrose 71.38 71.38 71.38 71.38 71.38
Milk Protein Concentrate 9.33 7.46 5.60 3.73 1.87
Canola Oil 27.5 27.5 27.5 27.5 27.5
Pea Protein Hydrolysate 31.50 39.61 41.82 55.34 50.93
Sodium Caseinate 13.25 10.67 8.00 5.34 2.67
Soy Protein Concentrate 7.00 5.60 4.22 2.81 1.40
Corn Oil 15.70 15.70 15.70 15.70 15.70
Whey Protein Concentrate 1.75 1.40 1.05 0.70 0.35
Magnesium Phosphate 1.92 1.92 1.92 1.92 1.92
Potassium Citrate 6.92 6.92 6.92 6.92 6.92
Sodium Citrate 0.903 0.903 0.903 0.903 0.903
Lecithin 1.50 1.50 1.50 1.50 1.50
Sodium Tripolyphosphate 1.06 1.06 1.06 1.06 1.06
Potassium Phosphate dibasic 0.730 0.730 0.730 0.730 0.730
Potassium Chloride 1.04 1.04 1.04 1.04 1.04
Ascorbic Acid 0.235 0.235 0.235 0.235 0.235
Carrageenan 0.150 0.150 0.150 0.150 0.150
Potassium Hydroxide 0.136 0.136 0.136 0.136 0.136
TM UTM Premix 0.1684 0.1684 0.1684 0.1684 0.1684
Gellan Gum 0.050 0.050 0.050 0.050 0.050
Vitamin A,D, E Premix 0.0758 0.0758 0.0758 0.0758 0.0758
Water sol. Vitamin premix 0.0728 0.0728 0.0728 0.0728 0.0728
Potassium Iodide 0.00022 0.00022 0.00022 0.00022 0.00022
Chromium Chloride 0.000217 0.000217 0.000217 0.000217 0.000217
Flavor 3.3 3.3 3.3 3.3 3.3
Examples 65-74
[0136] Examples 65-74 illustrate substantially clear nutritional liquids of the present disclosure, the ingredients of which are listed in the table below. To prepare the nutritional liquids, at least two separate slurries (e.g., CHO-MIN slurry and PIW slurry) are prepared and then blended together, heat-treated, homogenized, and standardized. The resulting composition is aseptically packaged into plastic bottles or retort sterilized. The embodiments set forth below that include pea protein
hydro lysates as the sole source of protein are hypoallergenic embodiments.
Ingredients Amounts (kg) per 1000 kg
Example 65 Example 66 Example 67 Example 68 Example 69
Water Q.S. Q.S. Q.S. Q.S. Q.S.
Sucrose 109.0 109.0 0 54.5 54.5
Isomaltulose 0 0 109.0 54.5 54.5
Pea Protein Hydrolysate 42.90 45.05 40.76 47.19 38.61
Phosphoric Acid 2.0 2.0 2.0 2.0 2.0
Citric Acid 1.4 1.4 1.4 1.4 1.4
N&A Apple Flavor 700 g 700 g 700 g 700 g 700 g
Ascorbic Acid 535 g 535 g 535 g 535 g 535 g
Caramel Liquid Color 400 g 400 g 400 g 400 g 400 g
UTM/TM Premix 230 g 230 g 230 g 230 g 230 g
Zinc Sulfate monohydrate* 52.1 g 52.1 g 52.1 g 52.1 g 52.1 g
Ferrous Sulfate* 40.8 g 40.8 g 40.8 g 40.8 g 40.8 g
Citric Acid* 14.2 g 14.2 g 14.2 g 14.2 g 14.2 g
Manganese sulfate* 13.0 13.0 13.0 13.0 13.0
Copper Sulfate* 7.1 g 7.1 g 7.1 g 7.1 g 7.1 g
Chromium Chloride* 430 mg 430 mg 430 mg 430 mg 430 mg
Sodium Molybdate* 339 mg 339 mg 339 mg 339 mg 339 mg
Sodium Selenate* 146 mg 146 mg 146 mg 146 mg 146 mg
Water Dispersible ADEK Premix 178 g 178 g 178 g 178 g 178 g di-Alpha-Tocopheryl Acetate** 45.3 g 45.3 g 45.3 g 45.3 g 45.3 g
Vitamin A Palmitate** 4.2 g 4.2 g 4.2 g 4.2 g 4.2 g
Phylloquinone * * 127 mg 127 mg 127 mg 127 mg 127 mg
Vitamin D3** 23 mg 23 mg 23 mg 23 mg 23 mg
WSV Vitamin Premix 37.9 g 37.9 g 37.9 g 37.9 g 37.9 g
Niacinamide*** 14.2 g 14.2 g 14.2 g 14.2 g 14.2 g d-Calcium pantothenate*** 9.2 g 9.2 g 9.2 g 9.2 g 9.2 g
Thiamine chloride hydrochloride*** 2.4 g 2.4 g 2.4 g 2.4 g 2.4 g
Pyridoxine hydrochloride*** 2.3 g 23 g 2.3 g 2.3 g 2.3 g
*UTM/TM Premix; "ADEK Premix; ***WSV Vitamin Premix
Ingredients Amounts (kg) per 1000 kg
Example 70 Example 71 Example 72 Example 73 Example 74
Water Q.S. Q.S. Q.S. Q.S. Q.S.
Sucrose 109.0 109.0 0 54.5 54.5
Isomaltulose 0 0 109.0 54.5 54.5
Pea Protein Hydrolysate 21.45 27.03 28.53 37.75 34.75
Whey Protein Isolate 18.59 12.87 1 1.15 6.24 3.44
Hydrolyzed Casein 2.86 4.29 1.72 2.14 0.75
Phosphoric Acid 2.0 2.0 2.0 2.0 2.0
Citric Acid 1.4 1.4 1.4 1.4 1.4
N&A Apple Flavor 700 g 700 g 700 g 700 g 700 g
Ascorbic Acid 535 g 535 g 535 g 535 g 535 g
Caramel Liquid Color 400 g 400 g 400 g 400 g 400 g
UTM/TM Premix 230 g 230 g 230 g 230 g 230 g
Zinc Sulfate monohydrate* 52.1 g 52.1 g 52.1 g 52.1 g 52.1 g
Ferrous Sulfate* 40.8 g 40.8 g 40.8 g 40.8 g 40.8 g
Citric Acid* 14.2 g 14.2 g 14.2 g 14.2 g 14.2 g
Manganese sulfate* 13.0 13.0 13.0 13.0 13.0
Copper Sulfate* 7.1 g 7.1 g 7.1 g 7.1 g 7.1 g
Chromium Chloride* 430 mg 430 mg 430 mg 430 mg 430 mg
Sodium Molybdate* 339 mg 339 mg 339 mg 339 mg 339 mg
Sodium Selenate* 146 mg 146 mg 146 mg 146 mg 146 mg
Water Dispersible ADEK Premix 178 g 178 g 178 g 178 g 178 g di-Alpha-Tocopheryl Acetate** 45.3 g 45.3 g 45.3 g 45.3 g 45.3 g
Vitamin A Palmitate** 4.2 g 4.2 g 4.2 g 4.2 g 4.2 g
Phylloquinone * * 127 mg 127 mg 127 mg 127 mg 127 mg
Vitamin D3** 23 mg 23 mg 23 mg 23 mg 23 mg
WSV Vitamin Premix 37.9 g 37.9 g 37.9 g 37.9 g 37.9 g
Niacinamide*** 14.2 g 14.2 g 14.2 g 14.2 g 14.2 g d-Calcium pantothenate*** 9.2 g 9.2 g 9.2 g 9.2 g 9.2 g
Thiamine chloride hydrochloride*** 2.4 g 2.4 g 2.4 g 2.4 g 2.4 g
Pyridoxine hydrochloride*** 2.3 g 23 g 2.3 g 2.3 g 2.3 g
Riboflavin*** 1.8 g 1.8 g 1.8 g 1.8 g 1.8 g
Folic Acid*** 350 mg 350 mg 350 mg 350 mg 350 mg
Biotin*** 277 mg 277 mg 277 mg 277 mg 277 mg
Cyanocobalamin* * * 6.3 mg 6.3 mg 6.3 mg 6.3 mg 6.3 mg
Folic Acid 1.3 g 1.3 g 1.3 g 1.3 g 1.3 g
Potassium Iodide 204 mg 204 mg 204 mg 204 mg 204 mg
Beta-Alanine 0 0 0 1.0 1.0
*UTM/TM Premix; "ADEK Premix; ***WSV Vitamin Premix
Examples 75-84
[0137] In Examples 75-84 illustrate concentrated liquid human milk fortifiers of the present disclosure, the ingredients of which are listed in the table
below. To prepare the concentrated liquid human milk fortifiers, at least three separate slurries (e.g., CHO-MIN slurry and PIW slurry) are prepared and then blended
together. The embodiments set forth below that include pea protein hydrolysates as the sole source of protein are hypoallergenic embodiments.
Ingredients Amount per 1000 lbs
Example 75 Example 76 Example 77 Example 78 Example 79
Water Q.S. Q.S. Q.S. Q.S. Q.S.
Pea Protein Hydrolysate 104.6 lb 99.4 lb 109.8 lb 94.1 lb 115.1 lb
Maltodextrin 93.01b 93.0 lb 93.0 lb 93.01b 93.0 lb
MCT Oil 21.61b 21.61b 21.61b 21.61b 21.6 lb
Ultra Micronized Tricalcium Phosphate 17.81b 17.81b 17.8 lb 17.8 lb 17.81b
Soy Oil 12.9 lb 12.9 lb 12.9 lb 12.9 lb 12.9 lb
OSA-Modified Corn Starch 12.0 lb 12.01b 12.01b 12.01b 12.0 lb
Coconut Oil 7.91b 7.91b 7.91b 7.91b 7.91b
Potassium Citrate 7.01b 7.01b 7.01b 7.01b 7.01b
Ascorbic Acid 5.41b 5.41b 5.41b 5.41b 5.41b
Magnesium Chloride 3.91b 3.91b 3.91b 3.91b 3.91b
ARA 3.41b 3.41b 3.41b 3.41b 3.41b
L-Leucine 2.8 lb 2.81b 2.81b 2.81b 2.81b
DHA 2.61b 2.6 lb 2.6 lb 2.61b 2.61b
Potassium Chloride 1.61b 1.61b 1.61b 1.61b 1.61b
L-Tyrosine 1.41b 1.41b 1.41b 1.41b 1.41b
Distilled Monoglycerides 1.01b 1.01b 1.01b 1.01b 1.01b
Nucleotide/Choline Premix 399.0 g 399.0 g 399.0 g 399.0 g 399.0 g
M-Inositol 296.0 g 296.0 g 296.0 g 296.0 g 296.0 g
Sodium Chloride 246.3 g 246.3 g 246.3 g 246.3 g 246.3 g
L-Carnitine 147.0 g 147.0 g 147.0 g 147.0 g 147.0 g
Zinc Sulfate 127.0 g 127.0 g 127.0 g 127.0 g 127.0 g
Niacinamide 124.0 g 124.0 g 124.0 g 124.0 g 124.0 g dl-Alpha-Tocopheryl Acetate 114.0g 114.0g 114.0g 114.0g 114.0g
Gellan Gum 90.7 g 90.7 g 90.7 g 90.7 g 90.7 g
Ferrous Sulfate 56.0 g 56.0 g 56.0 g 56.0 g 56.0 g
Choline Chloride 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g
Calcium Pantothenate 39.3 g 39.3 g 39.3 g 39.3 g 39.3 g
Vitamin A Palmitate 24.0 g 24.0 g 24.0 g 24.0 g 24.0 g
Riboflavin 9.4 g 9.4 g 9.4 g 9.4 g 9.4 g
Vitamin D3 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g
Copper Sulfate 8.2 g 8.2 g 8.2 g 8.2 g 8.2 g
Pyridoxine Hydrochloride 6.3 g 6.3 g 6.3 g 6.3 g 6.3 g
Thiamin Hydrochloride 6.1 g 6.1 g 6.1 g 6.1 g 6.1 g
Lutein 2.5 g 2.5 g 2.5 g 2.5 g 2.5 g
Beta Carotene 1-7 g l-7g 1.7 g 1.7 g 1.7 g
Folic Acid 0.88 g 0.88 g 0.88 g 0.88 g 0.88 g
Biotin 0.74 g 0.74 g 0.74 g 0.74 g 0.74 g
Manganese Sulfate 06.8 g 06.8 g 06.8 g 06.8 g 06.8 g
Phylloquinone 031 g 0.31 g 0.31 g 0.31 g 0.31 g
Sodium Selenate 0.06 g 0.06 g 0.06 g 0.06 g 0.06 g
Cyanocobalamin 0.02 g 0.02 g 0.02 g 0.02 g 0.02 g
Ingredients Amount per 1000 lbs
Example 80 Example 81 Example 82 Example 83 Example 84
Water Q.S. Q.S. Q.S. Q.S. Q.S.
Pea Protein Hydrolysate 52.3 lb 62.76 lb 73.22 lb. 83.68 lb 94.141b
Calcium Hydrolysate 52.3 lb 41.841b 31.381b 20.92 lb 10.46 lb
Maltodextrin 93.0 lb 93.01b 93.0 lb 93.0 lb 93.01b
MCT Oil 21.6 lb 21.61b 21.61b 21.6 lb 21.61b
Ultra Micronized Tricalcium 17.81b 17.81b 17.8 lb 17.81b 17.81b Phosphate
Soy Oil 12.9 lb 12.9 lb 12.9 lb 12.9 lb 12.9 lb
OSA-Modified Corn Starch 12.0 lb 12.01b 12.01b 12.0 lb 12.01b
Coconut Oil 7.91b 7.91b 7.91b 7.91b 7.91b
Potassium Citrate 7.01b 7.01b 7.01b 7.01b 7.01b
Ascorbic Acid 5.41b 5.41b 5.41b 5.41b 5.41b
Magnesium Chloride 3.91b 3.91b 3.91b 3.91b 3.91b
ARA 3.41b 3.41b 3.41b 3.41b 3.41b
L-Leucine 2.8 lb 2.8 lb 2.8 lb 2.81b 2.81b
DHA 2.61b 2.61b 2.61b 2.61b 2.61b
Potassium Chloride 1.61b 1.61b 1.61b 1.61b 1.61b
L-Tyrosine 1.41b 1.41b 1.41b 1.41b 1.41b
Distilled Monoglycerides 1.01b 1.01b 1.01b 1.01b 1.01b
Nucleotide/Choline Premix 399.0 g 399.0 g 399.0 g 399.0 g 399.0 g
M-Inositol 296.0 g 296.0 g 296.0 g 296.0 g 296.0 g
Sodium Chloride 246.3 g 246.3 g 246.3 g 246.3 g 246.3 g
L-Carnitine 147.0 g 147.0 g 147.0 g 147.0 g 147.0 g
Zinc Sulfate 127.0 g 127.0 g 127.0 g 127.0 g 127.0 g
Niacinamide 124.0 g 124.0 g 124.0 g 124.0 g 124.0 g dl-Alpha-Tocopheryl Acetate 114.0g 114.0g 114.0 g 114.0g 114.0g
Gellan Gum 90.7 g 90.7 g 90.7 g 90.7 g 90.7 g
Ferrous Sulfate 56.0 g 56.0 g 56.0 g 56.0 g 56.0 g
Choline Chloride 48.0 g 48.0 g 48.0 g 48.0 g 48.0 g
Calcium Pantothenate 39.3 g 39.3 g 39.3 g 39.3 g 39.3 g
Vitamin A Palmitate 24.0 g 24.0 g 24.0 g 24.0 g 24.0 g
Riboflavin 9.4 g 9.4 g 9.4 g 9.4 g 9.4 g
Vitamin D3 8.6 g 8.6 g 8.6 g 8.6 g 8.6 g
Copper Sulfate 8.2 g 8.2 g 8.2 g 8.2 g 8.2 g
Pyridoxine Hydrochloride 6.3 g 6.3 g 6.3 g 6.3 g 6.3 g
Thiamin Hydrochloride 6.1 g 6.1 g 6.1 g 6.1 g 6.1 g
Lutein 2.5 g 2.5 g 2.5 g 2.5 g 2.5 g
Beta Carotene 1 -7 g l -7 g 1-7 g 1 -7 g 1 -7 g
Folic Acid 0.88 g 0.88 g 0.88 g 0.88 g 0.88 g
Biotin 0.74 g 0.74 g 0.74 g 0.74 g 0.74 g
Manganese Sulfate 06.8 g 06.8 g 06.8 g 06.8 g 06.8 g
Phylloquinone 031 g 0.31 g 0.31 g 0.31 g 0.31 g
Sodium Selenate 0.06 g 0.06 g 0.06 g 0.06 g 0.06 g
Cyanocobalamin 0.02 g 0.02 g 0.02 g 0.02 g 0.02 g
Examples 85-94
[0138] The following examples illustrate a human milk fortifier powder, which is added to human milk that may be administered to an infant in accordance
with the methods of the present disclosure. Ingredients for manufacturing 8,172 kg of powdered human milk fortifier are listed in the table below.
Ingredients Quantity to formulate 8,172 kg of fortifier
Example 85 Example 86 Example 87 Example 88 Example 89
Ingredient Water 16,205 L 16,205 L 16,205 L 16,205 L 16,205 L
Corn syrup solids 1603 kg 1603 kg 1603 kg 1603 kg 1603 kg
Magnesium chloride 96.2 kg 96.2 kg 96.2 kg 96.2 kg 96.2 kg
Potassium citrate 223.8 kg 223.8 kg 223.8 kg 223.8 kg 223.8 kg
Sodium citrate 6.6 kg 6.6 kg 6.6 kg 6.6 kg 6.6 kg
Sodium chloride 15.4 kg 15.4 kg 15.4 kg 15.4 kg 15.4 kg
MTC oil 801 kg 801 kg 801 kg 801 kg 801 kg
Lecithin 16.6 kg 16.6 kg 16.6 kg 16.6 kg 16.6 kg
Vitamin A 2.36 kg 2.36 kg 2.36 kg 2.36 kg 2.36 kg
Vitamin D 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g
Vitamin K 27.5 g 27.5 g 27.5 g 27.5 g 27.5 g
Tocopherol acetate 15.8 kg 15.8 kg 15.8 kg 15.8 kg 15.8 kg
Calcium carbonate 33.1 kg 33.1 kg 33.1 kg 33.1 kg 33.1 kg
Tricalcium phosphate 646 kg 646 kg 646 kg 646 kg 646 kg
Pea Protein Hydrolysate 2696.5 kg 2561.7 kg 2831.3 kg 2426.9 kg 2966.2 kg
Potassium citrate 257.2 g 257.2 g 257.2 g 257.2 g 257.2 g
Ferrous sulfate 3.7 kg 3.7 kg 3.7 kg 3.7 kg 3.7 kg
Zinc sulfate 11.1 kg 1 1.1 kg 1 1.1 kg 1 1.1 kg 1 1.1 kg
Copper sulfate 1.84 kg 1.84 kg 1.84 kg 1.84 kg 1.84 kg
Manganese sulfate 0.320 kg 0.320 kg 0.320 kg 0.320 kg 0.320 kg
Sodium selenate 0.001 kg 0.001 kg 0.001 kg 0.001 kg 0.001 kg
Ingredients Quantity to formulate 8,172 kg of fortifier
Niacinamide 0.98 kg 0.98 kg 0.98 kg 0.98 kg 0.98 kg
Riboflavin 1.14 kg 1.14 kg 1.14 kg 1.14 kg 1.14 kg
Calcium pantothenate 4.08 kg 4.08 kg 4.08 kg 4.08 kg 4.08 kg
Pyridoxine 0.655 kg 0.655 kg 0.655 kg 0.655 kg 0.655 kg hydrochloride
m-inositol 9.55 kg 9.55 kg 9.55 kg 9.55 kg 9.55 kg
Biotin 0.0727 kg 0.0727 kg 0.0727 kg 0.0727 kg 0.0727 kg
Folic acid 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg
Cyanocobalamin 0.0016 kg 0.0016 kg 0.0016 kg 0.0016 kg 0.0016 kg
Ascorbic acid 153.5 kg 153.5 kg 153.5 kg 153.5 kg 153.5 kg
Ingredients Quantity to formulate 8,172 kg of fortifier
Example 90 Example 91 Example 92 Example 93 Example 94
Ingredient Water 16,205 L 16,205 L 16,205 L 16,205 L 16,205 L
Corn syrup solids 1603 kg 1603 kg 1603 kg 1603 kg 1603 kg
Magnesium chloride 96.2 kg 96.2 kg 96.2 kg 96.2 kg 96.2 kg
Potassium citrate 223.8 kg 223.8 kg 223.8 kg 223.8 kg 223.8 kg
Sodium citrate 6.6 kg 6.6 kg 6.6 kg 6.6 kg 6.6 kg
Sodium chloride 15.4 kg 15.4 kg 15.4 kg 15.4 kg 15.4 kg
MTC oil 801 kg 801 kg 801 kg 801 kg 801 kg
Lecithin 16.6 kg 16.6 kg 16.6 kg 16.6 kg 16.6 kg
Vitamin A 2.36 kg 2.36 kg 2.36 kg 2.36 kg 2.36 kg
Vitamin D 359.3 g 359.3 g 359.3 g 359.3 g 359.3 g
Vitamin K 27.5 g 27.5 g 27.5 g 27.5 g 27.5 g
Tocopherol acetate 15.8 kg 15.8 kg 15.8 kg 15.8 kg 15.8 kg
Calcium carbonate 33.1 kg 33.1 kg 33.1 kg 33.1 kg 33.1 kg
Tricalcium phosphate 646 kg 646 kg 646 kg 646 kg 646 kg
Pea Protein Hydrolysate 1348.3 kg 1537.0 kg 1981.9 kg 1941.5 kg 2669.58 kg
Soy protein concentrate 753.0 kg 602.4 kg 451.8 kg 301.2 kg 150.6 kg
Non fat dry milk 1653.5 kg 1322.8 kg 992.1 kg 661.4 kg 3.31 kg
Potassium citrate 257.2 g 257.2 g 257.2 g 257.2 g 257.2 g
Ferrous sulfate 3.7 kg 3.7 kg 3.7 kg 3.7 kg 3.7 kg
Zinc sulfate 1 1.1 kg 1 1.1 kg 1 1.1 kg 1 1.1 kg 1 1.1 kg
Copper sulfate 1.84 kg 1.84 kg 1.84 kg 1.84 kg 1.84 kg
Manganese sulfate 0.320 kg 0.320 kg 0.320 kg 0.320 kg 0.320 kg
Sodium selenate 0.001 kg 0.001 kg 0.001 kg 0.001 kg 0.001 kg
Niacinamide 0.98 kg 0.98 kg 0.98 kg 0.98 kg 0.98 kg
Riboflavin 1.14 kg 1.14 kg 1.14 kg 1.14 kg 1.14 kg
Calcium pantothenate 4.08 kg 4.08 kg 4.08 kg 4.08 kg 4.08 kg
Pyridoxine hydrochloride 0.655 kg 0.655 kg 0.655 kg 0.655 kg 0.655 kg
m-inositol 9.55 kg 9.55 kg 9.55 kg 9.55 kg 9.55 kg
Biotin 0.0727 kg 0.0727 kg 0.0727 kg 0.0727 kg 0.0727 kg
Folic acid 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg
Cyanocobalamin 0.0016 kg 0.0016 kg 0.0016 kg 0.0016 kg 0.0016 kg
Ascorbic acid 153.5 kg 153.5 kg 153.5 kg 153.5 kg 153.5 kg
Examples 95-104
[0139] In these Examples, a gelled human milk fortifier is prepared in
accordance with the present disclosure. The ingredients for the gelled human milk
fortifier are shown in the following table.
[0140] The gelled human milk fortifier is prepared by solubilizing and
combining ingredients into a homogeneous aqueous mixture which is subjected to an
adequate heat treatment to achieve long term shelf stability.
[0141] To begin the manufacturing process, the ingredients that supply the
macronutrients (carbohydrate, protein, fat and minerals) are combined in multiple
slurries together and with water. This blend is subjected to an initial heat treatment
and then tested to verify proper nutrient levels.
Ingredients Quantity to formulate 32,000 lbs of fortifier
Example 95 Example 96 Example 97 Example 98 Example 99
Water Q.S. Q.S. Q.S. Q.S. Q.S.
Corn Maltodextrin 1450 kg 1450 kg 1450 kg 1450 kg 1450 kg
Corn Syrup Solids 1388 kg 1388 kg 1388 kg 1388 kg 1388 kg
Medium Chain triglycerides 694 kg 694 kg 694 kg 694 kg 694 kg
Pea Protein Hydrolysate 1944.4 kg 1847.18 kg 2041.6 kg 1750.0 kg 2138.8 kg
Calcium Phosphate 271 kg 271 kg 271 kg 271 kg 271 kg
Ascorbic Acid 152 kg 152 kg 152 kg 152 kg 152 kg
Magnesium Chloride 38.0 kg 38.0 kg 38.0 kg 38.0 kg 38.0 kg
Potassium Citrate 12.2 kg 12.2 kg 12.2 kg 12.2 kg 12.2 kg
Sodium Chloride 12.1 kg 12.1 kg 12.1 kg 12.1 kg 12.1 kg
Soy Lecithin 8.84 kg 8.84 kg 8.84 kg 8.84 kg 8.84 kg
M-Inositol 7.98 kg 7.98 kg 7.98 kg 7.98 kg 7.98 kg
Magnesium Phosphate 5.55 kg 5.55 kg 5.55 kg 5.55 kg 5.55 kg
M. Alpina Oil 5.35 kg 5.35 kg 5.35 kg 5.35 kg 5.35 kg
Niacinamide 4.35 kg 4.35 kg 4.35 kg 4.35 kg 4.35 kg
Alpha-Tocopheryl Acetate 4.21 kg 4.21 kg 4.21 kg 4.21 kg 4.21 kg
Zinc Sulfate 3.51 kg 3.51 kg 3.51 kg 3.51 kg 3.51 kg
C. Cohnii Oil 3.45 kg 3.45 kg 3.45 kg 3.45 kg 3.45 kg
Choline Chloride 2.90 kg 2.90 kg 2.90 kg 2.90 kg 2.90 kg
Calcium Pantothenate 1.89 kg 1.89 kg 1.89 kg 1.89 kg 1.89 kg
Potassium Phosphate 1.62 kg 1.62 kg 1.62 kg 1.62 kg 1.62 kg
Ferrous Sulfate 1.64 kg 1.64 kg 1.64 kg 1.64 kg 1.64 kg
Vitamin A Palmitate 900 g 900 g 900 g 900 g 900 g
Cupric Sulfate 678 g 678 g 678 g 678 g 678 g
Riboflavin 572 g 572 g 572 g 572 g 572 g
Thiamine Hydrochloride 373 g 373 g 373 g 373 g 373 g
Pyridoxine Hydrochloride 232 g 232 g 232 g 232 g 232 g
Vitamin D3 152 g 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg
Folic Acid 47.9 g 0.0016 kg 0.0016 kg 0.0016 kg 0.0016 kg
Biotin 34.1 g 153.5 kg 153.5 kg 153.5 kg 153.5 kg
Manganese Sulfate 23.2 g 23.2 g 23.2 g 23.2 g 23.2 g
Phylloquinone 1 1.6 g 1 1.6 g 11.6 g 1 1.6 g 1 1.6 g
Cyanocobalamin 1.60 g 1.60 g 1.60 g 1.60 g 1.60 g
Sodium Selenate 0.798 g 0.798 g 0.798 g 0.798 g 0.798 g
Calcium Carbonate as needed as needed as needed as needed as needed
Sodium Citrate as needed as needed as needed as needed as needed
Potassium Hydroxide as needed as needed as needed as needed as needed
Ingredients Quantity to formulate 32,000 lbs of fortifier
Example 100 Example 101 Example 102 Example 103 Example 104
Water Q.S. Q.S. Q.S. Q.S. Q.S.
Condensed Skim Milk 2625 kg 2100 kg 1575 kg 1050 kg 525 kg
Non-Fat Milk Solids 682.5 kg 546 kg 409.5 kg 273 kg 136.5 kg
Corn Maltodextrin 1450 kg 1450 kg 1450 kg 1450 kg 1450 kg
Corn Syrup Solids 1388 kg 1388 kg 1388 kg 1388 kg 1388 kg
Medium Chain triglycerides 694 kg 694 kg 694 kg 694 kg 694 kg
Pea Protein Hydrolysate 972.2 kg 1 166.6 kg 1361.1 kg 1555.5 kg 1750.0 kg
Whey Protein Concentrate 317 kg 253.6 kg 190.2 kg 126.8 kg 63.4 kg
Calcium Phosphate 271 kg 271 kg 271 kg 271 kg 271 kg
Ascorbic Acid 152 kg 152 kg 152 kg 152 kg 152 kg
Magnesium Chloride 38.0 kg 38.0 kg 38.0 kg 38.0 kg 38.0 kg
Potassium Citrate 12.2 kg 12.2 kg 12.2 kg 12.2 kg 12.2 kg
Sodium Chloride 12.1 kg 12.1 kg 12.1 kg 12.1 kg 12.1 kg
Soy Lecithin 8.84 kg 8.84 kg 8.84 kg 8.84 kg 8.84 kg
M-Inositol 7.98 kg 7.98 kg 7.98 kg 7.98 kg 7.98 kg
Magnesium Phosphate 5.55 kg 5.55 kg 5.55 kg 5.55 kg 5.55 kg
M. Alpina Oil 5.35 kg 5.35 kg 5.35 kg 5.35 kg 5.35 kg
Niacinamide 4.35 kg 4.35 kg 4.35 kg 4.35 kg 4.35 kg
Alpha-Tocopheryl Acetate 4.21 kg 4.21 kg 4.21 kg 4.21 kg 4.21 kg
Zinc Sulfate 3.51 kg 3.51 kg 3.51 kg 3.51 kg 3.51 kg
C. Cohnii Oil 3.45 kg 3.45 kg 3.45 kg 3.45 kg 3.45 kg
Choline Chloride 2.90 kg 2.90 kg 2.90 kg 2.90 kg 2.90 kg
Calcium Pantothenate 1.89 kg 1.89 kg 1.89 kg 1.89 kg 1.89 kg
Potassium Phosphate 1.62 kg 1.62 kg 1.62 kg 1.62 kg 1.62 kg
Ferrous Sulfate 1.64 kg 1.64 kg 1.64 kg 1.64 kg 1.64 kg
Vitamin A Palmitate 900 g 900 g 900 g 900 g 900 g
Cupric Sulfate 678 g 678 g 678 g 678 g 678 g
Riboflavin 572 g 572 g 572 g 572 g 572 g
Thiamine Hydrochloride 373 g 373 g 373 g 373 g 373 g
Pyridoxine Hydrochloride 232 g 232 g 232 g 232 g 232 g
Vitamin D3 152 g 0.0775 kg 0.0775 kg 0.0775 kg 0.0775 kg
Folic Acid 47.9 g 0.0016 kg 0.0016 kg 0.0016 kg 0.0016 kg
Biotin 34.1 g 153.5 kg 153.5 kg 153.5 kg 153.5 kg
Manganese Sulfate 23.2 g 23.2 g 23.2 g 23.2 g 23.2 g
Phylloquinone 1 1.6 g 1 1.6 g 11.6 g 1 1.6 g 1 1.6 g
Cyanocobalamin 1.60 g 1.60 g 1.60 g 1.60 g 1.60 g
Sodium Selenate 0.798 g 0.798 g 0.798 g 0.798 g 0.798 g
Calcium Carbonate as needed as needed as needed as needed as needed
Sodium Citrate as needed as needed as needed as needed as needed
Potassium Hydroxide as needed as needed as needed as needed as needed
Examples 105-114
[0142] Examples 105-114 illustrate nutritional powders of the present disclosure, the ingredients of which are listed in the table below. These products are prepared by spray drying methods in separate batches, are reconstituted with water prior to use to the desired target ingredient concentrations. All ingredient amounts are listed as kg per 1000 kg batch of product, unless otherwise specified.
Ingredients Amounts (kg) per 1000 kg
Example 105 Example 106 Example 107 Example 108 Example 109
Maltrin 436.7 436.7 436.7 436.7 436.7
Sucrose 145.5 145.5 145.5 145.5 145.5
Pea Protein 186.8 177.5 196.14 168.12 205.5 Hydrolysate
Conjugated Linoleic 67.0 63.65 70.35 60.3 73.7 Acid
FOS Powder 33.6 33.6 33.6 33.6 33.6
High oleic sunflower 33.1 33.1 33.1 33.1 33.1 oil
Calcium β-hydroxy- 31.6 31.6 31.6 31.6 31.6 β-methylbutarate
Canola Oil 28.3 28.3 28.3 28.3 28.3
Soy Oil 13.3 13.3 13.3 13.3 13.3
Potassium Citrate 10.3 10.3 10.3 10.3 10.3
Sodium Citrate 5.8 5.8 5.8 5.8 5.8
Potassium Chloride 5.2 5.2 5.2 5.2 5.2
Magnesium 4.7 4.7 4.7 4.7 4.7 Chloride
Potassium 3.1 3.1 3.1 3.1 3.1 hydroxide
Sodium phosphate 3.0 3.0 3.0 3.0 3.0 dibasic dehydrate
Sodium chloride 2.5 2.5 2.5 2.5 2.5
Choline Chloride 1.8 1.8 1.8 1.8 1.8
Natural and 1.8 1.8 1.8 1.8 1.8 Artificial Vanilla
Flavor
Sodium phosphate 1.6 1.6 1.6 1.6 1.6 monobasic
monohydrate
Potassium 1.1 1.1 1.1 1.1 1.1 phosphate dibasic
trihydrate
Art. Cotton candy 1.0 1.0 1.0 1.0 1.0 flavor
Vitamin premix 1.0 1.0 1.0 1.0 1.0
Ascorbyl plamitate 0.2437 0.2437 0.2437 0.2437 0.2437
Ascorbic acid 0.2400 0.2400 0.2400 0.2400 0.2400
Tocopherol-2 food 0.1161 0.1161 0.1 161 0.1161 0.1161 grade antioxidant
Ferrous sulfate 0.0929 0.0929 0.0929 0.0929 0.0929
Vitamin premix 0.065 0.065 0.065 0.065 0.065
Zinc sulfate 0.057 0.057 0.057 0.057 0.057 monohydrate
Manganese sulfate 0.0454 0.0454 0.0454 0.0454 0.0454
Mineral mix copper 0.0353 0.0353 0.0353 0.0353 0.0353 sulfate
Beta carotene 30% 0.0056 0.0056 0.0056 0.0056 0.0056
Chromium chloride 0.0013 0.0013 0.0013 0.0013 0.0013
Sodium molybdate 0.0012 0.0012 0.0012 0.0012 0.0012
Potassium iodide 0.001 0.001 0.001 0.001 0.001
Sodium selenite 0.0004008 0.0004008 0.0004008 0.0004008 0.0004008
Citric acid As needed As needed As needed As needed As needed
Potassium As needed As needed As needed As needed As needed hydroxide
Magnesium sulfate As needed As needed As needed As needed As needed dry
Ultra micronized As needed As needed As needed As needed As needed tricalcium
phosphate
Ascorbic acid As needed As needed As needed As needed As needed
Water q.s. q.s. q.s. q.s. q.s.
Ingredients Amounts (kg) per 1000 kg
Example 110 Example 111 Example 112 Example 113 Example 114
Malodextrin 436.7 436.7 436.7 436.7 436.7
Sucrose 145.5 145.5 145.5 145.5 145.5
Calcium Caseinate 64.6 51.6 38.7 25.8 12.91
Pea Protein 93.4 1 12.1 130.8 149.4 168.1 Hydrolysate
Conjugated Linoleic 67.0 63.65 70.35 60.3 73.7 Acid
Isolated Soy Protein 28.8 23.1 17.3 1 1.5 5.77
FOS Powder 33.6 33.6 33.6 33.6 33.6
High oleic sunflower 33.1 33.1 33.1 33.1 33.1 oil
Calcium β-hydroxy- 31.6 31.6 31.6 31.6 31.6 β-methylbutarate
Canola Oil 28.3 28.3 28.3 28.3 28.3
Soy Oil 13.3 13.3 13.3 13.3 13.3
Potassium Citrate 10.3 10.3 10.3 10.3 10.3
Sodium Citrate 5.8 5.8 5.8 5.8 5.8
Potassium Chloride 5.2 5.2 5.2 5.2 5.2
Magnesium 4.7 4.7 4.7 4.7 4.7 Chloride
Potassium 3.1 3.1 3.1 3.1 3.1 hydroxide
Sodium phosphate 3.0 3.0 3.0 3.0 3.0 dibasic dehydrate
Sodium chloride 2.5 2.5 2.5 2.5 2.5
Choline Chloride 1.8 1.8 1.8 1.8 1.8
Natural and 1.8 1.8 1.8 1.8 1.8 Artificial Vanilla
Flavor
Sodium phosphate 1.6 1.6 1.6 1.6 1.6 monobasic
monohydrate
Potassium 1.1 1.1 1.1 1.1 1.1 phosphate dibasic
trihydrate
Art. Cotton candy 1.0 1.0 1.0 1.0 1.0 flavor
Vitamin premix 1.0 1.0 1.0 1.0 1.0
Ascorbyl plamitate 0.2437 0.2437 0.2437 0.2437 0.2437
Ascorbic acid 0.2400 0.2400 0.2400 0.2400 0.2400
Tocopherol-2 food 0.1161 0.1161 0.1 161 0.1161 0.1161 grade antioxidant
Ferrous sulfate 0.0929 0.0929 0.0929 0.0929 0.0929
Vitamin premix 0.065 0.065 0.065 0.065 0.065
Zinc sulfate 0.057 0.057 0.057 0.057 0.057 monohydrate
Manganese sulfate 0.0454 0.0454 0.0454 0.0454 0.0454
Mineral mix copper 0.0353 0.0353 0.0353 0.0353 0.0353 sulfate
Beta carotene 30% 0.0056 0.0056 0.0056 0.0056 0.0056
Chromium chloride 0.0013 0.0013 0.0013 0.0013 0.0013
Sodium molybdate 0.0012 0.0012 0.0012 0.0012 0.0012
Potassium iodide 0.001 0.001 0.001 0.001 0.001
Sodium selenite 0.0004008 0.0004008 0.0004008 0.0004008 0.0004008
Citric acid As needed As needed As needed As needed As needed
Potassium As needed As needed As needed As needed As needed hydroxide
Magnesium sulfate As needed As needed As needed As needed As needed dry
Ultra micronized As needed As needed As needed As needed As needed tricalcium
phosphate
Ascorbic acid As needed As needed As needed As needed As needed
Water q.s. q.s. q.s. q.s. q.s.
Claims
1. A nutritional product comprising a pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% and less than 19.0%.
2. The nutritional product of claim 1 wherein the pea protein hydrolysate has an adjusted degree of hydrolysis of between about 8.0%> and about 16.0%.
3. The nutritional product of claim 1 wherein less than 5% of the proteins in the pea protein hydrolysate have a molecular weight of greater than 3 kDa.
4. The nutritional product of claim 3 wherein from about 1% to about 5% of the proteins in the pea protein hydrolysate have a molecular weight of greater than 3 kDa.
5. The nutritional product of claim 1 wherein the product is a hypoallergenic product selected from the group consisting of a preterm infant formula, a human milk fortifier, and an infant formula.
6. The nutritional product of claim 2 further comprising a fat and a carbohydrate.
7. The nutritional product of claim 6 comprising from about 0.5% to about 30% by weight of protein.
8. The nutritional product of claim 7 comprising from about 1% to about 30% by weight of fat.
9. The nutritional product of claim 8 comprising from about 5% to about 40% by weight of carbohydrate.
10. A method of making a nutritional product comprising combining a protein and a carbohydrate, wherein the protein comprises a pea protein hydrolysate having an adjusted degree of hydrolysis of between about 7.0% and less than 19.0%.
11. The method of claim 10 further comprising combining a fat with the protein and the carbohydrate.
12. A method of making a hypoallergenic infant formula having improved taste comprising combining a protein and a carbohydrate, wherein the protein comprises from about 50% to about 100% by weight of a pea protein hydro lysate having an adjusted degree of hydrolysis of between about 7.0%> and less than 19.0%.
13. The method of claim 12 wherein the protein comprises from about 70% to about 90%) by weight of the pea protein hydrolysate.
14. The method of claim 12 further comprising combining a fat with the protein and the carbohydrate.
15. The method of claim 12 wherein the hypoallergenic infant formula comprises from about 0.5% to about 30% by weight total protein, from about 1% to about 30% by weight fat, and from about 5% to about 40% by weight of a carbohydrate.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37651410P | 2010-08-24 | 2010-08-24 | |
US37650910P | 2010-08-24 | 2010-08-24 | |
US61/376,509 | 2010-08-24 | ||
US61/376,514 | 2010-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012027287A1 true WO2012027287A1 (en) | 2012-03-01 |
Family
ID=44645787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/048665 WO2012027287A1 (en) | 2010-08-24 | 2011-08-22 | Nutritional products including pea protein hydrolysates |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW201212828A (en) |
WO (1) | WO2012027287A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016014519A1 (en) * | 2014-07-21 | 2016-01-28 | Abbott Laboratories | Nutrient delivery system |
CN109068691A (en) * | 2016-03-15 | 2018-12-21 | 可口可乐公司 | The chilled beverage composition of pea protein containing hydrolysis |
WO2019222000A1 (en) | 2018-05-15 | 2019-11-21 | Kate Farms Inc. | Hydrolyzed pea protein-based nutrient composition |
WO2021105287A1 (en) | 2019-11-26 | 2021-06-03 | Roquette Freres | Liquid food composition comprising pea or fava bean proteins and improved mineral profile for nutrition |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017129921A1 (en) * | 2016-01-29 | 2017-08-03 | Roquette Freres | Nutritional formulations comprising a pea protein isolate |
CN114395600B (en) * | 2022-01-14 | 2023-12-12 | 琛蓝(美国)营养制品股份有限公司 | Preparation method and application of multifunctional pea peptide |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015697A1 (en) * | 1991-03-07 | 1992-09-17 | Novo Nordisk A/S | Pea protein hydrolyzate, method for production thereof and use thereof |
US5514656A (en) * | 1993-05-28 | 1996-05-07 | Abbott Laboratories | Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy |
US6306908B1 (en) | 1997-02-21 | 2001-10-23 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
US6365218B1 (en) | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
US20030118703A1 (en) | 2001-12-12 | 2003-06-26 | Nguyen Minhthy Le | Methods and compositions for brightening the color of thermally processed nutritionals |
WO2004023896A1 (en) * | 2002-09-10 | 2004-03-25 | Abbott Laboratories | Infant formula |
WO2006130200A1 (en) * | 2005-06-01 | 2006-12-07 | Bristol-Myers Squibb Company | Methods for producing protein partial hydrolysates and infant formulas containing the same |
EP1911457A1 (en) * | 2006-10-12 | 2008-04-16 | N.V. Nutricia | Composition to treat or prevent gastrointestinal infection |
US20090098240A1 (en) | 2007-05-17 | 2009-04-16 | The Regents Of The University Of California | Human milk oligosaccharides to promote growth of beneficial gut bacteria |
-
2011
- 2011-08-22 WO PCT/US2011/048665 patent/WO2012027287A1/en active Application Filing
- 2011-08-24 TW TW100130367A patent/TW201212828A/en unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992015697A1 (en) * | 1991-03-07 | 1992-09-17 | Novo Nordisk A/S | Pea protein hydrolyzate, method for production thereof and use thereof |
US5514656A (en) * | 1993-05-28 | 1996-05-07 | Abbott Laboratories | Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy |
US6306908B1 (en) | 1997-02-21 | 2001-10-23 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
US6365218B1 (en) | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
US6589576B2 (en) | 2000-02-04 | 2003-07-08 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
US20030118703A1 (en) | 2001-12-12 | 2003-06-26 | Nguyen Minhthy Le | Methods and compositions for brightening the color of thermally processed nutritionals |
WO2004023896A1 (en) * | 2002-09-10 | 2004-03-25 | Abbott Laboratories | Infant formula |
WO2006130200A1 (en) * | 2005-06-01 | 2006-12-07 | Bristol-Myers Squibb Company | Methods for producing protein partial hydrolysates and infant formulas containing the same |
EP1911457A1 (en) * | 2006-10-12 | 2008-04-16 | N.V. Nutricia | Composition to treat or prevent gastrointestinal infection |
US20090098240A1 (en) | 2007-05-17 | 2009-04-16 | The Regents Of The University Of California | Human milk oligosaccharides to promote growth of beneficial gut bacteria |
Non-Patent Citations (2)
Title |
---|
L.M. HUMISKI AND R.E. ALUKO: "Physicochemical and Bitterness Propertiesof Enzymatic Pea Protein Hydrolysates", JOURNAL OF FOOD SCIENCE, vol. 72, no. 8, 2007, pages 605 - 611, XP002664213, DOI: 10.1111/j.1750-3841.2007.00475.x * |
R.J. FRACZEK, E. KOSTYRA, H. KOSTYRA AND S. KRAWCZUK: "Immunoreactive properties of pea protein extract and its trypsin hydrolysates", JOURNAL OF ANIMAL AND FEED SCIENCES, vol. 16, 2007, pages 472 - 484, XP002664212 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016014519A1 (en) * | 2014-07-21 | 2016-01-28 | Abbott Laboratories | Nutrient delivery system |
CN109068691A (en) * | 2016-03-15 | 2018-12-21 | 可口可乐公司 | The chilled beverage composition of pea protein containing hydrolysis |
WO2019222000A1 (en) | 2018-05-15 | 2019-11-21 | Kate Farms Inc. | Hydrolyzed pea protein-based nutrient composition |
CN112118748A (en) * | 2018-05-15 | 2020-12-22 | 凯特农场有限公司 | Hydrolyzed pea protein based nutritional composition |
WO2021105287A1 (en) | 2019-11-26 | 2021-06-03 | Roquette Freres | Liquid food composition comprising pea or fava bean proteins and improved mineral profile for nutrition |
CN114727626A (en) * | 2019-11-26 | 2022-07-08 | 罗盖特公司 | Liquid food composition comprising pea or broad bean proteins and improved nutritional mineral distribution |
Also Published As
Publication number | Publication date |
---|---|
TW201212828A (en) | 2012-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2808126C (en) | Nutritional products comprising pea protein and having improved taste | |
JP6857175B2 (en) | Liquid nutritional composition containing micelle casein and hydrolyzed whey protein | |
JP4838477B2 (en) | Carbohydrate formulation to enhance immune response (prebiotic adjuvant) | |
US20130337144A1 (en) | Nutritional products comprising calcium hmb and conjugated linoleic acid | |
TW201429477A (en) | Nutritional formulations using human milk oligosaccharides for modulating inflammation | |
CA2801339A1 (en) | Substantially clear nutritional liquids comprising calcium hmb and soluble protein | |
EP2230940A1 (en) | High energy liquid enteral nutritional composition | |
WO2012027287A1 (en) | Nutritional products including pea protein hydrolysates | |
KR20080012842A (en) | Methods for producing protein partial hydrolysates and infant formulas containing the same | |
CN104394714A (en) | Dietary management of celiac disease and food allergy | |
JP2016040274A (en) | Cardio-protective agent derived from kiwifruit | |
CN110312440A (en) | Protolysate and preparation method thereof | |
US20160037817A1 (en) | Composition comprising a multifunctional viscosity modifying agent | |
US20110129573A1 (en) | Soy Protein-Based Nutritional Formula with Superior Stability | |
US20180228196A1 (en) | High-energy and protein-enriched nutritional composition | |
US20200214330A1 (en) | Rice protein hydrolysates with anti-inflammatory properties | |
TW201519794A (en) | Low-buffer nutritional compositions and uses thereof | |
CA2890223A1 (en) | Stabilized liquid nutritionals including insoluble calcium salts | |
EP2422629A1 (en) | Methods for enhancing cognition and/or memory using maltodextrins | |
JP2015529470A (en) | Composition containing β-hydroxy-β-methylbutyric acid (METHYLBUTRYICACID) and use thereof | |
WO2017116805A1 (en) | Nutritional products comprising lutein | |
Giannetti et al. | Dietary management in atopic eczema |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11755472 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11755472 Country of ref document: EP Kind code of ref document: A1 |